Annotation Id	Term	Number of TFs	Proportion of times significant (p < 0.05)	Median Rank
WP3617	Photodynamic therapy-induced NF-kB survival signaling	30	0.37	153.5
WP3617	Photodynamic therapy-induced NF-kB survival signaling	20	0.284	242
WP45	G1 to S cell cycle control	30	0.283	244
WP4891	COVID-19 adverse outcome pathway	30	0.28	179
WP5095	Overview of proinflammatory and profibrotic mediators	30	0.271	351
WP179	Cell cycle	30	0.27	232
WP4754	IL-18 signaling pathway	30	0.266	173
WP5088	Prostaglandin signaling	30	0.261	260
WP5115	Network map of SARS-CoV-2 signaling pathway	20	0.258	268.5
WP5115	Network map of SARS-CoV-2 signaling pathway	30	0.258	249.5
WP5088	Prostaglandin signaling	20	0.257	277
WP3611	Photodynamic therapy-induced AP-1 survival signaling	30	0.253	117.5
WP530	Cytokines and inflammatory response	30	0.252	156
WP4754	IL-18 signaling pathway	20	0.249	200.5
WP3624	Lung fibrosis	30	0.249	189.5
WP179	Cell cycle	20	0.239	298
WP530	Cytokines and inflammatory response	20	0.237	187.5
WP5095	Overview of proinflammatory and profibrotic mediators	20	0.236	325.5
WP1971	Integrated cancer pathway	30	0.236	215.5
WP4891	COVID-19 adverse outcome pathway	20	0.235	230
WP2446	Retinoblastoma gene in cancer	30	0.233	403
WP254	Apoptosis	30	0.228	242
WP3624	Lung fibrosis	20	0.227	222
WP466	DNA replication	30	0.224	531.5
WP3611	Photodynamic therapy-induced AP-1 survival signaling	20	0.222	146.5
WP2328	Allograft Rejection	20	0.221	249
WP45	G1 to S cell cycle control	20	0.216	251
WP615	Senescence and autophagy in cancer	30	0.216	166.5
WP75	Toll-like receptor signaling pathway	20	0.214	312.5
WP5055	Burn wound healing	20	0.213	219
WP254	Apoptosis	20	0.209	267
WP176	Folate metabolism	30	0.209	194.5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	30	0.208	230
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	30	0.204	342.5
WP5055	Burn wound healing	30	0.204	185
WP1533	Vitamin B12 metabolism	30	0.203	201
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20	0.201	316
WP1604	Codeine and morphine metabolism	30	0.201	461.5
WP1449	Regulation of toll-like receptor signaling pathway	20	0.2	277.5
WP615	Senescence and autophagy in cancer	20	0.2	189
WP4263	Pancreatic adenocarcinoma pathway	30	0.199	191
WP4946	DNA repair pathways, full network	30	0.199	497
WP179	Cell cycle	10	0.196	323
WP2877	Vitamin D receptor pathway	30	0.196	195.5
WP2877	Vitamin D receptor pathway	20	0.195	197.5
WP2882	Nuclear receptors meta-pathway	20	0.195	213
WP4655	Cytosolic DNA-sensing pathway	20	0.195	333.5
WP1449	Regulation of toll-like receptor signaling pathway	30	0.195	237
WP1772	Apoptosis modulation and signaling	30	0.195	279
WP2328	Allograft Rejection	30	0.194	282.5
WP2882	Nuclear receptors meta-pathway	30	0.193	219
WP3617	Photodynamic therapy-induced NF-kB survival signaling	10	0.192	316.5
WP1530	miRNA regulation of DNA damage response	30	0.192	281
WP4016	DNA IR-damage and cellular response via ATR	30	0.192	410.5
WP5087	Malignant pleural mesothelioma	30	0.191	156
WP707	DNA damage response	30	0.191	270
WP5095	Overview of proinflammatory and profibrotic mediators	10	0.19	365.5
WP4018	Clear cell renal cell carcinoma pathways	30	0.188	270
WP2828	Bladder cancer	30	0.186	142
WP1971	Integrated cancer pathway	20	0.185	259.5
WP75	Toll-like receptor signaling pathway	30	0.185	263
WP176	Folate metabolism	20	0.183	225
WP4754	IL-18 signaling pathway	10	0.181	286.5
WP619	Type II interferon signaling (IFNG)	30	0.181	370
WP2328	Allograft Rejection	10	0.18	339
WP1530	miRNA regulation of DNA damage response	20	0.18	301.5
WP4172	PI3K-Akt signaling pathway	20	0.18	205
WP430	Statin inhibition of cholesterol production	20	0.179	292
WP710	DNA damage response (only ATM dependent)	30	0.179	184
WP430	Statin inhibition of cholesterol production	30	0.178	287.5
WP1984	Integrated breast cancer pathway	30	0.177	244
WP4329	miRNAs involvement in the immune response in sepsis	30	0.177	288
WP4462	Platelet-mediated interactions with vascular and circulating cells	30	0.177	232
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	30	0.176	420
WP530	Cytokines and inflammatory response	10	0.175	295.5
WP3942	PPAR signaling pathway	20	0.175	407
WP430	Statin inhibition of cholesterol production	10	0.174	331.5
WP1533	Vitamin B12 metabolism	20	0.174	209.5
WP2446	Retinoblastoma gene in cancer	20	0.174	408
WP236	Adipogenesis	30	0.174	186
WP4172	PI3K-Akt signaling pathway	30	0.174	198.5
WP707	DNA damage response	20	0.173	283
WP4016	DNA IR-damage and cellular response via ATR	20	0.172	414
WP4329	miRNAs involvement in the immune response in sepsis	20	0.172	291
WP4462	Platelet-mediated interactions with vascular and circulating cells	20	0.172	282
WP4946	DNA repair pathways, full network	20	0.172	457
WP3942	PPAR signaling pathway	30	0.172	443
WP4022	Pyrimidine metabolism	30	0.172	492
WP4658	Small cell lung cancer	30	0.172	230
WP45	G1 to S cell cycle control	10	0.171	294
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	20	0.171	401.5
WP4197	Immune response to tuberculosis	30	0.171	461
WP5088	Prostaglandin signaling	10	0.17	332.5
WP4290	Metabolic reprogramming in colon cancer	30	0.169	381
WP4462	Platelet-mediated interactions with vascular and circulating cells	10	0.166	334
WP4478	LTF danger signal response pathway	20	0.165	280.5
WP466	DNA replication	20	0.165	497
WP3646	Hepatitis C and hepatocellular carcinoma	30	0.165	145
WP5094	Orexin receptor pathway	30	0.165	200
WP619	Type II interferon signaling (IFNG)	20	0.164	363.5
WP2431	Spinal cord injury	30	0.164	181
WP5055	Burn wound healing	10	0.163	291
WP4197	Immune response to tuberculosis	20	0.163	430
WP4655	Cytosolic DNA-sensing pathway	30	0.163	305.5
WP4216	Chromosomal and microsatellite instability in colorectal cancer	30	0.162	228.5
WP15	Selenium micronutrient network	20	0.161	242.5
WP3937	Microglia pathogen phagocytosis pathway	30	0.161	381
WP5095	Overview of proinflammatory and profibrotic mediators	5	0.16	301.5
WP1449	Regulation of toll-like receptor signaling pathway	10	0.16	293.5
WP3624	Lung fibrosis	10	0.16	296.5
WP176	Folate metabolism	10	0.159	275.5
WP5115	Network map of SARS-CoV-2 signaling pathway	10	0.159	291
WP2516	ATM signaling pathway	30	0.159	293.5
WP4494	Selective expression of chemokine receptors during T-cell polarization	30	0.158	244.5
WP5087	Malignant pleural mesothelioma	20	0.157	190
WP1772	Apoptosis modulation and signaling	20	0.156	291
WP4484	Control of immune tolerance by vasoactive intestinal peptide	30	0.156	199.5
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	30	0.156	341.5
WP530	Cytokines and inflammatory response	4	0.155	307
WP1604	Codeine and morphine metabolism	20	0.155	440.5
WP4659	Gastrin signaling pathway	30	0.155	148.5
WP5049	Glycolysis in senescence	30	0.155	352.5
WP1742	TP53 network	30	0.154	182.5
WP530	Cytokines and inflammatory response	5	0.153	294
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10	0.153	245
WP4172	PI3K-Akt signaling pathway	10	0.153	240
WP4655	Cytosolic DNA-sensing pathway	10	0.153	370.5
WP702	Metapathway biotransformation Phase I and II	20	0.153	368
WP531	DNA mismatch repair	30	0.153	463
WP534	Glycolysis and gluconeogenesis	30	0.153	362
WP254	Apoptosis	10	0.152	305.5
WP15	Selenium micronutrient network	30	0.152	232
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	30	0.152	356.5
WP3893	Development and heterogeneity of the ILC family	30	0.152	237.5
WP3601	Lipid particles composition	20	0.151	287
WP2328	Allograft Rejection	4	0.15	273
WP2877	Vitamin D receptor pathway	10	0.15	213
WP2882	Nuclear receptors meta-pathway	10	0.15	250.5
WP4946	DNA repair pathways, full network	10	0.15	399
WP702	Metapathway biotransformation Phase I and II	30	0.15	380
WP4891	COVID-19 adverse outcome pathway	10	0.149	327
WP231	TNF-alpha signaling pathway	30	0.149	274
WP4754	IL-18 signaling pathway	4	0.148	233.5
WP615	Senescence and autophagy in cancer	10	0.148	250
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	20	0.148	343.5
WP5095	Overview of proinflammatory and profibrotic mediators	4	0.147	280.5
WP2446	Retinoblastoma gene in cancer	10	0.147	360
WP4016	DNA IR-damage and cellular response via ATR	10	0.147	364
WP75	Toll-like receptor signaling pathway	10	0.147	320.5
WP2516	ATM signaling pathway	20	0.147	318
WP4018	Clear cell renal cell carcinoma pathways	20	0.146	306
WP4658	Small cell lung cancer	20	0.146	251.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	30	0.146	380
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	30	0.146	245.5
WP2328	Allograft Rejection	5	0.145	280.5
WP710	DNA damage response (only ATM dependent)	20	0.145	212
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	30	0.145	290
WP2374	Oncostatin M signaling pathway	30	0.144	197
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	30	0.144	211
WP4022	Pyrimidine metabolism	20	0.143	456
WP4754	IL-18 signaling pathway	5	0.142	252
WP2431	Spinal cord injury	10	0.142	275.5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	10	0.142	331.5
WP1530	miRNA regulation of DNA damage response	10	0.141	317.5
WP1533	Vitamin B12 metabolism	10	0.141	256.5
WP1772	Apoptosis modulation and signaling	10	0.141	302
WP3601	Lipid particles composition	10	0.141	334.5
WP4629	Aerobic glycolysis	30	0.141	382.5
WP4329	miRNAs involvement in the immune response in sepsis	10	0.14	317.5
WP466	DNA replication	10	0.14	434.5
WP231	TNF-alpha signaling pathway	20	0.14	283
WP4494	Selective expression of chemokine receptors during T-cell polarization	20	0.14	263.5
WP5098	T-cell activation SARS-CoV-2	30	0.14	206.5
WP1984	Integrated breast cancer pathway	20	0.139	263
WP3893	Development and heterogeneity of the ILC family	20	0.139	275
WP43	Oxidation by cytochrome P450	20	0.139	316
WP1981	Thyroxine (thyroid hormone) production	30	0.139	427.5
WP3929	Chemokine signaling pathway	30	0.139	255
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	30	0.139	212.5
WP1449	Regulation of toll-like receptor signaling pathway	5	0.138	255.5
WP5115	Network map of SARS-CoV-2 signaling pathway	5	0.138	250
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10	0.138	308.5
WP2374	Oncostatin M signaling pathway	20	0.137	217.5
WP4263	Pancreatic adenocarcinoma pathway	20	0.137	235
WP453	Inflammatory response pathway	20	0.137	249.5
WP5108	Familial  hyperlipidemia type 1	20	0.137	292.5
WP2261	Glioblastoma signaling pathways	30	0.137	177.5
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	30	0.137	206.5
WP707	DNA damage response	10	0.136	310
WP2431	Spinal cord injury	20	0.136	236
WP4298	Acute viral myocarditis	30	0.136	207
WP43	Oxidation by cytochrome P450	30	0.136	363.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	20	0.135	294
WP75	Toll-like receptor signaling pathway	5	0.134	275
WP1742	TP53 network	20	0.134	204
WP4484	Control of immune tolerance by vasoactive intestinal peptide	20	0.134	231
WP5094	Orexin receptor pathway	20	0.134	197
WP1946	Cori cycle	30	0.134	351
WP530	Cytokines and inflammatory response	3	0.133	360.5
WP364	IL-6 signaling pathway	10	0.133	278
WP4136	Fibrin complement receptor 3 signaling pathway	10	0.133	285
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	20	0.132	260.5
WP364	IL-6 signaling pathway	20	0.132	271.5
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	30	0.132	201.5
WP4217	Ebola virus pathway in host	30	0.132	308.5
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	30	0.132	385
WP3646	Hepatitis C and hepatocellular carcinoma	20	0.131	181.5
WP2877	Vitamin D receptor pathway	5	0.13	219
WP4494	Selective expression of chemokine receptors during T-cell polarization	5	0.13	297
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	10	0.13	317.5
WP4290	Metabolic reprogramming in colon cancer	20	0.13	381.5
WP4685	Melanoma	30	0.13	211.5
WP4494	Selective expression of chemokine receptors during T-cell polarization	4	0.129	306
WP1971	Integrated cancer pathway	10	0.129	268
WP4352	Ciliary landscape	10	0.129	282
WP2828	Bladder cancer	20	0.129	167.5
WP5115	Network map of SARS-CoV-2 signaling pathway	4	0.128	236.5
WP236	Adipogenesis	20	0.128	205
WP197	Cholesterol biosynthesis pathway	30	0.128	439.5
WP4478	LTF danger signal response pathway	30	0.128	262.5
WP1533	Vitamin B12 metabolism	4	0.127	227.5
WP1533	Vitamin B12 metabolism	5	0.127	238
WP176	Folate metabolism	5	0.127	251.5
WP2876	Pregnane X receptor pathway	20	0.127	371
WP3982	miRNA regulation of p53 pathway in prostate cancer	30	0.127	388
WP4255	Non-small cell lung cancer	30	0.127	251
WP5108	Familial  hyperlipidemia type 1	30	0.127	297
WP4754	IL-18 signaling pathway	3	0.126	198.5
WP4146	Macrophage markers	10	0.126	328.5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	20	0.126	352
WP2878	PPAR-alpha pathway	20	0.126	315
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	20	0.126	367
WP5114	Nucleotide excision repair in xeroderma pigmentosum	20	0.126	438.5
WP3594	Circadian rhythm genes	30	0.126	277.5
WP698	Glucuronidation	30	0.126	431.5
WP1449	Regulation of toll-like receptor signaling pathway	4	0.125	241
WP176	Folate metabolism	4	0.125	234.5
WP2516	ATM signaling pathway	10	0.125	329
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	20	0.125	243
WP4674	Head and neck squamous cell carcinoma	30	0.125	215
WP691	Tamoxifen metabolism	30	0.125	385
WP15	Selenium micronutrient network	10	0.124	289
WP4216	Chromosomal and microsatellite instability in colorectal cancer	20	0.124	261
WP4217	Ebola virus pathway in host	20	0.124	295
WP2876	Pregnane X receptor pathway	30	0.124	373
WP299	Nuclear receptors in lipid metabolism and toxicity	30	0.124	371.5
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	30	0.124	270.5
WP5109	Familial hyperlipidemia type 2	30	0.124	348.5
WP15	Selenium micronutrient network	4	0.123	232.5
WP4494	Selective expression of chemokine receptors during T-cell polarization	10	0.123	313
WP5110	Familial hyperlipidemia type 3	10	0.123	309
WP5110	Familial hyperlipidemia type 3	20	0.123	282
WP2849	Hematopoietic stem cell differentiation	30	0.123	214
WP453	Inflammatory response pathway	30	0.123	221
WP5114	Nucleotide excision repair in xeroderma pigmentosum	30	0.123	446.5
WP15	Selenium micronutrient network	5	0.122	247
WP2276	Glial cell differentiation	30	0.122	635.5
WP2586	Aryl hydrocarbon receptor Netpath	30	0.122	188.5
WP2882	Nuclear receptors meta-pathway	3	0.121	184.5
WP5055	Burn wound healing	4	0.121	233
WP4136	Fibrin complement receptor 3 signaling pathway	5	0.121	267.5
WP430	Statin inhibition of cholesterol production	5	0.121	313
WP4478	LTF danger signal response pathway	10	0.121	320
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	20	0.121	222
WP3959	DNA IR-double strand breaks and cellular response via ATM	20	0.121	394
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	20	0.121	238.5
WP558	Complement and coagulation cascades	20	0.121	273.5
WP364	IL-6 signaling pathway	30	0.121	253
WP4806	EGFR tyrosine kinase inhibitor resistance	30	0.121	191.5
WP2882	Nuclear receptors meta-pathway	5	0.12	231.5
WP129	Matrix metalloproteinases	10	0.12	310
WP4658	Small cell lung cancer	10	0.12	271.5
WP619	Type II interferon signaling (IFNG)	10	0.12	329.5
WP2884	NRF2 pathway	20	0.12	283.5
WP697	Estrogen metabolism	20	0.12	358
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	30	0.12	367.5
WP3617	Photodynamic therapy-induced NF-kB survival signaling	5	0.119	284
WP4462	Platelet-mediated interactions with vascular and circulating cells	5	0.119	421.5
WP5055	Burn wound healing	5	0.119	251
WP129	Matrix metalloproteinases	20	0.119	266
WP4659	Gastrin signaling pathway	20	0.119	196
WP2873	Aryl hydrocarbon receptor pathway	30	0.119	243
WP4963	p53 transcriptional gene network	30	0.119	513
WP69	T-cell receptor (TCR) signaling pathway	30	0.119	229.5
WP430	Statin inhibition of cholesterol production	3	0.118	427.25
WP4172	PI3K-Akt signaling pathway	4	0.118	205
WP615	Senescence and autophagy in cancer	4	0.118	222
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	5	0.118	325
WP4298	Acute viral myocarditis	20	0.118	240
WP5109	Familial hyperlipidemia type 2	20	0.118	334
WP138	Androgen receptor signaling pathway	30	0.118	226.5
WP2064	Neural crest differentiation	30	0.118	312
WP4286	Genotoxicity pathway	30	0.118	455.5
WP558	Complement and coagulation cascades	30	0.118	305.5
WP2877	Vitamin D receptor pathway	4	0.117	201
WP4396	Nonalcoholic fatty liver disease	5	0.117	231
WP4891	COVID-19 adverse outcome pathway	5	0.117	317
WP231	TNF-alpha signaling pathway	10	0.117	294.5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10	0.117	311
WP3929	Chemokine signaling pathway	10	0.117	225.5
WP5087	Malignant pleural mesothelioma	10	0.117	220.5
WP710	DNA damage response (only ATM dependent)	10	0.117	253
WP1981	Thyroxine (thyroid hormone) production	20	0.117	463
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	20	0.117	269
WP5112	Familial hyperlipidemia type 5	20	0.117	296.5
WP1545	miRNAs involved in DNA damage response	30	0.117	167
WP3601	Lipid particles composition	30	0.117	280
WP4666	Hepatitis B infection	30	0.117	253
WP5112	Familial hyperlipidemia type 5	30	0.117	294
WP2328	Allograft Rejection	3	0.116	247
WP430	Statin inhibition of cholesterol production	4	0.116	376
WP45	G1 to S cell cycle control	4	0.116	258.5
WP236	Adipogenesis	10	0.116	225
WP5108	Familial  hyperlipidemia type 1	10	0.116	327
WP299	Nuclear receptors in lipid metabolism and toxicity	20	0.116	361
WP5088	Prostaglandin signaling	4	0.115	293
WP3624	Lung fibrosis	5	0.115	260
WP4298	Acute viral myocarditis	10	0.115	283
WP5114	Nucleotide excision repair in xeroderma pigmentosum	10	0.115	385.5
WP2873	Aryl hydrocarbon receptor pathway	20	0.115	248
WP4462	Platelet-mediated interactions with vascular and circulating cells	4	0.114	445.5
WP3942	PPAR signaling pathway	10	0.114	360
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	10	0.114	339
WP4685	Melanoma	20	0.114	242.5
WP2324	AGE/RAGE pathway	30	0.114	217
WP3303	RAC1/PAK1/p38/MMP2 pathway	30	0.114	215.5
WP697	Estrogen metabolism	30	0.114	360.5
WP4754	IL-18 signaling pathway	2	0.113	166
WP43	Oxidation by cytochrome P450	3	0.113	424.75
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	3	0.113	447.25
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	4	0.113	420
WP4655	Cytosolic DNA-sensing pathway	4	0.113	410.25
WP3959	DNA IR-double strand breaks and cellular response via ATM	10	0.113	349.5
WP4396	Nonalcoholic fatty liver disease	20	0.113	233
WP698	Glucuronidation	20	0.113	398
WP4172	PI3K-Akt signaling pathway	3	0.112	187
WP4478	LTF danger signal response pathway	4	0.112	438
WP75	Toll-like receptor signaling pathway	4	0.112	257
WP5088	Prostaglandin signaling	5	0.112	307.5
WP1984	Integrated breast cancer pathway	10	0.112	284
WP4262	Breast cancer pathway	30	0.112	260.5
WP179	Cell cycle	4	0.111	251
WP3624	Lung fibrosis	4	0.111	227
WP4018	Clear cell renal cell carcinoma pathways	10	0.111	280
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10	0.111	252.5
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	20	0.111	269
WP5111	Familial hyperlipidemia type 4	20	0.111	279.5
WP357	Fatty acid biosynthesis	30	0.111	430
WP4396	Nonalcoholic fatty liver disease	30	0.111	227
WP5097	CCL18 signaling pathway	30	0.111	225.5
WP5110	Familial hyperlipidemia type 3	30	0.111	268
WP5095	Overview of proinflammatory and profibrotic mediators	3	0.11	263.5
WP4172	PI3K-Akt signaling pathway	5	0.11	232
WP4655	Cytosolic DNA-sensing pathway	5	0.11	341
WP43	Oxidation by cytochrome P450	10	0.11	327.5
WP5112	Familial hyperlipidemia type 5	10	0.11	330.5
WP702	Metapathway biotransformation Phase I and II	10	0.11	331
WP3937	Microglia pathogen phagocytosis pathway	20	0.11	384
WP534	Glycolysis and gluconeogenesis	20	0.11	340.5
WP306	Focal adhesion	30	0.11	222.5
WP4494	Selective expression of chemokine receptors during T-cell polarization	3	0.109	414.5
WP2882	Nuclear receptors meta-pathway	4	0.109	214.5
WP4396	Nonalcoholic fatty liver disease	4	0.109	203.5
WP3893	Development and heterogeneity of the ILC family	5	0.109	272
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	5	0.109	274.5
WP453	Inflammatory response pathway	10	0.109	297
WP4806	EGFR tyrosine kinase inhibitor resistance	20	0.109	217
WP5061	Fatty acid transporters	20	0.109	596.25
WP691	Tamoxifen metabolism	20	0.109	392
WP477	Cytoplasmic ribosomal proteins	30	0.109	580
WP2882	Nuclear receptors meta-pathway	2	0.108	154
WP5115	Network map of SARS-CoV-2 signaling pathway	2	0.108	180
WP129	Matrix metalloproteinases	4	0.108	312.5
WP4478	LTF danger signal response pathway	5	0.108	331.5
WP5110	Familial hyperlipidemia type 3	5	0.108	452.5
WP4197	Immune response to tuberculosis	10	0.108	415.5
WP5094	Orexin receptor pathway	10	0.108	228
WP2586	Aryl hydrocarbon receptor Netpath	20	0.108	215.5
WP5098	T-cell activation SARS-CoV-2	20	0.108	240
WP179	Cell cycle	5	0.107	281
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	20	0.107	363
WP4136	Fibrin complement receptor 3 signaling pathway	30	0.107	255
WP1449	Regulation of toll-like receptor signaling pathway	3	0.106	225
WP2877	Vitamin D receptor pathway	3	0.106	186
WP4891	COVID-19 adverse outcome pathway	4	0.106	381
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	4	0.106	264
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	10	0.106	305
WP691	Tamoxifen metabolism	10	0.106	436.5
WP4674	Head and neck squamous cell carcinoma	20	0.106	239
WP5049	Glycolysis in senescence	20	0.106	366
WP4155	Endometrial cancer	30	0.106	217
WP5087	Malignant pleural mesothelioma	4	0.105	202.5
WP2884	NRF2 pathway	5	0.105	233.5
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	20	0.105	233
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	20	0.105	320.5
WP531	DNA mismatch repair	20	0.105	444
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	30	0.105	241
WP4136	Fibrin complement receptor 3 signaling pathway	4	0.104	267.5
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	5	0.104	256.5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	5	0.104	269
WP702	Metapathway biotransformation Phase I and II	5	0.104	272.5
WP4396	Nonalcoholic fatty liver disease	10	0.104	257.5
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	10	0.104	403
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	20	0.104	235
WP4558	Overview of interferons-mediated signaling pathway	20	0.104	335
WP5097	CCL18 signaling pathway	20	0.104	233
WP2034	Leptin signaling pathway	30	0.104	282
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	30	0.104	240
WP5095	Overview of proinflammatory and profibrotic mediators	2	0.103	277
WP3624	Lung fibrosis	3	0.103	212
WP3893	Development and heterogeneity of the ILC family	4	0.103	287.5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	10	0.103	316
WP3893	Development and heterogeneity of the ILC family	10	0.103	307.5
WP2324	AGE/RAGE pathway	20	0.103	236.5
WP3303	RAC1/PAK1/p38/MMP2 pathway	20	0.103	256.5
WP4629	Aerobic glycolysis	20	0.103	407
WP2507	Nanomaterial induced apoptosis	30	0.103	327.5
WP314	Fas ligand pathway and stress induction of heat shock proteins	30	0.103	263
WP5110	Familial hyperlipidemia type 3	3	0.102	456.5
WP4329	miRNAs involvement in the immune response in sepsis	4	0.102	288
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	4	0.102	239.5
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	4	0.102	254
WP43	Oxidation by cytochrome P450	5	0.102	310
WP45	G1 to S cell cycle control	5	0.102	277.5
WP691	Tamoxifen metabolism	5	0.102	503.5
WP4484	Control of immune tolerance by vasoactive intestinal peptide	10	0.102	298
WP1403	AMP-activated protein kinase (AMPK) signaling	20	0.102	260.5
WP306	Focal adhesion	20	0.102	227
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	30	0.102	354
WP4838	Regucalcin in proximal tubule epithelial kidney cells	30	0.102	345
WP1533	Vitamin B12 metabolism	3	0.101	223
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	3	0.101	278
WP5115	Network map of SARS-CoV-2 signaling pathway	3	0.101	205.5
WP254	Apoptosis	4	0.101	239
WP5110	Familial hyperlipidemia type 3	4	0.101	464.5
WP619	Type II interferon signaling (IFNG)	4	0.101	287.5
WP3611	Photodynamic therapy-induced AP-1 survival signaling	5	0.101	253.5
WP3942	PPAR signaling pathway	5	0.101	294.5
WP3594	Circadian rhythm genes	10	0.101	267
WP4969	RAS and bradykinin pathways in COVID-19	10	0.101	286
WP697	Estrogen metabolism	10	0.101	398.5
WP197	Cholesterol biosynthesis pathway	20	0.101	456
WP4262	Breast cancer pathway	20	0.101	268
WP366	TGF-beta signaling pathway	30	0.101	199.5
WP3888	VEGFA-VEGFR2 signaling pathway	30	0.101	213.5
WP5108	Familial  hyperlipidemia type 1	3	0.1	463.5
WP5087	Malignant pleural mesothelioma	5	0.1	227.5
WP4022	Pyrimidine metabolism	10	0.1	448
WP4493	Cells and molecules involved in local acute inflammatory response	10	0.1	329.5
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	20	0.1	276
WP3298	Melatonin metabolism and effects	30	0.1	343
WP4141	PI3K/AKT/mTOR - VitD3 signaling	30	0.1	236.5
WP4324	Mitochondrial complex I assembly model OXPHOS system	30	0.1	642
WP4753	Nucleotide excision repair	30	0.1	468
WP5111	Familial hyperlipidemia type 4	30	0.1	295
WP58	Monoamine GPCRs	30	0.1	637.5
WP179	Cell cycle	3	0.099	229
WP2884	NRF2 pathway	4	0.099	213
WP3617	Photodynamic therapy-induced NF-kB survival signaling	4	0.099	273
WP4493	Cells and molecules involved in local acute inflammatory response	5	0.099	326
WP5083	Neuroinflammation and glutamatergic signaling	10	0.099	264.5
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	20	0.099	365.5
WP2261	Glioblastoma signaling pathways	20	0.099	225
WP229	Irinotecan pathway	20	0.099	373.5
WP4545	Oxysterols derived from cholesterol	30	0.099	399
WP5083	Neuroinflammation and glutamatergic signaling	30	0.099	252.5
WP430	Statin inhibition of cholesterol production	2	0.098	418.5
WP15	Selenium micronutrient network	3	0.098	223
WP5111	Familial hyperlipidemia type 4	4	0.098	437.75
WP1772	Apoptosis modulation and signaling	5	0.098	267.5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	5	0.098	400.5
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	10	0.098	217
WP2884	NRF2 pathway	10	0.098	283.5
WP3937	Microglia pathogen phagocytosis pathway	10	0.098	340
WP5109	Familial hyperlipidemia type 2	10	0.098	336
WP5083	Neuroinflammation and glutamatergic signaling	20	0.098	267.5
WP69	T-cell receptor (TCR) signaling pathway	20	0.098	247
WP1403	AMP-activated protein kinase (AMPK) signaling	30	0.098	244.5
WP4462	Platelet-mediated interactions with vascular and circulating cells	3	0.097	449
WP43	Oxidation by cytochrome P450	4	0.097	412.25
WP236	Adipogenesis	5	0.097	198
WP2431	Spinal cord injury	5	0.097	255
WP254	Apoptosis	5	0.097	257.5
WP453	Inflammatory response pathway	5	0.097	270
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	10	0.097	317.5
WP2828	Bladder cancer	10	0.097	229.5
WP2865	IL1 and megakaryocytes in obesity	10	0.097	286
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	10	0.097	300.5
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	10	0.097	225.5
WP5092	Interactions of natural killer cells in pancreatic cancer	10	0.097	301
WP5098	T-cell activation SARS-CoV-2	10	0.097	272.5
WP2875	Constitutive androstane receptor pathway	20	0.097	341
WP4155	Endometrial cancer	20	0.097	249
WP4255	Non-small cell lung cancer	20	0.097	278.5
WP4352	Ciliary landscape	30	0.097	367
WP4789	MED and pseudoachondroplasia genes	30	0.097	647
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	4	0.096	189.5
WP5083	Neuroinflammation and glutamatergic signaling	4	0.096	223
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	5	0.096	249
WP1742	TP53 network	10	0.096	245.5
WP2806	Complement system	10	0.096	268
WP3646	Hepatitis C and hepatocellular carcinoma	10	0.096	236
WP4263	Pancreatic adenocarcinoma pathway	10	0.096	247.5
WP558	Complement and coagulation cascades	10	0.096	300.5
WP2507	Nanomaterial induced apoptosis	20	0.096	328.5
WP3929	Chemokine signaling pathway	20	0.096	264
WP5111	Familial hyperlipidemia type 4	3	0.095	449.5
WP5112	Familial hyperlipidemia type 5	3	0.095	463.5
WP364	IL-6 signaling pathway	5	0.095	253
WP4262	Breast cancer pathway	10	0.095	275
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	10	0.095	293
WP357	Fatty acid biosynthesis	20	0.095	415.5
WP4136	Fibrin complement receptor 3 signaling pathway	20	0.095	272
WP4524	Alternative pathway of fetal androgen synthesis	20	0.095	328.5
WP4816	TGF-beta receptor signaling in skeletal dysplasias	20	0.095	241.5
WP2884	NRF2 pathway	30	0.095	287.5
WP530	Cytokines and inflammatory response	2	0.094	406.5
WP176	Folate metabolism	3	0.094	230.5
WP45	G1 to S cell cycle control	3	0.094	241
WP4484	Control of immune tolerance by vasoactive intestinal peptide	4	0.094	334.5
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	5	0.094	278
WP615	Senescence and autophagy in cancer	5	0.094	238
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	10	0.094	361
WP1981	Thyroxine (thyroid hormone) production	10	0.094	563.75
WP3945	TYROBP causal network in microglia	10	0.094	272
WP5111	Familial hyperlipidemia type 4	10	0.094	323
WP2849	Hematopoietic stem cell differentiation	20	0.094	251
WP2874	Liver X receptor pathway	20	0.094	343
WP23	B cell receptor signaling pathway	30	0.094	251
WP4558	Overview of interferons-mediated signaling pathway	30	0.094	355
WP2328	Allograft Rejection	2	0.093	272
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	3	0.093	264.5
WP5055	Burn wound healing	3	0.093	216
WP3611	Photodynamic therapy-induced AP-1 survival signaling	4	0.093	237.5
WP129	Matrix metalloproteinases	5	0.093	305.5
WP4329	miRNAs involvement in the immune response in sepsis	5	0.093	281
WP5111	Familial hyperlipidemia type 4	5	0.093	397
WP143	Fatty acid beta-oxidation	20	0.093	419
WP1545	miRNAs involved in DNA damage response	20	0.093	208
WP3613	Photodynamic therapy-induced unfolded protein response	20	0.093	321
WP410	Exercise-induced circadian regulation	20	0.093	367.5
WP560	TGF-beta receptor signaling	20	0.093	241
WP58	Monoamine GPCRs	20	0.093	621
WP2018	RANKL/RANK signaling pathway	30	0.093	244
WP2878	PPAR-alpha pathway	30	0.093	339.5
WP43	Oxidation by cytochrome P450	2	0.092	418
WP2874	Liver X receptor pathway	3	0.092	459.75
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	3	0.092	231
WP2865	IL1 and megakaryocytes in obesity	4	0.092	254.5
WP453	Inflammatory response pathway	4	0.092	275
WP3601	Lipid particles composition	5	0.092	477.75
WP619	Type II interferon signaling (IFNG)	5	0.092	295
WP697	Estrogen metabolism	5	0.092	499.25
WP4629	Aerobic glycolysis	10	0.092	522.75
WP5097	CCL18 signaling pathway	10	0.092	240
WP4969	RAS and bradykinin pathways in COVID-19	20	0.092	280.5
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	20	0.092	264
WP2858	Ectoderm differentiation	30	0.092	244
WP4146	Macrophage markers	30	0.092	301
WP5108	Familial  hyperlipidemia type 1	5	0.091	487
WP1403	AMP-activated protein kinase (AMPK) signaling	10	0.091	267
WP2876	Pregnane X receptor pathway	10	0.091	342
WP4290	Metabolic reprogramming in colon cancer	10	0.091	336.5
WP4558	Overview of interferons-mediated signaling pathway	10	0.091	316.5
WP4146	Macrophage markers	20	0.091	340
WP4545	Oxysterols derived from cholesterol	20	0.091	354.5
WP4666	Hepatitis B infection	20	0.091	265.5
WP496	Steroid biosynthesis	20	0.091	399.5
WP4494	Selective expression of chemokine receptors during T-cell polarization	2	0.09	412.5
WP45	G1 to S cell cycle control	2	0.09	226
WP3915	Angiopoietin-like protein 8 regulatory pathway	4	0.09	210
WP4493	Cells and molecules involved in local acute inflammatory response	4	0.09	391
WP5108	Familial  hyperlipidemia type 1	4	0.09	477
WP2806	Complement system	5	0.09	234.5
WP2806	Complement system	20	0.09	279.5
WP3594	Circadian rhythm genes	20	0.09	298
WP4352	Ciliary landscape	20	0.09	342
WP4753	Nucleotide excision repair	20	0.09	447
WP2875	Constitutive androstane receptor pathway	30	0.09	373.5
WP3658	Wnt/beta-catenin signaling pathway in leukemia	30	0.09	253.5
WP4970	Galanin receptor pathway	30	0.09	203
WP179	Cell cycle	2	0.089	210
WP3893	Development and heterogeneity of the ILC family	3	0.089	309
WP2806	Complement system	4	0.089	223
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4	0.089	256
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	4	0.089	320
WP2874	Liver X receptor pathway	5	0.089	462.5
WP710	DNA damage response (only ATM dependent)	5	0.089	228
WP2858	Ectoderm differentiation	10	0.089	222.5
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	10	0.089	349
WP262	Ebstein-Barr virus LMP1 signaling	20	0.089	305
WP2858	Ectoderm differentiation	20	0.089	231
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	30	0.089	284
WP2877	Vitamin D receptor pathway	2	0.088	174
WP236	Adipogenesis	3	0.088	165.5
WP364	IL-6 signaling pathway	4	0.088	241
WP702	Metapathway biotransformation Phase I and II	4	0.088	277
WP5109	Familial hyperlipidemia type 2	5	0.088	471.5
WP5112	Familial hyperlipidemia type 5	5	0.088	487
WP4753	Nucleotide excision repair	10	0.088	408.5
WP1946	Cori cycle	20	0.088	356
WP2037	Prolactin signaling pathway	30	0.088	233
WP4925	Unfolded protein response	30	0.088	241
WP560	TGF-beta receptor signaling	30	0.088	214
WP1533	Vitamin B12 metabolism	2	0.087	252
WP3915	Angiopoietin-like protein 8 regulatory pathway	3	0.087	180
WP3942	PPAR signaling pathway	3	0.087	287
WP453	Inflammatory response pathway	3	0.087	324
WP2446	Retinoblastoma gene in cancer	5	0.087	291
WP5083	Neuroinflammation and glutamatergic signaling	5	0.087	235
WP2873	Aryl hydrocarbon receptor pathway	10	0.087	286
WP4493	Cells and molecules involved in local acute inflammatory response	20	0.087	280.5
WP455	GPCRs, class A rhodopsin-like	20	0.087	375
WP4830	GDNF/RET signaling axis	20	0.087	335.5
WP4970	Galanin receptor pathway	20	0.087	215
WP185	Integrin-mediated cell adhesion	30	0.087	243.5
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	2	0.086	427.5
WP2884	NRF2 pathway	3	0.086	203
WP4396	Nonalcoholic fatty liver disease	3	0.086	196.5
WP5087	Malignant pleural mesothelioma	3	0.086	190
WP2446	Retinoblastoma gene in cancer	4	0.086	279
WP1971	Integrated cancer pathway	5	0.086	251
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	5	0.086	214.5
WP4352	Ciliary landscape	5	0.086	244
WP382	MAPK signaling pathway	10	0.086	255
WP138	Androgen receptor signaling pathway	20	0.086	277
WP2034	Leptin signaling pathway	20	0.086	285.5
WP5064	7-oxo-C and 7-beta-HC pathways	20	0.086	381
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	30	0.086	223.5
WP262	Ebstein-Barr virus LMP1 signaling	30	0.086	294
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	30	0.086	316.5
WP15	Selenium micronutrient network	2	0.085	240.5
WP3601	Lipid particles composition	3	0.085	458.75
WP3611	Photodynamic therapy-induced AP-1 survival signaling	3	0.085	223
WP4891	COVID-19 adverse outcome pathway	3	0.085	431.25
WP5083	Neuroinflammation and glutamatergic signaling	3	0.085	200
WP1434	Osteopontin signaling	4	0.085	455.5
WP3942	PPAR signaling pathway	4	0.085	305.5
WP4018	Clear cell renal cell carcinoma pathways	4	0.085	232
WP4352	Ciliary landscape	4	0.085	231
WP697	Estrogen metabolism	4	0.085	489.5
WP3298	Melatonin metabolism and effects	10	0.085	302
WP4752	Base excision repair	10	0.085	344.5
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	10	0.085	343.5
WP404	Nucleotide metabolism	20	0.085	452
WP129	Matrix metalloproteinases	30	0.085	277
WP702	Metapathway biotransformation Phase I and II	3	0.084	267.5
WP558	Complement and coagulation cascades	4	0.084	287.5
WP710	DNA damage response (only ATM dependent)	4	0.084	215
WP35	G protein signaling pathways	5	0.084	226
WP357	Fatty acid biosynthesis	10	0.084	457
WP496	Steroid biosynthesis	10	0.084	553
WP534	Glycolysis and gluconeogenesis	10	0.084	320
WP314	Fas ligand pathway and stress induction of heat shock proteins	20	0.084	276.5
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	30	0.084	320
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	30	0.084	254
WP254	Apoptosis	3	0.083	227
WP615	Senescence and autophagy in cancer	3	0.083	197
WP1772	Apoptosis modulation and signaling	4	0.083	244.5
WP236	Adipogenesis	4	0.083	198
WP5112	Familial hyperlipidemia type 5	4	0.083	477
WP2858	Ectoderm differentiation	5	0.083	170
WP4298	Acute viral myocarditis	5	0.083	242
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	10	0.083	324
WP262	Ebstein-Barr virus LMP1 signaling	10	0.083	302
WP2874	Liver X receptor pathway	10	0.083	345
WP2878	PPAR-alpha pathway	10	0.083	309.5
WP3935	Leptin-insulin signaling overlap	10	0.083	296.5
WP410	Exercise-induced circadian regulation	10	0.083	332.5
WP4830	GDNF/RET signaling axis	10	0.083	339
WP531	DNA mismatch repair	10	0.083	459.5
WP3298	Melatonin metabolism and effects	20	0.083	328.5
WP382	MAPK signaling pathway	20	0.083	278
WP4141	PI3K/AKT/mTOR - VitD3 signaling	20	0.083	249
WP4723	Omega-3 / omega-6 fatty acid synthesis	20	0.083	390
WP4838	Regucalcin in proximal tubule epithelial kidney cells	20	0.083	335.5
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	30	0.083	214
WP4969	RAS and bradykinin pathways in COVID-19	30	0.083	263
WP5072	Modulators of TCR signaling and T cell activation	30	0.083	296
WP75	Toll-like receptor signaling pathway	3	0.082	239
WP4298	Acute viral myocarditis	4	0.082	222
WP4496	Signal transduction through IL1R	4	0.082	259
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	4	0.082	431.75
WP231	TNF-alpha signaling pathway	5	0.082	249.5
WP299	Nuclear receptors in lipid metabolism and toxicity	5	0.082	298.5
WP466	DNA replication	5	0.082	464.5
WP69	T-cell receptor (TCR) signaling pathway	10	0.082	247
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	10	0.082	245
WP3935	Leptin-insulin signaling overlap	20	0.082	312.5
WP395	IL-4 signaling pathway	20	0.082	252
WP3982	miRNA regulation of p53 pathway in prostate cancer	20	0.082	382.5
WP5092	Interactions of natural killer cells in pancreatic cancer	20	0.082	290
WP2865	IL1 and megakaryocytes in obesity	30	0.082	233
WP2874	Liver X receptor pathway	30	0.082	347
WP3892	Development of pulmonary dendritic cells and macrophage subsets	30	0.082	245
WP364	IL-6 signaling pathway	3	0.081	252.5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	3	0.081	451.75
WP4830	GDNF/RET signaling axis	4	0.081	484
WP3646	Hepatitis C and hepatocellular carcinoma	5	0.081	248
WP4197	Immune response to tuberculosis	5	0.081	486.75
WP2374	Oncostatin M signaling pathway	10	0.081	243
WP3613	Photodynamic therapy-induced unfolded protein response	10	0.081	297.5
WP4217	Ebola virus pathway in host	10	0.081	282
WP5049	Glycolysis in senescence	10	0.081	328
WP2865	IL1 and megakaryocytes in obesity	20	0.081	261
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	30	0.081	253
WP5061	Fatty acid transporters	30	0.081	517
WP51	Regulation of actin cytoskeleton	30	0.081	276.5
WP129	Matrix metalloproteinases	3	0.08	435.75
WP3929	Chemokine signaling pathway	3	0.08	170.5
WP619	Type II interferon signaling (IFNG)	3	0.08	400
WP2873	Aryl hydrocarbon receptor pathway	4	0.08	236
WP2849	Hematopoietic stem cell differentiation	5	0.08	226
WP3929	Chemokine signaling pathway	5	0.08	201.5
WP536	Calcium regulation in cardiac cells	5	0.08	218
WP197	Cholesterol biosynthesis pathway	10	0.08	560
WP2034	Leptin signaling pathway	10	0.08	278
WP2064	Neural crest differentiation	10	0.08	270.5
WP299	Nuclear receptors in lipid metabolism and toxicity	10	0.08	328
WP4912	SARS coronavirus and innate immunity	10	0.08	399
WP2596	Gastric acid production	20	0.08	613
WP3888	VEGFA-VEGFR2 signaling pathway	20	0.08	228.5
WP5053	Development of ureteric collection system	20	0.08	281
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	30	0.08	238.5
WP4541	Hippo-Merlin signaling dysregulation	30	0.08	237
WP4136	Fibrin complement receptor 3 signaling pathway	3	0.079	351
WP697	Estrogen metabolism	3	0.079	468.5
WP710	DNA damage response (only ATM dependent)	3	0.079	200.5
WP5098	T-cell activation SARS-CoV-2	4	0.079	235.5
WP2865	IL1 and megakaryocytes in obesity	5	0.079	269
WP5094	Orexin receptor pathway	5	0.079	227
WP707	DNA damage response	5	0.079	267
WP4853	Linoleic acid metabolism affected by coronavirus infection	20	0.079	625.5
WP53	ID signaling pathway	20	0.079	318
WP4149	White fat cell differentiation	30	0.079	244
WP455	GPCRs, class A rhodopsin-like	30	0.079	407.5
WP5055	Burn wound healing	2	0.078	189
WP4478	LTF danger signal response pathway	3	0.078	447
WP4493	Cells and molecules involved in local acute inflammatory response	3	0.078	442.5
WP4655	Cytosolic DNA-sensing pathway	3	0.078	445.75
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	3	0.078	266.5
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	4	0.078	357
WP2431	Spinal cord injury	4	0.078	233.5
WP2874	Liver X receptor pathway	4	0.078	472.5
WP1530	miRNA regulation of DNA damage response	5	0.078	269
WP2876	Pregnane X receptor pathway	5	0.078	319.5
WP3915	Angiopoietin-like protein 8 regulatory pathway	5	0.078	218
WP4685	Melanoma	10	0.078	250
WP185	Integrin-mediated cell adhesion	20	0.078	250
WP2064	Neural crest differentiation	20	0.078	306
WP366	TGF-beta signaling pathway	20	0.078	198
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	20	0.078	314
WP2526	PDGF pathway	30	0.078	263.5
WP410	Exercise-induced circadian regulation	30	0.078	360
WP3893	Development and heterogeneity of the ILC family	2	0.077	404.5
WP4172	PI3K-Akt signaling pathway	2	0.077	149
WP5110	Familial hyperlipidemia type 3	2	0.077	430.25
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	2	0.077	398
WP615	Senescence and autophagy in cancer	2	0.077	175
WP3617	Photodynamic therapy-induced NF-kB survival signaling	3	0.077	255
WP4197	Immune response to tuberculosis	4	0.077	476.25
WP5094	Orexin receptor pathway	4	0.077	217
WP4016	DNA IR-damage and cellular response via ATR	5	0.077	298.5
WP4484	Control of immune tolerance by vasoactive intestinal peptide	5	0.077	292.5
WP5098	T-cell activation SARS-CoV-2	5	0.077	251.5
WP1434	Osteopontin signaling	10	0.077	323
WP2849	Hematopoietic stem cell differentiation	10	0.077	254.5
WP4524	Alternative pathway of fetal androgen synthesis	10	0.077	336.5
WP455	GPCRs, class A rhodopsin-like	10	0.077	328.5
WP53	ID signaling pathway	10	0.077	307.5
WP2359	Parkin-ubiquitin proteasomal system pathway	20	0.077	380.5
WP4912	SARS coronavirus and innate immunity	20	0.077	379
WP4925	Unfolded protein response	20	0.077	247.5
WP536	Calcium regulation in cardiac cells	20	0.077	336.5
WP395	IL-4 signaling pathway	30	0.077	235
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	30	0.077	428
WP3624	Lung fibrosis	2	0.076	212
WP5087	Malignant pleural mesothelioma	2	0.076	150
WP5108	Familial  hyperlipidemia type 1	2	0.076	435
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	3	0.076	417.25
WP35	G protein signaling pathways	4	0.076	229
WP558	Complement and coagulation cascades	5	0.076	289
WP698	Glucuronidation	5	0.076	511
WP3915	Angiopoietin-like protein 8 regulatory pathway	10	0.076	263.5
WP4216	Chromosomal and microsatellite instability in colorectal cancer	10	0.076	260
WP536	Calcium regulation in cardiac cells	10	0.076	281
WP1434	Osteopontin signaling	20	0.076	294.5
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	20	0.076	422
WP4746	Thyroid hormones production and peripheral downstream signaling effects	20	0.076	286
WP229	Irinotecan pathway	30	0.076	393
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	2	0.075	251.5
WP4329	miRNAs involvement in the immune response in sepsis	3	0.075	385.5
WP5088	Prostaglandin signaling	3	0.075	291
WP1424	Globo sphingolipid metabolism	4	0.075	493.75
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	4	0.075	468.5
WP691	Tamoxifen metabolism	4	0.075	491.75
WP185	Integrin-mediated cell adhesion	10	0.075	217
WP2359	Parkin-ubiquitin proteasomal system pathway	10	0.075	378
WP306	Focal adhesion	10	0.075	244.5
WP4496	Signal transduction through IL1R	10	0.075	273.5
WP4666	Hepatitis B infection	10	0.075	266
WP2113	Type III interferon signaling	20	0.075	424.5
WP2276	Glial cell differentiation	20	0.075	624
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	20	0.075	277
WP4816	TGF-beta receptor signaling in skeletal dysplasias	30	0.075	216
WP5064	7-oxo-C and 7-beta-HC pathways	30	0.075	405
WP2446	Retinoblastoma gene in cancer	2	0.074	230.5
WP4462	Platelet-mediated interactions with vascular and circulating cells	2	0.074	425.5
WP702	Metapathway biotransformation Phase I and II	2	0.074	383.25
WP299	Nuclear receptors in lipid metabolism and toxicity	3	0.074	331.5
WP5094	Orexin receptor pathway	3	0.074	185
WP3601	Lipid particles composition	4	0.074	468
WP466	DNA replication	4	0.074	471
WP1984	Integrated breast cancer pathway	5	0.074	254
WP382	MAPK signaling pathway	5	0.074	240.5
WP4146	Macrophage markers	5	0.074	494.25
WP4148	Splicing factor NOVA regulated synaptic proteins	5	0.074	248
WP69	T-cell receptor (TCR) signaling pathway	5	0.074	225.5
WP1601	Fluoropyrimidine activity	10	0.074	348
WP2324	AGE/RAGE pathway	10	0.074	259
WP404	Nucleotide metabolism	10	0.074	561.5
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	20	0.074	320
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	20	0.074	253.5
WP4752	Base excision repair	20	0.074	380.5
WP2332	Interleukin-11 signaling pathway	30	0.074	289
WP3599	Transcription factor regulation in adipogenesis	30	0.074	276.5
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	30	0.074	251
WP4723	Omega-3 / omega-6 fatty acid synthesis	30	0.074	383
WP4352	Ciliary landscape	2	0.073	237
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	2	0.073	354
WP619	Type II interferon signaling (IFNG)	2	0.073	410.5
WP691	Tamoxifen metabolism	3	0.073	472
WP1971	Integrated cancer pathway	4	0.073	244.5
WP231	TNF-alpha signaling pathway	4	0.073	224.5
WP51	Regulation of actin cytoskeleton	4	0.073	193
WP2853	Endoderm differentiation	5	0.073	202.5
WP4823	Genes controlling nephrogenesis	5	0.073	263
WP4946	DNA repair pathways, full network	5	0.073	327
WP4969	RAS and bradykinin pathways in COVID-19	5	0.073	277.5
WP4155	Endometrial cancer	10	0.073	257
WP716	Vitamin A and carotenoid metabolism	10	0.073	320.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	20	0.073	236.5
WP3915	Angiopoietin-like protein 8 regulatory pathway	20	0.073	300
WP170	Nuclear receptors	30	0.073	286.5
WP3981	miRNA regulation of prostate cancer signaling pathways	30	0.073	200.5
WP437	EGF/EGFR signaling pathway	30	0.073	252
WP4524	Alternative pathway of fetal androgen synthesis	30	0.073	322.5
WP4853	Linoleic acid metabolism affected by coronavirus infection	30	0.073	641.5
WP129	Matrix metalloproteinases	2	0.072	421
WP176	Folate metabolism	2	0.072	225
WP3601	Lipid particles composition	2	0.072	434
WP558	Complement and coagulation cascades	3	0.072	355.5
WP1403	AMP-activated protein kinase (AMPK) signaling	4	0.072	222.5
WP23	B cell receptor signaling pathway	4	0.072	212
WP2858	Ectoderm differentiation	4	0.072	170
WP4658	Small cell lung cancer	4	0.072	233
WP2873	Aryl hydrocarbon receptor pathway	5	0.072	241.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	5	0.072	307.5
WP4496	Signal transduction through IL1R	5	0.072	267
WP51	Regulation of actin cytoskeleton	5	0.072	210
WP138	Androgen receptor signaling pathway	10	0.072	259
WP2113	Type III interferon signaling	10	0.072	569.5
WP4148	Splicing factor NOVA regulated synaptic proteins	10	0.072	302.5
WP2118	Arrhythmogenic right ventricular cardiomyopathy	20	0.072	266
WP477	Cytoplasmic ribosomal proteins	20	0.072	559.5
WP5066	FOXA2 pathway	20	0.072	342.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	20	0.072	521.5
WP2806	Complement system	30	0.072	306
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	30	0.072	268
WP4493	Cells and molecules involved in local acute inflammatory response	30	0.072	241
WP678	Arachidonate epoxygenase / epoxide hydrolase	30	0.072	505
WP3611	Photodynamic therapy-induced AP-1 survival signaling	2	0.071	205
WP4655	Cytosolic DNA-sensing pathway	2	0.071	421.75
WP1772	Apoptosis modulation and signaling	3	0.071	229.5
WP2858	Ectoderm differentiation	3	0.071	170
WP4484	Control of immune tolerance by vasoactive intestinal peptide	3	0.071	426
WP3982	miRNA regulation of p53 pathway in prostate cancer	4	0.071	370
WP4969	RAS and bradykinin pathways in COVID-19	4	0.071	280
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	4	0.071	215
WP2118	Arrhythmogenic right ventricular cardiomyopathy	5	0.071	209.5
WP4875	Disruption of postsynaptic signaling by CNV	5	0.071	320
WP2261	Glioblastoma signaling pathways	10	0.071	231
WP3303	RAC1/PAK1/p38/MMP2 pathway	10	0.071	263
WP3982	miRNA regulation of p53 pathway in prostate cancer	10	0.071	350
WP4220	Neurotransmitter disorders	10	0.071	575
WP2289	Drug induction of bile acid pathway	20	0.071	367
WP4756	Renin-angiotensin-aldosterone system (RAAS)	20	0.071	316
WP51	Regulation of actin cytoskeleton	20	0.071	269.5
WP3945	TYROBP causal network in microglia	30	0.071	313
WP481	Insulin signaling	30	0.071	281.5
WP4830	GDNF/RET signaling axis	30	0.071	333.5
WP5112	Familial hyperlipidemia type 5	2	0.07	435
WP185	Integrin-mediated cell adhesion	3	0.07	168.5
WP2446	Retinoblastoma gene in cancer	3	0.07	246
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	3	0.07	167
WP5098	T-cell activation SARS-CoV-2	3	0.07	213
WP382	MAPK signaling pathway	4	0.07	218
WP3851	TLR4 signaling and tolerance	4	0.07	345.5
WP534	Glycolysis and gluconeogenesis	4	0.07	442.5
WP2374	Oncostatin M signaling pathway	5	0.07	236
WP2516	ATM signaling pathway	5	0.07	284.5
WP262	Ebstein-Barr virus LMP1 signaling	5	0.07	337.5
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	5	0.07	265
WP1604	Codeine and morphine metabolism	10	0.07	418
WP4806	EGFR tyrosine kinase inhibitor resistance	10	0.07	237
WP5031	Biotin metabolism, including IEMs	10	0.07	583.5
WP58	Monoamine GPCRs	10	0.07	583.25
WP698	Glucuronidation	10	0.07	509.5
WP4286	Genotoxicity pathway	20	0.07	406.5
WP437	EGF/EGFR signaling pathway	20	0.07	264.5
WP4963	p53 transcriptional gene network	20	0.07	456.5
WP2431	Spinal cord injury	2	0.069	178
WP3929	Chemokine signaling pathway	2	0.069	148
WP231	TNF-alpha signaling pathway	3	0.069	223.5
WP2879	Farnesoid X receptor pathway	3	0.069	461.75
WP4496	Signal transduction through IL1R	3	0.069	280.5
WP2516	ATM signaling pathway	4	0.069	278.5
WP3646	Hepatitis C and hepatocellular carcinoma	4	0.069	230
WP3929	Chemokine signaling pathway	4	0.069	182
WP4016	DNA IR-damage and cellular response via ATR	4	0.069	309
WP5066	FOXA2 pathway	4	0.069	464
WP707	DNA damage response	4	0.069	252
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	10	0.069	297.5
WP5066	FOXA2 pathway	10	0.069	332.5
WP51	Regulation of actin cytoskeleton	10	0.069	252
WP2870	Extracellular vesicle-mediated signaling in recipient cells	20	0.069	281.5
WP4496	Signal transduction through IL1R	20	0.069	265.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	30	0.069	223.5
WP286	IL-3 signaling pathway	30	0.069	250.5
WP4496	Signal transduction through IL1R	30	0.069	275
WP4698	Vitamin D-sensitive calcium signaling in depression	30	0.069	278
WP5092	Interactions of natural killer cells in pancreatic cancer	30	0.069	280
WP2853	Endoderm differentiation	2	0.068	162.5
WP5094	Orexin receptor pathway	2	0.068	160.5
WP5066	FOXA2 pathway	3	0.068	453.75
WP1530	miRNA regulation of DNA damage response	4	0.068	255
WP2876	Pregnane X receptor pathway	4	0.068	385.5
WP299	Nuclear receptors in lipid metabolism and toxicity	4	0.068	313.5
WP3982	miRNA regulation of p53 pathway in prostate cancer	5	0.068	336
WP4629	Aerobic glycolysis	5	0.068	512
WP4830	GDNF/RET signaling axis	5	0.068	497
WP4674	Head and neck squamous cell carcinoma	10	0.068	248.5
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	10	0.068	243.5
WP2332	Interleukin-11 signaling pathway	20	0.068	287.5
WP3931	Embryonic stem cell pluripotency pathways	20	0.068	316.5
WP716	Vitamin A and carotenoid metabolism	20	0.068	346.5
WP2509	Nanoparticle triggered autophagic cell death	30	0.068	369
WP3287	Overview of nanoparticle effects	30	0.068	207.5
WP1449	Regulation of toll-like receptor signaling pathway	2	0.067	216
WP453	Inflammatory response pathway	2	0.067	409.25
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	2	0.067	402.75
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3	0.067	226.5
WP5109	Familial hyperlipidemia type 2	3	0.067	459
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	4	0.067	202
WP4673	Male infertility	4	0.067	212
WP4746	Thyroid hormones production and peripheral downstream signaling effects	4	0.067	244.5
WP4946	DNA repair pathways, full network	4	0.067	343.5
WP5092	Interactions of natural killer cells in pancreatic cancer	4	0.067	278.5
WP1604	Codeine and morphine metabolism	5	0.067	485.5
WP185	Integrin-mediated cell adhesion	5	0.067	191
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	5	0.067	300
WP229	Irinotecan pathway	5	0.067	499.75
WP3945	TYROBP causal network in microglia	5	0.067	247
WP4746	Thyroid hormones production and peripheral downstream signaling effects	5	0.067	244.5
WP4752	Base excision repair	5	0.067	475.25
WP5092	Interactions of natural killer cells in pancreatic cancer	5	0.067	279
WP23	B cell receptor signaling pathway	10	0.067	248
WP2853	Endoderm differentiation	10	0.067	234
WP465	Tryptophan metabolism	10	0.067	364
WP4823	Genes controlling nephrogenesis	10	0.067	287
WP23	B cell receptor signaling pathway	20	0.067	274.5
WP2542	Sulindac metabolic pathway	20	0.067	619.5
WP3658	Wnt/beta-catenin signaling pathway in leukemia	20	0.067	256.5
WP4239	Epithelial to mesenchymal transition in colorectal cancer	20	0.067	293.5
WP2596	Gastric acid production	30	0.067	464.5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	30	0.067	308
WP4538	Regulatory circuits of the STAT3 signaling pathway	30	0.067	283.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	4	0.066	307.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	5	0.066	276
WP3594	Circadian rhythm genes	5	0.066	234
WP4018	Clear cell renal cell carcinoma pathways	5	0.066	249
WP4149	White fat cell differentiation	5	0.066	210
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	5	0.066	217
WP696	Benzo(a)pyrene metabolism	5	0.066	509.25
WP1545	miRNAs involved in DNA damage response	10	0.066	235.5
WP2018	RANKL/RANK signaling pathway	10	0.066	249
WP2289	Drug induction of bile acid pathway	10	0.066	358.5
WP4584	Biomarkers for pyrimidine metabolism disorders	10	0.066	558.5
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	10	0.066	556.5
WP5061	Fatty acid transporters	10	0.066	572.5
WP465	Tryptophan metabolism	20	0.066	360.5
WP4823	Genes controlling nephrogenesis	20	0.066	326
WP5052	Nephrogenesis	20	0.066	431
WP2113	Type III interferon signaling	30	0.066	437
WP4223	Ras signaling	30	0.066	269.5
WP4746	Thyroid hormones production and peripheral downstream signaling effects	30	0.066	289.5
WP5053	Development of ureteric collection system	30	0.066	284.5
WP536	Calcium regulation in cardiac cells	30	0.066	358.5
WP299	Nuclear receptors in lipid metabolism and toxicity	2	0.065	409.75
WP3942	PPAR signaling pathway	2	0.065	405
WP75	Toll-like receptor signaling pathway	2	0.065	266
WP2374	Oncostatin M signaling pathway	3	0.065	194
WP4352	Ciliary landscape	3	0.065	236
WP534	Glycolysis and gluconeogenesis	3	0.065	447.5
WP185	Integrin-mediated cell adhesion	4	0.065	198
WP4146	Macrophage markers	4	0.065	482
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	4	0.065	227
WP2064	Neural crest differentiation	5	0.065	234
WP4262	Breast cancer pathway	5	0.065	253
WP4540	Hippo signaling regulation pathways	5	0.065	205.5
WP4658	Small cell lung cancer	5	0.065	254
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	5	0.065	220
WP206	Fatty acid omega-oxidation	10	0.065	536.25
WP229	Irinotecan pathway	10	0.065	393.5
WP3658	Wnt/beta-catenin signaling pathway in leukemia	10	0.065	266
WP2037	Prolactin signaling pathway	20	0.065	261
WP2355	Corticotropin-releasing hormone signaling pathway	20	0.065	241.5
WP5124	Alzheimer's disease	20	0.065	257
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	30	0.065	201
WP3613	Photodynamic therapy-induced unfolded protein response	30	0.065	354
WP254	Apoptosis	2	0.064	215
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	2	0.064	429.5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	2	0.064	425.25
WP5083	Neuroinflammation and glutamatergic signaling	2	0.064	185
WP558	Complement and coagulation cascades	2	0.064	414.25
WP1403	AMP-activated protein kinase (AMPK) signaling	3	0.064	207
WP322	Osteoblast signaling	3	0.064	454.75
WP4298	Acute viral myocarditis	3	0.064	208
WP4969	RAS and bradykinin pathways in COVID-19	3	0.064	331
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	4	0.064	265
WP5109	Familial hyperlipidemia type 2	4	0.064	469
WP5124	Alzheimer's disease	4	0.064	205
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	5	0.064	513
WP3937	Microglia pathogen phagocytosis pathway	5	0.064	377
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	5	0.064	209.5
WP4787	Osteoblast differentiation and related diseases	5	0.064	219
WP4912	SARS coronavirus and innate immunity	5	0.064	504.5
WP5097	CCL18 signaling pathway	5	0.064	225
WP4149	White fat cell differentiation	10	0.064	233
WP4746	Thyroid hormones production and peripheral downstream signaling effects	10	0.064	274
WP2526	PDGF pathway	20	0.064	282
WP3599	Transcription factor regulation in adipogenesis	20	0.064	275.5
WP4673	Male infertility	20	0.064	258
WP4789	MED and pseudoachondroplasia genes	20	0.064	630
WP2355	Corticotropin-releasing hormone signaling pathway	30	0.064	234.5
WP289	Myometrial relaxation and contraction pathways	30	0.064	269
WP382	MAPK signaling pathway	30	0.064	284
WP4919	Neuroinflammation	30	0.064	296
WP673	ErbB signaling pathway	30	0.064	261
WP4396	Nonalcoholic fatty liver disease	2	0.063	190
WP4484	Control of immune tolerance by vasoactive intestinal peptide	2	0.063	417.5
WP5111	Familial hyperlipidemia type 4	2	0.063	426.25
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	3	0.063	247
WP2806	Complement system	3	0.063	224
WP2849	Hematopoietic stem cell differentiation	3	0.063	210.5
WP2873	Aryl hydrocarbon receptor pathway	3	0.063	226
WP51	Regulation of actin cytoskeleton	3	0.063	188.5
WP2059	Alzheimer's disease and miRNA effects	4	0.063	201
WP2374	Oncostatin M signaling pathway	4	0.063	225
WP206	Fatty acid omega-oxidation	5	0.063	511.5
WP47	Hedgehog signaling pathway Netpath	5	0.063	504.5
WP716	Vitamin A and carotenoid metabolism	5	0.063	297.5
WP35	G protein signaling pathways	10	0.063	263
WP3925	Amino acid metabolism	10	0.063	320
WP4255	Non-small cell lung cancer	10	0.063	261
WP4659	Gastrin signaling pathway	10	0.063	237
WP4875	Disruption of postsynaptic signaling by CNV	10	0.063	299.5
WP560	TGF-beta receptor signaling	10	0.063	253
WP2059	Alzheimer's disease and miRNA effects	20	0.063	255.5
WP2509	Nanoparticle triggered autophagic cell death	20	0.063	349
WP35	G protein signaling pathways	20	0.063	313
WP4324	Mitochondrial complex I assembly model OXPHOS system	20	0.063	626.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	30	0.063	275
WP2880	Glucocorticoid receptor pathway	30	0.063	268
WP3995	Prion disease pathway	30	0.063	264.5
WP4479	Supression of HMGB1 mediated inflammation by THBD	30	0.063	342
WP4752	Base excision repair	30	0.063	396
WP4823	Genes controlling nephrogenesis	30	0.063	307
WP53	ID signaling pathway	30	0.063	316.5
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2	0.062	421.5
WP3915	Angiopoietin-like protein 8 regulatory pathway	2	0.062	173.5
WP4016	DNA IR-damage and cellular response via ATR	2	0.062	398.75
WP170	Nuclear receptors	3	0.062	208.5
WP23	B cell receptor signaling pathway	3	0.062	184
WP1984	Integrated breast cancer pathway	4	0.062	228
WP229	Irinotecan pathway	4	0.062	489
WP4666	Hepatitis B infection	4	0.062	218.5
WP536	Calcium regulation in cardiac cells	4	0.062	213
WP1403	AMP-activated protein kinase (AMPK) signaling	5	0.062	234.5
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	5	0.062	490.25
WP5114	Nucleotide excision repair in xeroderma pigmentosum	5	0.062	377.5
WP534	Glycolysis and gluconeogenesis	5	0.062	349.5
WP1946	Cori cycle	10	0.062	312
WP2586	Aryl hydrocarbon receptor Netpath	10	0.062	251.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	10	0.062	250
WP4816	TGF-beta receptor signaling in skeletal dysplasias	10	0.062	254
WP727	Monoamine transport	10	0.062	278
WP2018	RANKL/RANK signaling pathway	20	0.062	251
WP2881	Estrogen receptor pathway	20	0.062	290
WP3878	ATM signaling in development and disease	20	0.062	331
WP3925	Amino acid metabolism	20	0.062	352.5
WP4844	Influence of laminopathies on Wnt signaling	20	0.062	290
WP2118	Arrhythmogenic right ventricular cardiomyopathy	30	0.062	265
WP2853	Endoderm differentiation	30	0.062	286
WP465	Tryptophan metabolism	30	0.062	379
WP4844	Influence of laminopathies on Wnt signaling	30	0.062	282.5
WP5066	FOXA2 pathway	30	0.062	370
WP1772	Apoptosis modulation and signaling	2	0.061	221.5
WP236	Adipogenesis	2	0.061	156
WP2858	Ectoderm differentiation	2	0.061	149
WP4239	Epithelial to mesenchymal transition in colorectal cancer	2	0.061	189
WP69	T-cell receptor (TCR) signaling pathway	3	0.061	198
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	3	0.061	193
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	4	0.061	265
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	4	0.061	500.5
WP4217	Ebola virus pathway in host	4	0.061	215.5
WP4629	Aerobic glycolysis	4	0.061	497
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	4	0.061	261.5
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	4	0.061	480.25
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	5	0.061	470.75
WP23	B cell receptor signaling pathway	5	0.061	214.5
WP2828	Bladder cancer	5	0.061	247
WP2857	Mesodermal commitment pathway	5	0.061	223
WP2878	PPAR-alpha pathway	5	0.061	269
WP5066	FOXA2 pathway	5	0.061	419
WP2507	Nanomaterial induced apoptosis	10	0.061	316
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	10	0.061	549
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	20	0.061	256
WP4541	Hippo-Merlin signaling dysregulation	20	0.061	255
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	20	0.061	396
WP4787	Osteoblast differentiation and related diseases	20	0.061	314
WP143	Fatty acid beta-oxidation	30	0.061	442.5
WP3915	Angiopoietin-like protein 8 regulatory pathway	30	0.061	325
WP4148	Splicing factor NOVA regulated synaptic proteins	30	0.061	341.5
WP5052	Nephrogenesis	30	0.061	447
WP1971	Integrated cancer pathway	2	0.06	222.5
WP2865	IL1 and megakaryocytes in obesity	2	0.06	410.5
WP2874	Liver X receptor pathway	2	0.06	434.5
WP364	IL-6 signaling pathway	2	0.06	396.5
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	2	0.06	140.5
WP2059	Alzheimer's disease and miRNA effects	3	0.06	199.5
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	3	0.06	407.5
WP4018	Clear cell renal cell carcinoma pathways	3	0.06	207
WP4545	Oxysterols derived from cholesterol	3	0.06	436.25
WP536	Calcium regulation in cardiac cells	3	0.06	198
WP262	Ebstein-Barr virus LMP1 signaling	4	0.06	423
WP2849	Hematopoietic stem cell differentiation	4	0.06	215
WP3594	Circadian rhythm genes	4	0.06	225
WP1742	TP53 network	5	0.06	253.5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	5	0.06	274
WP4538	Regulatory circuits of the STAT3 signaling pathway	5	0.06	233
WP314	Fas ligand pathway and stress induction of heat shock proteins	10	0.06	281.5
WP3851	TLR4 signaling and tolerance	10	0.06	298
WP4673	Male infertility	10	0.06	268
WP4723	Omega-3 / omega-6 fatty acid synthesis	10	0.06	560.75
WP561	Heme biosynthesis	10	0.06	583.5
WP272	Blood clotting cascade	20	0.06	323
WP3963	Mevalonate pathway	20	0.06	494.5
WP5063	FOXP3 in COVID-19	20	0.06	275.5
WP550	Biogenic amine synthesis	20	0.06	466.5
WP404	Nucleotide metabolism	30	0.06	439
WP4673	Male infertility	30	0.06	248
WP4912	SARS coronavirus and innate immunity	30	0.06	412.5
WP61	Notch signaling pathway (Netpath)	30	0.06	278
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	2	0.059	384.25
WP35	G protein signaling pathways	2	0.059	362.5
WP4969	RAS and bradykinin pathways in COVID-19	2	0.059	410.5
WP2118	Arrhythmogenic right ventricular cardiomyopathy	3	0.059	187
WP2431	Spinal cord injury	3	0.059	213
WP3613	Photodynamic therapy-induced unfolded protein response	3	0.059	438.5
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	3	0.059	250.5
WP4016	DNA IR-damage and cellular response via ATR	3	0.059	314.5
WP4830	GDNF/RET signaling axis	3	0.059	469
WP5124	Alzheimer's disease	3	0.059	199.5
WP2828	Bladder cancer	4	0.059	241.5
WP2848	Pluripotent stem cell differentiation pathway	4	0.059	238
WP4148	Splicing factor NOVA regulated synaptic proteins	4	0.059	303.5
WP4540	Hippo signaling regulation pathways	4	0.059	208.5
WP4545	Oxysterols derived from cholesterol	4	0.059	419
WP4814	Somatic sex determination	4	0.059	488
WP1424	Globo sphingolipid metabolism	5	0.059	507.5
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5	0.059	251.5
WP286	IL-3 signaling pathway	5	0.059	243
WP2875	Constitutive androstane receptor pathway	5	0.059	280.5
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	5	0.059	418
WP143	Fatty acid beta-oxidation	10	0.059	477
WP2879	Farnesoid X receptor pathway	10	0.059	331.5
WP3931	Embryonic stem cell pluripotency pathways	10	0.059	285
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	10	0.059	253.5
WP4724	Omega-9 fatty acid synthesis	10	0.059	463.5
WP5063	FOXP3 in COVID-19	10	0.059	309
WP550	Biogenic amine synthesis	10	0.059	560
WP3892	Development of pulmonary dendritic cells and macrophage subsets	20	0.059	273.5
WP4148	Splicing factor NOVA regulated synaptic proteins	20	0.059	325
WP4540	Hippo signaling regulation pathways	20	0.059	285.5
WP4751	HIPK2 in kidney fibrosis	20	0.059	625.5
WP696	Benzo(a)pyrene metabolism	20	0.059	343.5
WP727	Monoamine transport	20	0.059	294
WP2059	Alzheimer's disease and miRNA effects	30	0.059	297.5
WP496	Steroid biosynthesis	30	0.059	386.5
WP2324	AGE/RAGE pathway	2	0.058	191
WP2884	NRF2 pathway	2	0.058	223
WP4875	Disruption of postsynaptic signaling by CNV	2	0.058	429.5
WP5109	Familial hyperlipidemia type 2	2	0.058	433.75
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	2	0.058	162
WP1424	Globo sphingolipid metabolism	3	0.058	474.75
WP2324	AGE/RAGE pathway	3	0.058	203
WP3287	Overview of nanoparticle effects	3	0.058	252
WP3646	Hepatitis C and hepatocellular carcinoma	3	0.058	216
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3	0.058	375.5
WP1742	TP53 network	4	0.058	243.5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	4	0.058	261
WP4149	White fat cell differentiation	4	0.058	219
WP4823	Genes controlling nephrogenesis	4	0.058	250
WP5033	Genes associated with the development of rheumatoid arthritis	4	0.058	469.5
WP2324	AGE/RAGE pathway	5	0.058	233
WP4223	Ras signaling	5	0.058	216
WP437	EGF/EGFR signaling pathway	5	0.058	208.5
WP4685	Melanoma	5	0.058	240.5
WP496	Steroid biosynthesis	5	0.058	515.5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	10	0.058	268.5
WP3585	Cytosine methylation	10	0.058	579
WP3888	VEGFA-VEGFR2 signaling pathway	10	0.058	217.5
WP4239	Epithelial to mesenchymal transition in colorectal cancer	10	0.058	287
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	10	0.058	272
WP4838	Regucalcin in proximal tubule epithelial kidney cells	10	0.058	310
WP2853	Endoderm differentiation	20	0.058	278
WP4875	Disruption of postsynaptic signaling by CNV	20	0.058	328
WP5072	Modulators of TCR signaling and T cell activation	20	0.058	319.5
WP2447	Amyotrophic lateral sclerosis (ALS)	30	0.058	350
WP4331	Neovascularisation processes	30	0.058	281
WP716	Vitamin A and carotenoid metabolism	30	0.058	370
WP2849	Hematopoietic stem cell differentiation	2	0.057	196.5
WP51	Regulation of actin cytoskeleton	2	0.057	176
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	3	0.057	463.75
WP1984	Integrated breast cancer pathway	3	0.057	207.5
WP4197	Immune response to tuberculosis	3	0.057	468.75
WP2118	Arrhythmogenic right ventricular cardiomyopathy	4	0.057	204.5
WP4263	Pancreatic adenocarcinoma pathway	4	0.057	223
WP4912	SARS coronavirus and innate immunity	4	0.057	490.25
WP5097	CCL18 signaling pathway	4	0.057	212
WP696	Benzo(a)pyrene metabolism	4	0.057	499.5
WP3584	MECP2 and associated Rett syndrome	5	0.057	222
WP411	mRNA processing	5	0.057	488
WP4666	Hepatitis B infection	5	0.057	234
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	5	0.057	516.5
WP1539	Angiogenesis	10	0.057	269.5
WP2118	Arrhythmogenic right ventricular cardiomyopathy	10	0.057	240
WP3599	Transcription factor regulation in adipogenesis	10	0.057	289.5
WP395	IL-4 signaling pathway	10	0.057	239.5
WP411	mRNA processing	10	0.057	380
WP4141	PI3K/AKT/mTOR - VitD3 signaling	10	0.057	248
WP4538	Regulatory circuits of the STAT3 signaling pathway	10	0.057	275
WP4787	Osteoblast differentiation and related diseases	10	0.057	263
WP5033	Genes associated with the development of rheumatoid arthritis	10	0.057	299.5
WP3287	Overview of nanoparticle effects	20	0.057	219.5
WP4538	Regulatory circuits of the STAT3 signaling pathway	20	0.057	294.5
WP5036	Angiotensin II receptor type 1 pathway	20	0.057	295
WP1434	Osteopontin signaling	30	0.057	296
WP4891	COVID-19 adverse outcome pathway	2	0.056	416
WP5088	Prostaglandin signaling	2	0.056	398
WP35	G protein signaling pathways	3	0.056	204
WP3959	DNA IR-double strand breaks and cellular response via ATM	3	0.056	344
WP707	DNA damage response	3	0.056	233
WP1539	Angiogenesis	4	0.056	243
WP2261	Glioblastoma signaling pathways	4	0.056	215
WP496	Steroid biosynthesis	4	0.056	501.5
WP5114	Nucleotide excision repair in xeroderma pigmentosum	4	0.056	444.5
WP698	Glucuronidation	4	0.056	497
WP1434	Osteopontin signaling	5	0.056	460.75
WP2272	Pathogenic Escherichia coli infection	5	0.056	232
WP384	Apoptosis modulation by HSP70	5	0.056	456.5
WP3851	TLR4 signaling and tolerance	5	0.056	275.5
WP4558	Overview of interferons-mediated signaling pathway	5	0.056	406.5
WP5072	Modulators of TCR signaling and T cell activation	5	0.056	232
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	10	0.056	262.5
WP4540	Hippo signaling regulation pathways	10	0.056	264
WP4545	Oxysterols derived from cholesterol	10	0.056	345.5
WP5124	Alzheimer's disease	10	0.056	253.5
WP1601	Fluoropyrimidine activity	20	0.056	369
WP170	Nuclear receptors	20	0.056	270
WP206	Fatty acid omega-oxidation	20	0.056	395
WP2491	Diclofenac metabolic pathway	20	0.056	628
WP3981	miRNA regulation of prostate cancer signaling pathways	20	0.056	231
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	20	0.056	304
WP481	Insulin signaling	20	0.056	288
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	30	0.056	261.5
WP35	G protein signaling pathways	30	0.056	342
WP3972	PDGFR-beta pathway	30	0.056	283
WP4481	Resistin as a regulator of inflammation	30	0.056	264
WP4787	Osteoblast differentiation and related diseases	30	0.056	336
WP49	IL-2 signaling pathway	30	0.056	228
WP4932	7q11.23 copy number variation syndrome	30	0.056	326
WP231	TNF-alpha signaling pathway	2	0.055	232.5
WP4329	miRNAs involvement in the immune response in sepsis	2	0.055	406.25
WP4496	Signal transduction through IL1R	2	0.055	401.75
WP4787	Osteoblast differentiation and related diseases	2	0.055	234.5
WP1530	miRNA regulation of DNA damage response	3	0.055	235.5
WP2828	Bladder cancer	3	0.055	221.5
WP1604	Codeine and morphine metabolism	4	0.055	474.5
WP2034	Leptin signaling pathway	4	0.055	226
WP2064	Neural crest differentiation	4	0.055	218.5
WP272	Blood clotting cascade	4	0.055	456
WP2853	Endoderm differentiation	4	0.055	200.5
WP3613	Photodynamic therapy-induced unfolded protein response	4	0.055	365.5
WP3935	Leptin-insulin signaling overlap	4	0.055	443.25
WP3937	Microglia pathogen phagocytosis pathway	4	0.055	453
WP4558	Overview of interferons-mediated signaling pathway	4	0.055	460.25
WP465	Tryptophan metabolism	4	0.055	464.5
WP4971	Phosphoinositides metabolism	4	0.055	438.5
WP53	ID signaling pathway	4	0.055	466.5
WP170	Nuclear receptors	5	0.055	232
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	5	0.055	217.5
WP3297	EV release from cardiac cells and their functional effects	5	0.055	495.5
WP4524	Alternative pathway of fetal androgen synthesis	5	0.055	471.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	5	0.055	251.5
WP4584	Biomarkers for pyrimidine metabolism disorders	5	0.055	517.5
WP4814	Somatic sex determination	5	0.055	501.5
WP5033	Genes associated with the development of rheumatoid arthritis	5	0.055	461.75
WP3963	Mevalonate pathway	10	0.055	573
WP4756	Renin-angiotensin-aldosterone system (RAAS)	10	0.055	302
WP4844	Influence of laminopathies on Wnt signaling	10	0.055	274
WP5036	Angiotensin II receptor type 1 pathway	10	0.055	282
WP5053	Development of ureteric collection system	10	0.055	247
WP2267	Synaptic vesicle pathway	20	0.055	391
WP3972	PDGFR-beta pathway	20	0.055	290
WP3998	Prader-Willi and Angelman syndrome	20	0.055	262
WP4479	Supression of HMGB1 mediated inflammation by THBD	20	0.055	342
WP4571	Urea cycle and related diseases	20	0.055	625
WP474	Endochondral ossification	20	0.055	253.5
WP4808	Endochondral ossification with skeletal dysplasias	20	0.055	253.5
WP272	Blood clotting cascade	30	0.055	345
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	30	0.055	249.5
WP4241	Type 2 papillary renal cell carcinoma	30	0.055	306
WP4540	Hippo signaling regulation pathways	30	0.055	269
WP561	Heme biosynthesis	30	0.055	633.25
WP4018	Clear cell renal cell carcinoma pathways	2	0.054	199.5
WP707	DNA damage response	2	0.054	215
WP1971	Integrated cancer pathway	3	0.054	225
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	3	0.054	293.5
WP2865	IL1 and megakaryocytes in obesity	3	0.054	311.5
WP4540	Hippo signaling regulation pathways	3	0.054	187.5
WP5033	Genes associated with the development of rheumatoid arthritis	3	0.054	455.75
WP186	Homologous recombination	4	0.054	493.5
WP3945	TYROBP causal network in microglia	4	0.054	275
WP455	GPCRs, class A rhodopsin-like	4	0.054	328.5
WP474	Endochondral ossification	4	0.054	218
WP4808	Endochondral ossification with skeletal dysplasias	4	0.054	218
WP5053	Development of ureteric collection system	4	0.054	223.5
WP69	T-cell receptor (TCR) signaling pathway	4	0.054	218.5
WP1981	Thyroxine (thyroid hormone) production	5	0.054	519
WP2261	Glioblastoma signaling pathways	5	0.054	225
WP2289	Drug induction of bile acid pathway	5	0.054	437
WP4312	Rett syndrome causing genes	5	0.054	243
WP4481	Resistin as a regulator of inflammation	5	0.054	252.5
WP4545	Oxysterols derived from cholesterol	5	0.054	331
WP465	Tryptophan metabolism	5	0.054	455.5
WP5063	FOXP3 in COVID-19	5	0.054	323
WP170	Nuclear receptors	10	0.054	253
WP2059	Alzheimer's disease and miRNA effects	10	0.054	249.5
WP272	Blood clotting cascade	10	0.054	322.5
WP4259	Disorders of folate metabolism and transport	10	0.054	558.5
WP47	Hedgehog signaling pathway Netpath	10	0.054	372.5
WP474	Endochondral ossification	10	0.054	259
WP4808	Endochondral ossification with skeletal dysplasias	10	0.054	259
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	20	0.054	256.5
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	20	0.054	409
WP5033	Genes associated with the development of rheumatoid arthritis	20	0.054	308
WP561	Heme biosynthesis	20	0.054	622.75
WP1541	Energy metabolism	30	0.054	305
WP3878	ATM signaling in development and disease	30	0.054	335
WP3998	Prader-Willi and Angelman syndrome	30	0.054	240
WP1530	miRNA regulation of DNA damage response	2	0.053	218
WP2359	Parkin-ubiquitin proteasomal system pathway	2	0.053	442.5
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	2	0.053	410.5
WP3982	miRNA regulation of p53 pathway in prostate cancer	2	0.053	421.75
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2	0.053	367.75
WP4545	Oxysterols derived from cholesterol	2	0.053	421
WP4746	Thyroid hormones production and peripheral downstream signaling effects	2	0.053	366.25
WP2876	Pregnane X receptor pathway	3	0.053	438.5
WP3584	MECP2 and associated Rett syndrome	3	0.053	190.5
WP4875	Disruption of postsynaptic signaling by CNV	3	0.053	450.5
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	3	0.053	449.5
WP4155	Endometrial cancer	4	0.053	233.5
WP4537	Hippo-Yap signaling pathway	4	0.053	480
WP4584	Biomarkers for pyrimidine metabolism disorders	4	0.053	500.5
WP531	DNA mismatch repair	4	0.053	492
WP716	Vitamin A and carotenoid metabolism	4	0.053	358.5
WP2507	Nanomaterial induced apoptosis	5	0.053	297.5
WP3935	Leptin-insulin signaling overlap	5	0.053	306
WP4290	Metabolic reprogramming in colon cancer	5	0.053	464.75
WP4537	Hippo-Yap signaling pathway	5	0.053	477.25
WP4673	Male infertility	5	0.053	236
WP1424	Globo sphingolipid metabolism	10	0.053	387.5
WP2267	Synaptic vesicle pathway	10	0.053	384.5
WP2848	Pluripotent stem cell differentiation pathway	10	0.053	272.5
WP3892	Development of pulmonary dendritic cells and macrophage subsets	10	0.053	247
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	10	0.053	359
WP4223	Ras signaling	10	0.053	248.5
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	10	0.053	580.5
WP5072	Modulators of TCR signaling and T cell activation	10	0.053	272
WP325	Triacylglyceride synthesis	20	0.053	398
WP4149	White fat cell differentiation	20	0.053	262
WP47	Hedgehog signaling pathway Netpath	20	0.053	352.5
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	20	0.053	620.25
WP2289	Drug induction of bile acid pathway	30	0.053	390
WP2359	Parkin-ubiquitin proteasomal system pathway	30	0.053	382
WP474	Endochondral ossification	30	0.053	277.5
WP4808	Endochondral ossification with skeletal dysplasias	30	0.053	277.5
WP4875	Disruption of postsynaptic signaling by CNV	30	0.053	333
WP5063	FOXP3 in COVID-19	30	0.053	277
WP5124	Alzheimer's disease	30	0.053	296
WP696	Benzo(a)pyrene metabolism	30	0.053	352
WP2516	ATM signaling pathway	2	0.052	349
WP3617	Photodynamic therapy-induced NF-kB survival signaling	2	0.052	269
WP4146	Macrophage markers	3	0.052	470.25
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	3	0.052	454
WP4816	TGF-beta receptor signaling in skeletal dysplasias	3	0.052	203.5
WP170	Nuclear receptors	4	0.052	224.5
WP2875	Constitutive androstane receptor pathway	4	0.052	322
WP3287	Overview of nanoparticle effects	4	0.052	255
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	4	0.052	463.75
WP4816	TGF-beta receptor signaling in skeletal dysplasias	4	0.052	215.5
WP4875	Disruption of postsynaptic signaling by CNV	4	0.052	381.5
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4	0.052	209
WP560	TGF-beta receptor signaling	4	0.052	219
WP186	Homologous recombination	5	0.052	507.75
WP306	Focal adhesion	5	0.052	214.5
WP3298	Melatonin metabolism and effects	5	0.052	261
WP3613	Photodynamic therapy-induced unfolded protein response	5	0.052	288
WP391	Mitochondrial gene expression	5	0.052	499.75
WP4022	Pyrimidine metabolism	5	0.052	497.5
WP4263	Pancreatic adenocarcinoma pathway	5	0.052	236.5
WP4321	Thermogenesis	5	0.052	230.5
WP531	DNA mismatch repair	5	0.052	500.75
WP2509	Nanoparticle triggered autophagic cell death	10	0.052	311
WP2857	Mesodermal commitment pathway	10	0.052	271
WP2875	Constitutive androstane receptor pathway	10	0.052	310.5
WP3998	Prader-Willi and Angelman syndrome	10	0.052	256
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	10	0.052	450.5
WP585	Interferon type I signaling pathways	10	0.052	264
WP673	ErbB signaling pathway	10	0.052	272
WP2857	Mesodermal commitment pathway	20	0.052	287
WP286	IL-3 signaling pathway	20	0.052	257.5
WP289	Myometrial relaxation and contraction pathways	20	0.052	289.5
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	20	0.052	272
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	20	0.052	297
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	20	0.052	311.5
WP4932	7q11.23 copy number variation syndrome	20	0.052	314
WP2857	Mesodermal commitment pathway	30	0.052	307.5
WP322	Osteoblast signaling	30	0.052	327
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	30	0.052	327
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	30	0.052	281.5
WP3935	Leptin-insulin signaling overlap	30	0.052	305
WP185	Integrin-mediated cell adhesion	2	0.051	176
WP2064	Neural crest differentiation	2	0.051	185.5
WP2374	Oncostatin M signaling pathway	2	0.051	185
WP4136	Fibrin complement receptor 3 signaling pathway	2	0.051	412
WP4148	Splicing factor NOVA regulated synaptic proteins	2	0.051	418.75
WP4197	Immune response to tuberculosis	2	0.051	434
WP534	Glycolysis and gluconeogenesis	2	0.051	426
WP69	T-cell receptor (TCR) signaling pathway	2	0.051	202.5
WP2289	Drug induction of bile acid pathway	3	0.051	456.5
WP2516	ATM signaling pathway	3	0.051	283.5
WP3297	EV release from cardiac cells and their functional effects	3	0.051	468
WP3594	Circadian rhythm genes	3	0.051	198.5
WP3982	miRNA regulation of p53 pathway in prostate cancer	3	0.051	439.75
WP4148	Splicing factor NOVA regulated synaptic proteins	3	0.051	394.5
WP4321	Thermogenesis	3	0.051	203
WP4481	Resistin as a regulator of inflammation	3	0.051	252
WP4658	Small cell lung cancer	3	0.051	211.5
WP4823	Genes controlling nephrogenesis	3	0.051	276.5
WP696	Benzo(a)pyrene metabolism	3	0.051	476
WP1946	Cori cycle	4	0.051	474.25
WP206	Fatty acid omega-oxidation	4	0.051	499.5
WP4223	Ras signaling	4	0.051	209
WP4262	Breast cancer pathway	4	0.051	234
WP4290	Metabolic reprogramming in colon cancer	4	0.051	466.5
WP4685	Melanoma	4	0.051	233
WP4787	Osteoblast differentiation and related diseases	4	0.051	202.5
WP138	Androgen receptor signaling pathway	5	0.051	237
WP2879	Farnesoid X receptor pathway	5	0.051	474.25
WP4239	Epithelial to mesenchymal transition in colorectal cancer	5	0.051	236.5
WP4806	EGFR tyrosine kinase inhibitor resistance	5	0.051	236
WP437	EGF/EGFR signaling pathway	10	0.051	256.5
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	20	0.051	234.5
WP322	Osteoblast signaling	20	0.051	302
WP3595	mir-124 predicted interactions with cell cycle and differentiation	20	0.051	620
WP4223	Ras signaling	20	0.051	288
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	20	0.051	414
WP673	ErbB signaling pathway	20	0.051	271.5
WP690	Polyol pathway	20	0.051	626.5
WP2525	Trans-sulfuration and one-carbon metabolism	30	0.051	334
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	30	0.051	265.5
WP3931	Embryonic stem cell pluripotency pathways	30	0.051	323
WP3963	Mevalonate pathway	30	0.051	440.5
WP4239	Epithelial to mesenchymal transition in colorectal cancer	30	0.051	311.5
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	30	0.051	539.5
WP5090	Complement system in neuronal development and plasticity	30	0.051	297
WP1434	Osteopontin signaling	2	0.05	428
WP2857	Mesodermal commitment pathway	2	0.05	175.5
WP2873	Aryl hydrocarbon receptor pathway	2	0.05	263.5
WP3594	Circadian rhythm genes	2	0.05	174
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	2	0.05	267.5
WP437	EGF/EGFR signaling pathway	2	0.05	156
WP4673	Male infertility	2	0.05	174
WP5066	FOXA2 pathway	2	0.05	432.5
WP1434	Osteopontin signaling	3	0.05	454
WP1539	Angiogenesis	3	0.05	242
WP2272	Pathogenic Escherichia coli infection	3	0.05	250
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	3	0.05	179
WP2878	PPAR-alpha pathway	3	0.05	264
WP3945	TYROBP causal network in microglia	3	0.05	357
WP4673	Male infertility	3	0.05	190
WP4814	Somatic sex determination	3	0.05	471
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	3	0.05	198
WP2507	Nanomaterial induced apoptosis	4	0.05	305
WP2879	Farnesoid X receptor pathway	4	0.05	480.25
WP4022	Pyrimidine metabolism	4	0.05	484.75
WP410	Exercise-induced circadian regulation	4	0.05	424
WP4538	Regulatory circuits of the STAT3 signaling pathway	4	0.05	247
WP4674	Head and neck squamous cell carcinoma	4	0.05	224
WP47	Hedgehog signaling pathway Netpath	4	0.05	492.75
WP4842	Mammalian disorder of sexual development	4	0.05	449.25
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	4	0.05	443.25
WP585	Interferon type I signaling pathways	4	0.05	238.5
WP4971	Phosphoinositides metabolism	5	0.05	395.5
WP53	ID signaling pathway	5	0.05	434.5
WP3287	Overview of nanoparticle effects	10	0.05	278
WP366	TGF-beta signaling pathway	10	0.05	222.5
WP4481	Resistin as a regulator of inflammation	10	0.05	293.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	10	0.05	278
WP4932	7q11.23 copy number variation syndrome	10	0.05	287
WP696	Benzo(a)pyrene metabolism	10	0.05	440.5
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	20	0.05	232
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	20	0.05	272.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	20	0.05	288
WP3945	TYROBP causal network in microglia	20	0.05	328
WP4241	Type 2 papillary renal cell carcinoma	20	0.05	301
WP4321	Thermogenesis	20	0.05	341
WP4919	Neuroinflammation	20	0.05	317
WP501	GPCRs, class C metabotropic glutamate, pheromone	20	0.05	407
WP3651	Pathways affected in adenoid cystic carcinoma	30	0.05	243
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	30	0.05	281
WP5122	Prostaglandin and leukotriene metabolism in senescence	30	0.05	328.5
WP3959	DNA IR-double strand breaks and cellular response via ATM	2	0.049	401.5
WP4298	Acute viral myocarditis	2	0.049	183
WP4478	LTF danger signal response pathway	2	0.049	422.25
WP5098	T-cell activation SARS-CoV-2	2	0.049	199
WP206	Fatty acid omega-oxidation	3	0.049	476
WP2857	Mesodermal commitment pathway	3	0.049	192
WP4724	Omega-9 fatty acid synthesis	3	0.049	476
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	3	0.049	468.5
WP560	TGF-beta receptor signaling	3	0.049	206.5
WP716	Vitamin A and carotenoid metabolism	3	0.049	439
WP3584	MECP2 and associated Rett syndrome	4	0.049	212.5
WP384	Apoptosis modulation by HSP70	4	0.049	465
WP4239	Epithelial to mesenchymal transition in colorectal cancer	4	0.049	220
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	4	0.049	209
WP4752	Base excision repair	4	0.049	473
WP2023	Cell differentiation - expanded index	5	0.049	355
WP272	Blood clotting cascade	5	0.049	440.5
WP410	Exercise-induced circadian regulation	5	0.049	412.5
WP4155	Endometrial cancer	5	0.049	244.5
WP4659	Gastrin signaling pathway	5	0.049	234
WP4674	Head and neck squamous cell carcinoma	5	0.049	238.5
WP4723	Omega-3 / omega-6 fatty acid synthesis	5	0.049	516
WP4753	Nucleotide excision repair	5	0.049	487
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	5	0.049	296
WP5124	Alzheimer's disease	5	0.049	233
WP2332	Interleukin-11 signaling pathway	10	0.049	269
WP2526	PDGF pathway	10	0.049	264.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	10	0.049	288
WP2456	HIF1A and PPARG regulation of glycolysis	20	0.049	350.5
WP4698	Vitamin D-sensitive calcium signaling in depression	20	0.049	265.5
WP61	Notch signaling pathway (Netpath)	20	0.049	277
WP2881	Estrogen receptor pathway	30	0.049	282
WP325	Triacylglyceride synthesis	30	0.049	420.5
WP3853	ERK pathway in Huntington's disease	30	0.049	383
WP399	Wnt signaling pathway and pluripotency	30	0.049	281
WP47	Hedgehog signaling pathway Netpath	30	0.049	363.5
WP1403	AMP-activated protein kinase (AMPK) signaling	2	0.048	228.5
WP170	Nuclear receptors	2	0.048	251
WP2118	Arrhythmogenic right ventricular cardiomyopathy	2	0.048	229
WP2406	Cardiac progenitor differentiation	2	0.048	321.5
WP3584	MECP2 and associated Rett syndrome	2	0.048	242.5
WP4493	Cells and molecules involved in local acute inflammatory response	2	0.048	424
WP5033	Genes associated with the development of rheumatoid arthritis	2	0.048	430.75
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	3	0.048	192
WP3298	Melatonin metabolism and effects	3	0.048	389.5
WP3851	TLR4 signaling and tolerance	3	0.048	430
WP4263	Pancreatic adenocarcinoma pathway	3	0.048	197.5
WP4946	DNA repair pathways, full network	3	0.048	395
WP4225	Pyrimidine metabolism and related diseases	4	0.048	499.5
WP4753	Nucleotide excision repair	4	0.048	484.25
WP4917	Proximal tubule transport	4	0.048	428.5
WP727	Monoamine transport	4	0.048	291.5
WP143	Fatty acid beta-oxidation	5	0.048	511
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	5	0.048	225
WP474	Endochondral ossification	5	0.048	237.5
WP4808	Endochondral ossification with skeletal dysplasias	5	0.048	237.5
WP4842	Mammalian disorder of sexual development	5	0.048	440.25
WP550	Biogenic amine synthesis	5	0.048	516.5
WP286	IL-3 signaling pathway	10	0.048	261
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	10	0.048	277.5
WP3972	PDGFR-beta pathway	10	0.048	279
WP4236	Krebs cycle disorders	10	0.048	590
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	10	0.048	262.5
WP1539	Angiogenesis	20	0.048	274
WP1584	Type II diabetes mellitus	20	0.048	311.5
WP391	Mitochondrial gene expression	20	0.048	361
WP5122	Prostaglandin and leukotriene metabolism in senescence	20	0.048	315
WP1539	Angiogenesis	30	0.048	254.5
WP1544	MicroRNAs in cardiomyocyte hypertrophy	30	0.048	284.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	30	0.048	323
WP34	Ovarian infertility	30	0.048	285.5
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	30	0.048	442.5
WP5102	Familial partial lipodystrophy (FPLD)	30	0.048	315.5
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	2	0.047	434.5
WP2059	Alzheimer's disease and miRNA effects	2	0.047	173
WP2289	Drug induction of bile acid pathway	2	0.047	429.75
WP4204	Tumor suppressor activity of SMARCB1	2	0.047	404
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	2	0.047	179.5
WP5124	Alzheimer's disease	2	0.047	172.5
WP697	Estrogen metabolism	2	0.047	441.5
WP2023	Cell differentiation - expanded index	3	0.047	450.25
WP2034	Leptin signaling pathway	3	0.047	207
WP2261	Glioblastoma signaling pathways	3	0.047	190.5
WP268	Notch signaling	3	0.047	438.5
WP2853	Endoderm differentiation	3	0.047	175
WP2855	Dopaminergic neurogenesis	3	0.047	454.25
WP4149	White fat cell differentiation	3	0.047	203
WP4223	Ras signaling	3	0.047	191.5
WP4290	Metabolic reprogramming in colon cancer	3	0.047	458.5
WP466	DNA replication	3	0.047	463.5
WP4746	Thyroid hormones production and peripheral downstream signaling effects	3	0.047	234
WP437	EGF/EGFR signaling pathway	4	0.047	210
WP4659	Gastrin signaling pathway	4	0.047	223
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	4	0.047	500.5
WP5063	FOXP3 in COVID-19	4	0.047	390.5
WP5064	7-oxo-C and 7-beta-HC pathways	4	0.047	480.75
WP550	Biogenic amine synthesis	4	0.047	502.5
WP1539	Angiogenesis	5	0.047	266
WP2059	Alzheimer's disease and miRNA effects	5	0.047	229
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	5	0.047	234
WP4216	Chromosomal and microsatellite instability in colorectal cancer	5	0.047	256
WP4844	Influence of laminopathies on Wnt signaling	5	0.047	246
WP2596	Gastric acid production	10	0.047	575.25
WP3580	Methionine de novo and salvage pathway	10	0.047	406.5
WP391	Mitochondrial gene expression	10	0.047	375
WP399	Wnt signaling pathway and pluripotency	10	0.047	246.5
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	10	0.047	338
WP4803	Ciliopathies	10	0.047	357.5
WP5052	Nephrogenesis	10	0.047	516
WP5120	Inclusion body myositis	10	0.047	307
WP3995	Prion disease pathway	20	0.047	277
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	20	0.047	322
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	30	0.047	282.5
WP3297	EV release from cardiac cells and their functional effects	30	0.047	324
WP3640	Imatinib and chronic myeloid leukemia	30	0.047	238
WP3925	Amino acid metabolism	30	0.047	398.5
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	30	0.047	288
WP411	mRNA processing	30	0.047	436.5
WP2855	Dopaminergic neurogenesis	2	0.046	427.5
WP4149	White fat cell differentiation	2	0.046	268
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	2	0.046	452
WP4830	GDNF/RET signaling axis	2	0.046	438
WP4946	DNA repair pathways, full network	2	0.046	415.25
WP536	Calcium regulation in cardiac cells	2	0.046	233.5
WP2064	Neural crest differentiation	3	0.046	206
WP4629	Aerobic glycolysis	3	0.046	477
WP4787	Osteoblast differentiation and related diseases	3	0.046	208.5
WP1981	Thyroxine (thyroid hormone) production	4	0.046	504
WP2324	AGE/RAGE pathway	4	0.046	217
WP3931	Embryonic stem cell pluripotency pathways	4	0.046	238.5
WP4216	Chromosomal and microsatellite instability in colorectal cancer	4	0.046	245
WP4241	Type 2 papillary renal cell carcinoma	4	0.046	271
WP661	Glucose homeostasis	4	0.046	512
WP197	Cholesterol biosynthesis pathway	5	0.046	521
WP2848	Pluripotent stem cell differentiation pathway	5	0.046	250.5
WP289	Myometrial relaxation and contraction pathways	5	0.046	205
WP3287	Overview of nanoparticle effects	5	0.046	266.5
WP3658	Wnt/beta-catenin signaling pathway in leukemia	5	0.046	249.5
WP3925	Amino acid metabolism	5	0.046	344.5
WP4008	NO/cGMP/PKG mediated neuroprotection	5	0.046	280
WP4925	Unfolded protein response	5	0.046	246
WP186	Homologous recombination	10	0.046	470.5
WP3878	ATM signaling in development and disease	10	0.046	289
WP4747	Netrin-UNC5B signaling pathway	10	0.046	273
WP477	Cytoplasmic ribosomal proteins	10	0.046	563
WP581	EPO receptor signaling	10	0.046	286
WP2525	Trans-sulfuration and one-carbon metabolism	20	0.046	334
WP2880	Glucocorticoid receptor pathway	20	0.046	277
WP3651	Pathways affected in adenoid cystic carcinoma	20	0.046	268.5
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	20	0.046	384.5
WP206	Fatty acid omega-oxidation	30	0.046	404.5
WP2272	Pathogenic Escherichia coli infection	30	0.046	299
WP2911	miRNA targets in ECM and membrane receptors	30	0.046	400.5
WP384	Apoptosis modulation by HSP70	30	0.046	355
WP524	G13 signaling pathway	30	0.046	326
WP1984	Integrated breast cancer pathway	2	0.045	179
WP2806	Complement system	2	0.045	390
WP3646	Hepatitis C and hepatocellular carcinoma	2	0.045	203
WP4950	16p11.2 distal deletion syndrome	2	0.045	422
WP5102	Familial partial lipodystrophy (FPLD)	2	0.045	410
WP229	Irinotecan pathway	3	0.045	466.5
WP3527	Pre-implantation embryo	3	0.045	228
WP4141	PI3K/AKT/mTOR - VitD3 signaling	3	0.045	260
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	3	0.045	201
WP4685	Melanoma	3	0.045	209
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	4	0.045	210
WP2878	PPAR-alpha pathway	4	0.045	278
WP306	Focal adhesion	4	0.045	194
WP4008	NO/cGMP/PKG mediated neuroprotection	4	0.045	277
WP4524	Alternative pathway of fetal androgen synthesis	4	0.045	477.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	4	0.045	259.5
WP4806	EGFR tyrosine kinase inhibitor resistance	4	0.045	218.5
WP5090	Complement system in neuronal development and plasticity	4	0.045	216
WP3303	RAC1/PAK1/p38/MMP2 pathway	5	0.045	244
WP383	Striated muscle contraction pathway	5	0.045	464.75
WP5061	Fatty acid transporters	5	0.045	521.5
WP661	Glucose homeostasis	5	0.045	528.5
WP2037	Prolactin signaling pathway	10	0.045	250
WP2333	Trans-sulfuration pathway	10	0.045	561.5
WP2525	Trans-sulfuration and one-carbon metabolism	10	0.045	290
WP268	Notch signaling	10	0.045	299
WP304	Kit receptor signaling pathway	10	0.045	244.5
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	10	0.045	560
WP4241	Type 2 papillary renal cell carcinoma	10	0.045	278
WP4479	Supression of HMGB1 mediated inflammation by THBD	10	0.045	324.5
WP4961	STING pathway in Kawasaki-like disease and COVID-19	10	0.045	287
WP2197	Endothelin pathways	20	0.045	294
WP2911	miRNA targets in ECM and membrane receptors	20	0.045	365
WP4259	Disorders of folate metabolism and transport	20	0.045	432
WP4549	Fragile X syndrome	20	0.045	355
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	20	0.045	622.5
WP98	Prostaglandin synthesis and regulation	20	0.045	281
WP313	Hepatocyte growth factor receptor signaling	30	0.045	284
WP3580	Methionine de novo and salvage pathway	30	0.045	389
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	30	0.045	370
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	30	0.045	351
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	30	0.045	435
WP2261	Glioblastoma signaling pathways	2	0.044	164
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	2	0.044	186
WP53	ID signaling pathway	2	0.044	435
WP2037	Prolactin signaling pathway	3	0.044	202.5
WP474	Endochondral ossification	3	0.044	193.5
WP4808	Endochondral ossification with skeletal dysplasias	3	0.044	193.5
WP5031	Biotin metabolism, including IEMs	3	0.044	487.75
WP5064	7-oxo-C and 7-beta-HC pathways	3	0.044	463.25
WP53	ID signaling pathway	3	0.044	457
WP661	Glucose homeostasis	3	0.044	487.5
WP2361	Gastric cancer network 1	4	0.044	488
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4	0.044	384.5
WP3298	Melatonin metabolism and effects	4	0.044	275
WP3303	RAC1/PAK1/p38/MMP2 pathway	4	0.044	228
WP399	Wnt signaling pathway and pluripotency	4	0.044	210
WP4141	PI3K/AKT/mTOR - VitD3 signaling	4	0.044	242.5
WP4481	Resistin as a regulator of inflammation	4	0.044	235
WP4495	IL-10 anti-inflammatory signaling pathway	4	0.044	367.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	4	0.044	498.5
WP2037	Prolactin signaling pathway	5	0.044	231
WP3888	VEGFA-VEGFR2 signaling pathway	5	0.044	205
WP395	IL-4 signaling pathway	5	0.044	223
WP560	TGF-beta receptor signaling	5	0.044	225
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	10	0.044	236
WP2272	Pathogenic Escherichia coli infection	10	0.044	278.5
WP2361	Gastric cancer network 1	10	0.044	326.5
WP322	Osteoblast signaling	10	0.044	310
WP3527	Pre-implantation embryo	10	0.044	250
WP3680	Physico-chemical features and toxicity-associated pathways	10	0.044	269.5
WP4008	NO/cGMP/PKG mediated neuroprotection	10	0.044	339
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	10	0.044	290.5
WP4541	Hippo-Merlin signaling dysregulation	10	0.044	237
WP4925	Unfolded protein response	10	0.044	256.5
WP1541	Energy metabolism	20	0.044	302.5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	20	0.044	283
WP34	Ovarian infertility	20	0.044	290
WP3634	Insulin signaling in adipocytes (normal condition)	20	0.044	372
WP3635	Insulin signaling in adipocytes (diabetic condition)	20	0.044	372
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	20	0.044	348
WP411	mRNA processing	20	0.044	425
WP4724	Omega-9 fatty acid synthesis	20	0.044	361
WP1584	Type II diabetes mellitus	30	0.044	322
WP2023	Cell differentiation - expanded index	30	0.044	332.5
WP2456	HIF1A and PPARG regulation of glycolysis	30	0.044	361
WP3584	MECP2 and associated Rett syndrome	30	0.044	314.5
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	30	0.044	438.5
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	30	0.044	414
WP322	Osteoblast signaling	2	0.043	432.25
WP3527	Pre-implantation embryo	2	0.043	382.75
WP4223	Ras signaling	2	0.043	164.5
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	2	0.043	385.5
WP4540	Hippo signaling regulation pathways	2	0.043	173.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	2	0.043	417.75
WP466	DNA replication	2	0.043	434.5
WP4971	Phosphoinositides metabolism	2	0.043	432.75
WP691	Tamoxifen metabolism	2	0.043	441.5
WP710	DNA damage response (only ATM dependent)	2	0.043	177
WP384	Apoptosis modulation by HSP70	3	0.043	460
WP4524	Alternative pathway of fetal androgen synthesis	3	0.043	465.5
WP4538	Regulatory circuits of the STAT3 signaling pathway	3	0.043	222.5
WP47	Hedgehog signaling pathway Netpath	3	0.043	475.75
WP4842	Mammalian disorder of sexual development	3	0.043	457.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	3	0.043	462.75
WP496	Steroid biosynthesis	3	0.043	481
WP5053	Development of ureteric collection system	3	0.043	216.5
WP5097	CCL18 signaling pathway	3	0.043	198
WP2359	Parkin-ubiquitin proteasomal system pathway	4	0.043	490
WP2525	Trans-sulfuration and one-carbon metabolism	4	0.043	457.25
WP2583	T cell receptor and co-stimulatory signaling	4	0.043	271
WP3297	EV release from cardiac cells and their functional effects	4	0.043	484.5
WP395	IL-4 signaling pathway	4	0.043	216
WP4312	Rett syndrome causing genes	4	0.043	235
WP4838	Regucalcin in proximal tubule epithelial kidney cells	4	0.043	435
WP1601	Fluoropyrimidine activity	5	0.043	436
WP2034	Leptin signaling pathway	5	0.043	246.5
WP3527	Pre-implantation embryo	5	0.043	223
WP3931	Embryonic stem cell pluripotency pathways	5	0.043	242
WP4259	Disorders of folate metabolism and transport	5	0.043	517.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	5	0.043	311.5
WP4549	Fragile X syndrome	5	0.043	236
WP455	GPCRs, class A rhodopsin-like	5	0.043	314.5
WP4803	Ciliopathies	5	0.043	415
WP4816	TGF-beta receptor signaling in skeletal dysplasias	5	0.043	219.5
WP5053	Development of ureteric collection system	5	0.043	245.5
WP1471	Target of rapamycin (TOR) signaling	10	0.043	267.5
WP2881	Estrogen receptor pathway	10	0.043	292
WP3651	Pathways affected in adenoid cystic carcinoma	10	0.043	241
WP3934	Leptin and adiponectin	10	0.043	574
WP3981	miRNA regulation of prostate cancer signaling pathways	10	0.043	244
WP5064	7-oxo-C and 7-beta-HC pathways	10	0.043	387.5
WP5117	Cohesin complex - Cornelia de Lange syndrome	10	0.043	305
WP554	ACE inhibitor pathway	10	0.043	305.5
WP186	Homologous recombination	20	0.043	344
WP2848	Pluripotent stem cell differentiation pathway	20	0.043	296.5
WP313	Hepatocyte growth factor receptor signaling	20	0.043	279
WP408	Oxidative stress response	20	0.043	256
WP4312	Rett syndrome causing genes	20	0.043	303.5
WP4482	Vitamin D in inflammatory diseases	20	0.043	286
WP5102	Familial partial lipodystrophy (FPLD)	20	0.043	295.5
WP205	IL-7 signaling pathway	30	0.043	236
WP288	Nod-like receptor (NLR) signaling pathway	30	0.043	371.5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	30	0.043	288
WP4747	Netrin-UNC5B signaling pathway	30	0.043	245.5
WP5031	Biotin metabolism, including IEMs	30	0.043	632.5
WP581	EPO receptor signaling	30	0.043	294.5
WP727	Monoamine transport	30	0.043	311
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2	0.042	401.75
WP262	Ebstein-Barr virus LMP1 signaling	2	0.042	422
WP3888	VEGFA-VEGFR2 signaling pathway	2	0.042	136
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2	0.042	438.75
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2	0.042	428
WP496	Steroid biosynthesis	2	0.042	446.75
WP5053	Development of ureteric collection system	2	0.042	230.5
WP1471	Target of rapamycin (TOR) signaling	3	0.042	448.5
WP1946	Cori cycle	3	0.042	465.5
WP262	Ebstein-Barr virus LMP1 signaling	3	0.042	448.75
WP289	Myometrial relaxation and contraction pathways	3	0.042	185
WP383	Striated muscle contraction pathway	3	0.042	464
WP4537	Hippo-Yap signaling pathway	3	0.042	468.75
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	3	0.042	431.25
WP4674	Head and neck squamous cell carcinoma	3	0.042	210
WP4723	Omega-3 / omega-6 fatty acid synthesis	3	0.042	480.5
WP4844	Influence of laminopathies on Wnt signaling	3	0.042	228.5
WP585	Interferon type I signaling pathways	3	0.042	253.5
WP197	Cholesterol biosynthesis pathway	4	0.042	505.5
WP2272	Pathogenic Escherichia coli infection	4	0.042	233.5
WP2289	Drug induction of bile acid pathway	4	0.042	459.75
WP3658	Wnt/beta-catenin signaling pathway in leukemia	4	0.042	249
WP4803	Ciliopathies	4	0.042	464.75
WP1946	Cori cycle	5	0.042	483
WP2018	RANKL/RANK signaling pathway	5	0.042	232
WP3	Transcriptional activation by NRF2 in response to phytochemicals	5	0.042	334
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	5	0.042	267
WP4698	Vitamin D-sensitive calcium signaling in depression	5	0.042	224.5
WP4724	Omega-9 fatty acid synthesis	5	0.042	508.25
WP4756	Renin-angiotensin-aldosterone system (RAAS)	5	0.042	255.5
WP727	Monoamine transport	5	0.042	261.5
WP195	IL-1 signaling pathway	10	0.042	276.5
WP2355	Corticotropin-releasing hormone signaling pathway	10	0.042	245.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	10	0.042	272
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	10	0.042	270
WP4312	Rett syndrome causing genes	10	0.042	274.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	10	0.042	297
WP4698	Vitamin D-sensitive calcium signaling in depression	10	0.042	262
WP500	Glycogen synthesis and degradation	10	0.042	318.5
WP61	Notch signaling pathway (Netpath)	10	0.042	267
WP98	Prostaglandin synthesis and regulation	10	0.042	281
WP195	IL-1 signaling pathway	20	0.042	302.5
WP2272	Pathogenic Escherichia coli infection	20	0.042	312.5
WP2361	Gastric cancer network 1	20	0.042	351.5
WP2447	Amyotrophic lateral sclerosis (ALS)	20	0.042	337.5
WP3584	MECP2 and associated Rett syndrome	20	0.042	285
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	20	0.042	299.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	20	0.042	331
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	20	0.042	293
WP4961	STING pathway in Kawasaki-like disease and COVID-19	20	0.042	296
WP554	ACE inhibitor pathway	20	0.042	317
WP1471	Target of rapamycin (TOR) signaling	30	0.042	297.5
WP2361	Gastric cancer network 1	30	0.042	335
WP2839	Hair follicle development: organogenesis - part 2 of 3	30	0.042	276
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	30	0.042	283
WP391	Mitochondrial gene expression	30	0.042	373
WP408	Oxidative stress response	30	0.042	261
WP4549	Fragile X syndrome	30	0.042	371.5
WP4724	Omega-9 fatty acid synthesis	30	0.042	393
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	30	0.042	327.5
WP4971	Phosphoinositides metabolism	30	0.042	351
WP98	Prostaglandin synthesis and regulation	30	0.042	301.5
WP117	GPCRs, other	2	0.041	434
WP23	B cell receptor signaling pathway	2	0.041	195
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	2	0.041	175
WP34	Ovarian infertility	2	0.041	368.75
WP4211	Transcriptional cascade regulating adipogenesis	2	0.041	426.5
WP4658	Small cell lung cancer	2	0.041	189
WP474	Endochondral ossification	2	0.041	194.5
WP4803	Ciliopathies	2	0.041	434.25
WP4808	Endochondral ossification with skeletal dysplasias	2	0.041	194.5
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	2	0.041	189.5
WP5063	FOXP3 in COVID-19	2	0.041	424
WP524	G13 signaling pathway	2	0.041	432.25
WP2267	Synaptic vesicle pathway	3	0.041	467
WP304	Kit receptor signaling pathway	3	0.041	209
WP357	Fatty acid biosynthesis	3	0.041	475.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3	0.041	259
WP366	TGF-beta signaling pathway	3	0.041	186
WP4262	Breast cancer pathway	3	0.041	211
WP4549	Fragile X syndrome	3	0.041	205
WP4950	16p11.2 distal deletion syndrome	3	0.041	439
WP5063	FOXP3 in COVID-19	3	0.041	442
WP698	Glucuronidation	3	0.041	477.25
WP1601	Fluoropyrimidine activity	4	0.041	454.25
WP2023	Cell differentiation - expanded index	4	0.041	445.5
WP2037	Prolactin signaling pathway	4	0.041	221.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	4	0.041	220
WP24	Peptide GPCRs	4	0.041	449.5
WP322	Osteoblast signaling	4	0.041	468
WP357	Fatty acid biosynthesis	4	0.041	494
WP3888	VEGFA-VEGFR2 signaling pathway	4	0.041	190
WP4342	Vitamins A and D - action mechanisms	4	0.041	487.5
WP4549	Fragile X syndrome	4	0.041	225.5
WP4723	Omega-3 / omega-6 fatty acid synthesis	4	0.041	502.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	4	0.041	472.75
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	4	0.041	310.5
WP4925	Unfolded protein response	4	0.041	233
WP5072	Modulators of TCR signaling and T cell activation	4	0.041	229
WP5120	Inclusion body myositis	4	0.041	477
WP524	G13 signaling pathway	4	0.041	413
WP117	GPCRs, other	5	0.041	366
WP1495	Glycine metabolism	5	0.041	530.5
WP2267	Synaptic vesicle pathway	5	0.041	482.75
WP2355	Corticotropin-releasing hormone signaling pathway	5	0.041	225
WP268	Notch signaling	5	0.041	267
WP3599	Transcription factor regulation in adipogenesis	5	0.041	253
WP4217	Ebola virus pathway in host	5	0.041	236
WP4220	Neurotransmitter disorders	5	0.041	524.5
WP4838	Regucalcin in proximal tubule epithelial kidney cells	5	0.041	409
WP5102	Familial partial lipodystrophy (FPLD)	5	0.041	255
WP2646	Lidocaine metabolism	10	0.041	572.75
WP384	Apoptosis modulation by HSP70	10	0.041	318
WP4324	Mitochondrial complex I assembly model OXPHOS system	10	0.041	585
WP481	Insulin signaling	10	0.041	239
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	10	0.041	582
WP2112	IL-17 signaling pathway	20	0.041	320
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	20	0.041	287
WP3580	Methionine de novo and salvage pathway	20	0.041	347
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	20	0.041	296
WP3680	Physico-chemical features and toxicity-associated pathways	20	0.041	271
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	20	0.041	297
WP4481	Resistin as a regulator of inflammation	20	0.041	284
WP4747	Netrin-UNC5B signaling pathway	20	0.041	276
WP4803	Ciliopathies	20	0.041	408
WP2112	IL-17 signaling pathway	30	0.041	347.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	30	0.041	233
WP4756	Renin-angiotensin-aldosterone system (RAAS)	30	0.041	339.5
WP500	Glycogen synthesis and degradation	30	0.041	380
WP2272	Pathogenic Escherichia coli infection	2	0.04	394.5
WP2361	Gastric cancer network 1	2	0.04	440.75
WP3303	RAC1/PAK1/p38/MMP2 pathway	2	0.04	196.5
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	2	0.04	415
WP4146	Macrophage markers	2	0.04	442.25
WP4331	Neovascularisation processes	2	0.04	281.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	2	0.04	420.5
WP4558	Overview of interferons-mediated signaling pathway	2	0.04	427
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	2	0.04	410.5
WP2361	Gastric cancer network 1	3	0.04	472.25
WP2848	Pluripotent stem cell differentiation pathway	3	0.04	246
WP286	IL-3 signaling pathway	3	0.04	208
WP306	Focal adhesion	3	0.04	173.5
WP3599	Transcription factor regulation in adipogenesis	3	0.04	272
WP3878	ATM signaling in development and disease	3	0.04	409.25
WP4217	Ebola virus pathway in host	3	0.04	203
WP465	Tryptophan metabolism	3	0.04	457
WP4756	Renin-angiotensin-aldosterone system (RAAS)	3	0.04	350
WP5090	Complement system in neuronal development and plasticity	3	0.04	205
WP5092	Interactions of natural killer cells in pancreatic cancer	3	0.04	293
WP5102	Familial partial lipodystrophy (FPLD)	3	0.04	322
WP2029	Cell differentiation - index	4	0.04	480.75
WP2857	Mesodermal commitment pathway	4	0.04	222
WP286	IL-3 signaling pathway	4	0.04	224
WP3995	Prion disease pathway	4	0.04	213.5
WP404	Nucleotide metabolism	4	0.04	501.5
WP4321	Thermogenesis	4	0.04	225.5
WP4724	Omega-9 fatty acid synthesis	4	0.04	495.5
WP4747	Netrin-UNC5B signaling pathway	4	0.04	220
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4	0.04	330.5
WP98	Prostaglandin synthesis and regulation	4	0.04	242.5
WP3971	OSX and miRNAs in tooth development	5	0.04	494.75
WP4479	Supression of HMGB1 mediated inflammation by THBD	5	0.04	494
WP4747	Netrin-UNC5B signaling pathway	5	0.04	231
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	5	0.04	314
WP4961	STING pathway in Kawasaki-like disease and COVID-19	5	0.04	291
WP5064	7-oxo-C and 7-beta-HC pathways	5	0.04	489.5
WP1603	Nicotine effect on chromaffin cells	10	0.04	575.75
WP2023	Cell differentiation - expanded index	10	0.04	305
WP4853	Linoleic acid metabolism affected by coronavirus infection	10	0.04	587.5
WP2333	Trans-sulfuration pathway	20	0.04	401.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	20	0.04	318
WP2795	Cardiac hypertrophic response	20	0.04	295.5
WP399	Wnt signaling pathway and pluripotency	20	0.04	273
WP49	IL-2 signaling pathway	20	0.04	245.5
WP1601	Fluoropyrimidine activity	30	0.04	375
WP2267	Synaptic vesicle pathway	30	0.04	424
WP2848	Pluripotent stem cell differentiation pathway	30	0.04	292.5
WP3877	MYD88 distinct input-output pathway	30	0.04	377
WP3941	Oxidative damage response	30	0.04	290
WP4211	Transcriptional cascade regulating adipogenesis	30	0.04	289
WP4722	Glycerolipids and glycerophospholipids	30	0.04	344
WP4961	STING pathway in Kawasaki-like disease and COVID-19	30	0.04	291
WP5120	Inclusion body myositis	30	0.04	342.5
WP1539	Angiogenesis	2	0.039	389.5
WP2583	T cell receptor and co-stimulatory signaling	2	0.039	410.75
WP2828	Bladder cancer	2	0.039	206.5
WP2876	Pregnane X receptor pathway	2	0.039	424.25
WP2880	Glucocorticoid receptor pathway	2	0.039	252
WP4262	Breast cancer pathway	2	0.039	181.5
WP4290	Metabolic reprogramming in colon cancer	2	0.039	434.5
WP4753	Nucleotide excision repair	2	0.039	441
WP4844	Influence of laminopathies on Wnt signaling	2	0.039	319.5
WP5036	Angiotensin II receptor type 1 pathway	2	0.039	414.75
WP554	ACE inhibitor pathway	2	0.039	431
WP585	Interferon type I signaling pathways	2	0.039	393.5
WP661	Glucose homeostasis	2	0.039	453.5
WP1604	Codeine and morphine metabolism	3	0.039	466.5
WP1742	TP53 network	3	0.039	241.5
WP411	mRNA processing	3	0.039	471.5
WP4312	Rett syndrome causing genes	3	0.039	254
WP437	EGF/EGFR signaling pathway	3	0.039	176
WP455	GPCRs, class A rhodopsin-like	3	0.039	436.25
WP5072	Modulators of TCR signaling and T cell activation	3	0.039	222
WP531	DNA mismatch repair	3	0.039	476.25
WP581	EPO receptor signaling	3	0.039	426
WP727	Monoamine transport	3	0.039	432
WP2267	Synaptic vesicle pathway	4	0.039	479.5
WP2526	PDGF pathway	4	0.039	244
WP268	Notch signaling	4	0.039	342
WP2855	Dopaminergic neurogenesis	4	0.039	448.25
WP289	Myometrial relaxation and contraction pathways	4	0.039	209.5
WP3527	Pre-implantation embryo	4	0.039	219.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	4	0.039	266.5
WP3878	ATM signaling in development and disease	4	0.039	287.5
WP3998	Prader-Willi and Angelman syndrome	4	0.039	233
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	4	0.039	421.25
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	4	0.039	455.5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4	0.039	366.5
WP5036	Angiotensin II receptor type 1 pathway	4	0.039	263
WP2113	Type III interferon signaling	5	0.039	520
WP2359	Parkin-ubiquitin proteasomal system pathway	5	0.039	505.75
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	5	0.039	277
WP3972	PDGFR-beta pathway	5	0.039	257
WP399	Wnt signaling pathway and pluripotency	5	0.039	223.5
WP3995	Prion disease pathway	5	0.039	235
WP1541	Energy metabolism	10	0.039	276
WP1544	MicroRNAs in cardiomyocyte hypertrophy	10	0.039	257
WP2436	Dopamine metabolism	10	0.039	337.5
WP3971	OSX and miRNAs in tooth development	10	0.039	377
WP3995	Prion disease pathway	10	0.039	246.5
WP4331	Neovascularisation processes	10	0.039	264
WP4482	Vitamin D in inflammatory diseases	10	0.039	281
WP4842	Mammalian disorder of sexual development	10	0.039	313.5
WP501	GPCRs, class C metabotropic glutamate, pheromone	10	0.039	567.5
WP1471	Target of rapamycin (TOR) signaling	20	0.039	295.5
WP1531	Vitamin D metabolism	20	0.039	329.5
WP1544	MicroRNAs in cardiomyocyte hypertrophy	20	0.039	285
WP3851	TLR4 signaling and tolerance	20	0.039	306.5
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	20	0.039	385
WP581	EPO receptor signaling	20	0.039	310.5
WP1531	Vitamin D metabolism	30	0.039	352.5
WP2369	Histone modifications	30	0.039	420
WP2879	Farnesoid X receptor pathway	30	0.039	375.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	30	0.039	335
WP4147	PTF1A related regulatory pathway	30	0.039	320
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	30	0.039	326
WP2848	Pluripotent stem cell differentiation pathway	2	0.038	359.5
WP3287	Overview of nanoparticle effects	2	0.038	393
WP382	MAPK signaling pathway	2	0.038	166.5
WP3945	TYROBP causal network in microglia	2	0.038	415.5
WP4312	Rett syndrome causing genes	2	0.038	393.5
WP465	Tryptophan metabolism	2	0.038	431.75
WP4752	Base excision repair	2	0.038	437.75
WP4758	Nephrotic syndrome	2	0.038	413.75
WP4823	Genes controlling nephrogenesis	2	0.038	389.25
WP4842	Mammalian disorder of sexual development	2	0.038	426.5
WP5072	Modulators of TCR signaling and T cell activation	2	0.038	393.5
WP2880	Glucocorticoid receptor pathway	3	0.038	221.5
WP3888	VEGFA-VEGFR2 signaling pathway	3	0.038	174
WP3998	Prader-Willi and Angelman syndrome	3	0.038	226
WP4008	NO/cGMP/PKG mediated neuroprotection	3	0.038	298
WP4211	Transcriptional cascade regulating adipogenesis	3	0.038	448.25
WP4239	Epithelial to mesenchymal transition in colorectal cancer	3	0.038	204
WP4917	Proximal tubule transport	3	0.038	448.75
WP5120	Inclusion body myositis	3	0.038	467.75
WP1544	MicroRNAs in cardiomyocyte hypertrophy	4	0.038	206
WP3925	Amino acid metabolism	4	0.038	335.5
WP4357	NRF2-ARE regulation	4	0.038	245
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	4	0.038	221
WP4932	7q11.23 copy number variation syndrome	4	0.038	246
WP195	IL-1 signaling pathway	5	0.038	253
WP3585	Cytosine methylation	5	0.038	527.75
WP3651	Pathways affected in adenoid cystic carcinoma	5	0.038	221.5
WP4873	Peroxiredoxin 2 induced ovarian failure	5	0.038	506.25
WP5049	Glycolysis in senescence	5	0.038	443
WP585	Interferon type I signaling pathways	5	0.038	236.5
WP1584	Type II diabetes mellitus	10	0.038	310.5
WP2112	IL-17 signaling pathway	10	0.038	288
WP2371	Parkinson's disease pathway	10	0.038	390
WP4571	Urea cycle and related diseases	10	0.038	583.5
WP4657	22q11.2 copy number variation syndrome	10	0.038	317
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	10	0.038	321
WP49	IL-2 signaling pathway	10	0.038	259
WP4970	Galanin receptor pathway	10	0.038	264.5
WP690	Polyol pathway	10	0.038	587
WP107	Translation factors	20	0.038	419
WP2879	Farnesoid X receptor pathway	20	0.038	357.5
WP304	Kit receptor signaling pathway	20	0.038	271
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	20	0.038	339
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	20	0.038	286.5
WP5090	Complement system in neuronal development and plasticity	20	0.038	287.5
WP4249	Hedgehog signaling pathway	30	0.038	301
WP4482	Vitamin D in inflammatory diseases	30	0.038	267
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	30	0.038	344
WP4571	Urea cycle and related diseases	30	0.038	642
WP4751	HIPK2 in kidney fibrosis	30	0.038	642
WP4842	Mammalian disorder of sexual development	30	0.038	412
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	30	0.038	301
WP554	ACE inhibitor pathway	30	0.038	337
WP2253	Pilocytic astrocytoma	2	0.037	452.25
WP2881	Estrogen receptor pathway	2	0.037	417.75
WP3998	Prader-Willi and Angelman syndrome	2	0.037	230
WP4022	Pyrimidine metabolism	2	0.037	441
WP4816	TGF-beta receptor signaling in skeletal dysplasias	2	0.037	187
WP5090	Complement system in neuronal development and plasticity	2	0.037	233.5
WP5097	CCL18 signaling pathway	2	0.037	204
WP531	DNA mismatch repair	2	0.037	444
WP138	Androgen receptor signaling pathway	3	0.037	204.5
WP1541	Energy metabolism	3	0.037	223.5
WP197	Cholesterol biosynthesis pathway	3	0.037	484
WP2583	T cell receptor and co-stimulatory signaling	3	0.037	377.5
WP3303	RAC1/PAK1/p38/MMP2 pathway	3	0.037	217
WP382	MAPK signaling pathway	3	0.037	203
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3	0.037	424.5
WP410	Exercise-induced circadian regulation	3	0.037	450.75
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	3	0.037	420.5
WP4558	Overview of interferons-mediated signaling pathway	3	0.037	459.5
WP4747	Netrin-UNC5B signaling pathway	3	0.037	204
WP4803	Ciliopathies	3	0.037	463.5
WP4971	Phosphoinositides metabolism	3	0.037	456.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	3	0.037	478.5
WP1495	Glycine metabolism	4	0.037	513.5
WP1584	Type II diabetes mellitus	4	0.037	428.25
WP2406	Cardiac progenitor differentiation	4	0.037	220
WP2586	Aryl hydrocarbon receptor Netpath	4	0.037	228
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	4	0.037	262
WP481	Insulin signaling	4	0.037	194
WP4844	Influence of laminopathies on Wnt signaling	4	0.037	233
WP5102	Familial partial lipodystrophy (FPLD)	4	0.037	296
WP2361	Gastric cancer network 1	5	0.037	499.5
WP2586	Aryl hydrocarbon receptor Netpath	5	0.037	240
WP314	Fas ligand pathway and stress induction of heat shock proteins	5	0.037	256
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	5	0.037	235.5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	5	0.037	275
WP3878	ATM signaling in development and disease	5	0.037	271
WP4141	PI3K/AKT/mTOR - VitD3 signaling	5	0.037	253
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	5	0.037	330
WP4970	Galanin receptor pathway	5	0.037	244.5
WP2276	Glial cell differentiation	10	0.037	585
WP2542	Sulindac metabolic pathway	10	0.037	580.5
WP2911	miRNA targets in ECM and membrane receptors	10	0.037	348
WP325	Triacylglyceride synthesis	10	0.037	547.5
WP34	Ovarian infertility	10	0.037	289
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	10	0.037	261
WP4789	MED and pseudoachondroplasia genes	10	0.037	590
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	10	0.037	316
WP524	G13 signaling pathway	10	0.037	294
WP2023	Cell differentiation - expanded index	20	0.037	336.5
WP3286	Copper homeostasis	20	0.037	308
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	20	0.037	295.5
WP384	Apoptosis modulation by HSP70	20	0.037	347.5
WP3934	Leptin and adiponectin	20	0.037	605.5
WP4157	GABA metabolism (aka GHB)	20	0.037	631.5
WP4584	Biomarkers for pyrimidine metabolism disorders	20	0.037	447
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	30	0.037	295
WP3680	Physico-chemical features and toxicity-associated pathways	30	0.037	274
WP3845	Canonical and non-canonical Notch signaling	30	0.037	357.5
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	30	0.037	421
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	30	0.037	298
WP5033	Genes associated with the development of rheumatoid arthritis	30	0.037	304
WP1544	MicroRNAs in cardiomyocyte hypertrophy	2	0.036	194
WP2023	Cell differentiation - expanded index	2	0.036	428
WP2034	Leptin signaling pathway	2	0.036	196.5
WP2037	Prolactin signaling pathway	2	0.036	190.5
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	2	0.036	175
WP2525	Trans-sulfuration and one-carbon metabolism	2	0.036	432.75
WP3297	EV release from cardiac cells and their functional effects	2	0.036	437.25
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2	0.036	416.5
WP384	Apoptosis modulation by HSP70	2	0.036	431.5
WP3878	ATM signaling in development and disease	2	0.036	411.75
WP3925	Amino acid metabolism	2	0.036	421
WP4263	Pancreatic adenocarcinoma pathway	2	0.036	172
WP455	GPCRs, class A rhodopsin-like	2	0.036	419.5
WP4925	Unfolded protein response	2	0.036	397.75
WP5092	Interactions of natural killer cells in pancreatic cancer	2	0.036	398.5
WP560	TGF-beta receptor signaling	2	0.036	191
WP734	Serotonin receptor 4/6/7 and NR3C signaling	2	0.036	436.75
WP2355	Corticotropin-releasing hormone signaling pathway	3	0.036	194
WP2359	Parkin-ubiquitin proteasomal system pathway	3	0.036	471.75
WP2875	Constitutive androstane receptor pathway	3	0.036	395
WP3	Transcriptional activation by NRF2 in response to phytochemicals	3	0.036	435.75
WP3967	miR-509-3p alteration of YAP1/ECM axis	3	0.036	451.5
WP4241	Type 2 papillary renal cell carcinoma	3	0.036	255
WP4357	NRF2-ARE regulation	3	0.036	262.5
WP4389	Bile acids synthesis and enterohepatic circulation	3	0.036	470.25
WP4666	Hepatitis B infection	3	0.036	204
WP4698	Vitamin D-sensitive calcium signaling in depression	3	0.036	221
WP5117	Cohesin complex - Cornelia de Lange syndrome	3	0.036	460
WP12	Osteoclast signaling	4	0.036	462
WP1541	Energy metabolism	4	0.036	228.5
WP2113	Type III interferon signaling	4	0.036	505.5
WP304	Kit receptor signaling pathway	4	0.036	224
WP3972	PDGFR-beta pathway	4	0.036	262
WP3981	miRNA regulation of prostate cancer signaling pathways	4	0.036	234.5
WP411	mRNA processing	4	0.036	490.25
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4	0.036	246
WP4324	Mitochondrial complex I assembly model OXPHOS system	4	0.036	511.25
WP4657	22q11.2 copy number variation syndrome	4	0.036	240
WP4756	Renin-angiotensin-aldosterone system (RAAS)	4	0.036	278
WP4758	Nephrotic syndrome	4	0.036	252
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	4	0.036	509.75
WP554	ACE inhibitor pathway	4	0.036	468.75
WP1531	Vitamin D metabolism	5	0.036	499.75
WP1541	Energy metabolism	5	0.036	224
WP2029	Cell differentiation - index	5	0.036	483
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	5	0.036	224
WP2526	PDGF pathway	5	0.036	252
WP322	Osteoblast signaling	5	0.036	464.5
WP366	TGF-beta signaling pathway	5	0.036	216
WP3998	Prader-Willi and Angelman syndrome	5	0.036	251
WP481	Insulin signaling	5	0.036	211
WP4917	Proximal tubule transport	5	0.036	372.5
WP4932	7q11.23 copy number variation syndrome	5	0.036	262
WP2369	Histone modifications	10	0.036	440
WP2406	Cardiac progenitor differentiation	10	0.036	259
WP2447	Amyotrophic lateral sclerosis (ALS)	10	0.036	308
WP2456	HIF1A and PPARG regulation of glycolysis	10	0.036	343.5
WP2839	Hair follicle development: organogenesis - part 2 of 3	10	0.036	271
WP3584	MECP2 and associated Rett syndrome	10	0.036	274
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	10	0.036	296
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	10	0.036	260.5
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	10	0.036	287
WP4321	Thermogenesis	10	0.036	289.5
WP4873	Peroxiredoxin 2 induced ovarian failure	10	0.036	410.5
WP4971	Phosphoinositides metabolism	10	0.036	320
WP5102	Familial partial lipodystrophy (FPLD)	10	0.036	279.5
WP3297	EV release from cardiac cells and their functional effects	20	0.036	333.5
WP4814	Somatic sex determination	20	0.036	389
WP4861	Endoplasmic reticulum stress response in coronavirus infection	20	0.036	344
WP4971	Phosphoinositides metabolism	20	0.036	347.5
WP500	Glycogen synthesis and degradation	20	0.036	365.5
WP268	Notch signaling	30	0.036	348
WP4564	Neural crest cell migration during development	30	0.036	264
WP4758	Nephrotic syndrome	30	0.036	377
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	30	0.036	287
WP550	Biogenic amine synthesis	30	0.036	446
WP186	Homologous recombination	2	0.035	442.5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2	0.035	250
WP2826	Cocaine metabolism	2	0.035	452
WP3851	TLR4 signaling and tolerance	2	0.035	416.75
WP411	mRNA processing	2	0.035	444.25
WP4217	Ebola virus pathway in host	2	0.035	187
WP4747	Netrin-UNC5B signaling pathway	2	0.035	205.5
WP481	Insulin signaling	2	0.035	165.5
WP5114	Nucleotide excision repair in xeroderma pigmentosum	2	0.035	427.5
WP696	Benzo(a)pyrene metabolism	2	0.035	445
WP1495	Glycine metabolism	3	0.035	489
WP1584	Type II diabetes mellitus	3	0.035	447.25
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	3	0.035	487.5
WP3931	Embryonic stem cell pluripotency pathways	3	0.035	213.5
WP3935	Leptin-insulin signaling overlap	3	0.035	444.5
WP4342	Vitamins A and D - action mechanisms	3	0.035	472
WP4495	IL-10 anti-inflammatory signaling pathway	3	0.035	442.25
WP734	Serotonin receptor 4/6/7 and NR3C signaling	3	0.035	466.5
WP100	Glutathione metabolism	4	0.035	497
WP314	Fas ligand pathway and stress induction of heat shock proteins	4	0.035	237.5
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	4	0.035	503
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	4	0.035	233
WP4259	Disorders of folate metabolism and transport	4	0.035	503
WP4585	Cancer immunotherapy by PD-1 blockade	4	0.035	377.5
WP4698	Vitamin D-sensitive calcium signaling in depression	4	0.035	219
WP5049	Glycolysis in senescence	4	0.035	449.5
WP100	Glutathione metabolism	5	0.035	514
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5	0.035	225.5
WP1584	Type II diabetes mellitus	5	0.035	330.5
WP2881	Estrogen receptor pathway	5	0.035	293
WP4342	Vitamins A and D - action mechanisms	5	0.035	497
WP4482	Vitamin D in inflammatory diseases	5	0.035	240
WP4495	IL-10 anti-inflammatory signaling pathway	5	0.035	300
WP477	Cytoplasmic ribosomal proteins	5	0.035	518.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	5	0.035	513.75
WP1495	Glycine metabolism	10	0.035	586.25
WP2197	Endothelin pathways	10	0.035	270
WP2826	Cocaine metabolism	10	0.035	575.75
WP289	Myometrial relaxation and contraction pathways	10	0.035	263
WP3297	EV release from cardiac cells and their functional effects	10	0.035	339.5
WP3595	mir-124 predicted interactions with cell cycle and differentiation	10	0.035	582.5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	10	0.035	285
WP4495	IL-10 anti-inflammatory signaling pathway	10	0.035	307.5
WP4537	Hippo-Yap signaling pathway	10	0.035	327
WP100	Glutathione metabolism	20	0.035	404
WP4220	Neurotransmitter disorders	20	0.035	609.5
WP4331	Neovascularisation processes	20	0.035	279
WP4585	Cancer immunotherapy by PD-1 blockade	20	0.035	349.5
WP4657	22q11.2 copy number variation syndrome	20	0.035	336
WP4842	Mammalian disorder of sexual development	20	0.035	364
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	20	0.035	347
WP5031	Biotin metabolism, including IEMs	20	0.035	622
WP106	Alanine and aspartate metabolism	30	0.035	504.5
WP2363	Gastric cancer network 2	30	0.035	319
WP24	Peptide GPCRs	30	0.035	367.5
WP2795	Cardiac hypertrophic response	30	0.035	290
WP3527	Pre-implantation embryo	30	0.035	305
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	30	0.035	452
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	30	0.035	323
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	30	0.035	407.5
WP4542	Overview of leukocyte-intrinsic Hippo pathway functions	30	0.035	293
WP4585	Cancer immunotherapy by PD-1 blockade	30	0.035	358.5
WP4803	Ciliopathies	30	0.035	432
WP1471	Target of rapamycin (TOR) signaling	2	0.034	427.5
WP2267	Synaptic vesicle pathway	2	0.034	438.5
WP268	Notch signaling	2	0.034	424.25
WP3651	Pathways affected in adenoid cystic carcinoma	2	0.034	179.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	2	0.034	444.5
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2	0.034	427
WP12	Osteoclast signaling	3	0.034	458.25
WP195	IL-1 signaling pathway	3	0.034	237
WP2369	Histone modifications	3	0.034	478
WP2586	Aryl hydrocarbon receptor Netpath	3	0.034	208
WP2881	Estrogen receptor pathway	3	0.034	418.25
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	3	0.034	478.5
WP395	IL-4 signaling pathway	3	0.034	197
WP3995	Prion disease pathway	3	0.034	209
WP4204	Tumor suppressor activity of SMARCB1	3	0.034	284.5
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	3	0.034	461.75
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	3	0.034	446
WP4806	EGFR tyrosine kinase inhibitor resistance	3	0.034	207
WP4853	Linoleic acid metabolism affected by coronavirus infection	3	0.034	488
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	3	0.034	219.5
WP4925	Unfolded protein response	3	0.034	275.5
WP143	Fatty acid beta-oxidation	4	0.034	493.5
WP1545	miRNAs involved in DNA damage response	4	0.034	237
WP2826	Cocaine metabolism	4	0.034	508.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4	0.034	248.5
WP2881	Estrogen receptor pathway	4	0.034	348
WP3599	Transcription factor regulation in adipogenesis	4	0.034	250
WP3853	ERK pathway in Huntington's disease	4	0.034	478
WP3971	OSX and miRNAs in tooth development	4	0.034	489.5
WP4204	Tumor suppressor activity of SMARCB1	4	0.034	280.5
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	4	0.034	310
WP4873	Peroxiredoxin 2 induced ovarian failure	4	0.034	491
WP500	Glycogen synthesis and degradation	4	0.034	481.75
WP5061	Fatty acid transporters	4	0.034	506
WP1471	Target of rapamycin (TOR) signaling	5	0.034	343.5
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	5	0.034	208.5
WP2035	Follicle stimulating hormone (FSH) signaling pathway	5	0.034	373
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	5	0.034	240
WP304	Kit receptor signaling pathway	5	0.034	230
WP325	Triacylglyceride synthesis	5	0.034	512
WP357	Fatty acid biosynthesis	5	0.034	507
WP3591	Sleep regulation	5	0.034	275.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	5	0.034	268
WP3680	Physico-chemical features and toxicity-associated pathways	5	0.034	248
WP404	Nucleotide metabolism	5	0.034	516.5
WP4222	Phosphodiesterases in neuronal function	5	0.034	282
WP4241	Type 2 papillary renal cell carcinoma	5	0.034	262.5
WP4255	Non-small cell lung cancer	5	0.034	240.5
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	5	0.034	248
WP4269	Ethanol metabolism production of ROS by CYP2E1	5	0.034	495.5
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	5	0.034	358.5
WP4541	Hippo-Merlin signaling dysregulation	5	0.034	208.5
WP5117	Cohesin complex - Cornelia de Lange syndrome	5	0.034	469.25
WP107	Translation factors	10	0.034	438.5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	10	0.034	270.5
WP3630	NAD metabolism, sirtuins and aging	10	0.034	305
WP3634	Insulin signaling in adipocytes (normal condition)	10	0.034	548
WP3635	Insulin signaling in adipocytes (diabetic condition)	10	0.034	548
WP3845	Canonical and non-canonical Notch signaling	10	0.034	299.5
WP4157	GABA metabolism (aka GHB)	10	0.034	590.5
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	10	0.034	306.5
WP4286	Genotoxicity pathway	10	0.034	344
WP4389	Bile acids synthesis and enterohepatic circulation	10	0.034	404.5
WP4751	HIPK2 in kidney fibrosis	10	0.034	585.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	10	0.034	313
WP4950	16p11.2 distal deletion syndrome	10	0.034	300.5
WP4963	p53 transcriptional gene network	10	0.034	366.5
WP12	Osteoclast signaling	20	0.034	296.5
WP24	Peptide GPCRs	20	0.034	349.5
WP3640	Imatinib and chronic myeloid leukemia	20	0.034	259.5
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	20	0.034	335.5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	20	0.034	317.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	20	0.034	348
WP4922	Mitochondrial complex IV assembly	20	0.034	620.5
WP4950	16p11.2 distal deletion syndrome	20	0.034	306
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	20	0.034	302
WP107	Translation factors	30	0.034	439.5
WP1528	Physiological and pathological hypertrophy of the heart	30	0.034	302.5
WP186	Homologous recombination	30	0.034	357
WP195	IL-1 signaling pathway	30	0.034	314.5
WP363	Wnt signaling pathway	30	0.034	276
WP3943	Robo4 and VEGF signaling pathways crosstalk	30	0.034	329.5
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	30	0.034	383
WP4565	Neural crest cell migration in cancer	30	0.034	275
WP1601	Fluoropyrimidine activity	2	0.033	431
WP1981	Thyroxine (thyroid hormone) production	2	0.033	448.75
WP206	Fatty acid omega-oxidation	2	0.033	445.25
WP2646	Lidocaine metabolism	2	0.033	450
WP306	Focal adhesion	2	0.033	151
WP3613	Photodynamic therapy-induced unfolded protein response	2	0.033	421.25
WP383	Striated muscle contraction pathway	2	0.033	436
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2	0.033	446.75
WP408	Oxidative stress response	2	0.033	382.75
WP4321	Thermogenesis	2	0.033	228
WP4481	Resistin as a regulator of inflammation	2	0.033	401.5
WP4538	Regulatory circuits of the STAT3 signaling pathway	2	0.033	301.5
WP4685	Melanoma	2	0.033	198.5
WP4804	Cholesterol biosynthesis with skeletal dysplasias	2	0.033	453.75
WP186	Homologous recombination	3	0.033	473.5
WP1981	Thyroxine (thyroid hormone) production	3	0.033	480.5
WP2507	Nanomaterial induced apoptosis	3	0.033	438
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	3	0.033	279
WP408	Oxidative stress response	3	0.033	217.5
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	3	0.033	487.75
WP4536	Genes related to primary cilium development (based on CRISPR)	3	0.033	484.5
WP4657	22q11.2 copy number variation syndrome	3	0.033	227
WP5114	Nucleotide excision repair in xeroderma pigmentosum	3	0.033	453.5
WP2018	RANKL/RANK signaling pathway	4	0.033	217.5
WP391	Mitochondrial gene expression	4	0.033	491.75
WP4541	Hippo-Merlin signaling dysregulation	4	0.033	210
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	4	0.033	489.5
WP704	Methylation pathways	4	0.033	501.5
WP733	Serotonin receptor 2 and STAT3 signaling	4	0.033	505.5
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5	0.033	225
WP3981	miRNA regulation of prostate cancer signaling pathways	5	0.033	243
WP4225	Pyrimidine metabolism and related diseases	5	0.033	516.5
WP4536	Genes related to primary cilium development (based on CRISPR)	5	0.033	514.5
WP4585	Cancer immunotherapy by PD-1 blockade	5	0.033	317.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	5	0.033	471.75
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	5	0.033	236
WP5036	Angiotensin II receptor type 1 pathway	5	0.033	275
WP5052	Nephrogenesis	5	0.033	509.5
WP561	Heme biosynthesis	5	0.033	529
WP58	Monoamine GPCRs	5	0.033	528.5
WP699	Aflatoxin B1 metabolism	5	0.033	516.5
WP106	Alanine and aspartate metabolism	10	0.033	578.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	10	0.033	569.5
WP1600	Nicotine metabolism in liver cells	10	0.033	581.5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	10	0.033	270.5
WP2846	PCSK9-mediated LDL receptor degradation	10	0.033	561.5
WP2855	Dopaminergic neurogenesis	10	0.033	301
WP2880	Glucocorticoid receptor pathway	10	0.033	257
WP3408	Evolocumab mechanism to reduce LDL cholesterol	10	0.033	561.5
WP4814	Somatic sex determination	10	0.033	380.5
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	10	0.033	377
WP5090	Complement system in neuronal development and plasticity	10	0.033	266
WP5122	Prostaglandin and leukotriene metabolism in senescence	10	0.033	285
WP704	Methylation pathways	10	0.033	557
WP241	One-carbon metabolism	20	0.033	343.5
WP2436	Dopamine metabolism	20	0.033	325
WP268	Notch signaling	20	0.033	330
WP3407	FTO obesity variant mechanism	20	0.033	332.5
WP3655	Hypothetical craniofacial development pathway	20	0.033	598
WP4236	Krebs cycle disorders	20	0.033	631
WP4249	Hedgehog signaling pathway	20	0.033	298.5
WP5120	Inclusion body myositis	20	0.033	321
WP2533	Glycerophospholipid biosynthetic pathway	30	0.033	402
WP3407	FTO obesity variant mechanism	30	0.033	334
WP3413	NOTCH1 regulation of endothelial cell calcification	30	0.033	354
WP3591	Sleep regulation	30	0.033	291
WP4657	22q11.2 copy number variation syndrome	30	0.033	326
WP4928	MAPK pathway in congenital thyroid cancer	30	0.033	270
WP4950	16p11.2 distal deletion syndrome	30	0.033	309
WP195	IL-1 signaling pathway	2	0.032	393.5
WP2526	PDGF pathway	2	0.032	383
WP2878	PPAR-alpha pathway	2	0.032	359
WP2879	Farnesoid X receptor pathway	2	0.032	439
WP289	Myometrial relaxation and contraction pathways	2	0.032	172
WP3937	Microglia pathogen phagocytosis pathway	2	0.032	433
WP3972	PDGFR-beta pathway	2	0.032	410
WP399	Wnt signaling pathway and pluripotency	2	0.032	178
WP4216	Chromosomal and microsatellite instability in colorectal cancer	2	0.032	203
WP581	EPO receptor signaling	2	0.032	422
WP692	Sulfation biotransformation reaction	2	0.032	453
WP2035	Follicle stimulating hormone (FSH) signaling pathway	3	0.032	444.75
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	3	0.032	226
WP272	Blood clotting cascade	3	0.032	452.25
WP3925	Amino acid metabolism	3	0.032	446.75
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	3	0.032	452.25
WP4585	Cancer immunotherapy by PD-1 blockade	3	0.032	425
WP4753	Nucleotide excision repair	3	0.032	471.5
WP4838	Regucalcin in proximal tubule epithelial kidney cells	3	0.032	454
WP4912	SARS coronavirus and innate immunity	3	0.032	476.5
WP554	ACE inhibitor pathway	3	0.032	461.25
WP1471	Target of rapamycin (TOR) signaling	4	0.032	411.25
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	4	0.032	206.5
WP2369	Histone modifications	4	0.032	499.5
WP2846	PCSK9-mediated LDL receptor degradation	4	0.032	504
WP3408	Evolocumab mechanism to reduce LDL cholesterol	4	0.032	504
WP408	Oxidative stress response	4	0.032	227.5
WP4963	p53 transcriptional gene network	4	0.032	279
WP521	Amino acid conjugation of benzoic acid	4	0.032	514.5
WP58	Monoamine GPCRs	4	0.032	511.5
WP581	EPO receptor signaling	4	0.032	392
WP2369	Histone modifications	5	0.032	511.5
WP24	Peptide GPCRs	5	0.032	447
WP2583	T cell receptor and co-stimulatory signaling	5	0.032	264.5
WP2880	Glucocorticoid receptor pathway	5	0.032	242
WP3580	Methionine de novo and salvage pathway	5	0.032	510.5
WP408	Oxidative stress response	5	0.032	236
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5	0.032	348.5
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	5	0.032	502.75
WP521	Amino acid conjugation of benzoic acid	5	0.032	533
WP524	G13 signaling pathway	5	0.032	328
WP24	Peptide GPCRs	10	0.032	315
WP4357	NRF2-ARE regulation	10	0.032	288.5
WP2369	Histone modifications	20	0.032	408.5
WP2406	Cardiac progenitor differentiation	20	0.032	288.5
WP3585	Cytosine methylation	20	0.032	606.5
WP3971	OSX and miRNAs in tooth development	20	0.032	362.5
WP4923	Autophagy	20	0.032	348.5
WP5117	Cohesin complex - Cornelia de Lange syndrome	20	0.032	339.5
WP2371	Parkinson's disease pathway	30	0.032	398
WP2436	Dopamine metabolism	30	0.032	366.5
WP2542	Sulindac metabolic pathway	30	0.032	624.75
WP383	Striated muscle contraction pathway	30	0.032	363.5
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	30	0.032	318
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	30	0.032	363
WP4861	Endoplasmic reticulum stress response in coronavirus infection	30	0.032	365
WP4874	CAMKK2 pathway	30	0.032	298
WP138	Androgen receptor signaling pathway	2	0.031	183.5
WP1742	TP53 network	2	0.031	276.5
WP2355	Corticotropin-releasing hormone signaling pathway	2	0.031	179
WP272	Blood clotting cascade	2	0.031	430
WP2870	Extracellular vesicle-mediated signaling in recipient cells	2	0.031	383.25
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	2	0.031	410.5
WP3845	Canonical and non-canonical Notch signaling	2	0.031	431.5
WP3938	miR-222 in exercise-induced cardiac growth	2	0.031	446.5
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	2	0.031	218
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	2	0.031	414
WP4342	Vitamins A and D - action mechanisms	2	0.031	441.5
WP4524	Alternative pathway of fetal androgen synthesis	2	0.031	437
WP4666	Hepatitis B infection	2	0.031	175.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	2	0.031	452.75
WP4814	Somatic sex determination	2	0.031	440
WP1531	Vitamin D metabolism	3	0.031	471.75
WP1544	MicroRNAs in cardiomyocyte hypertrophy	3	0.031	192.5
WP2018	RANKL/RANK signaling pathway	3	0.031	194.5
WP2029	Cell differentiation - index	3	0.031	466
WP2525	Trans-sulfuration and one-carbon metabolism	3	0.031	458.5
WP3937	Microglia pathogen phagocytosis pathway	3	0.031	457
WP399	Wnt signaling pathway and pluripotency	3	0.031	196
WP4155	Endometrial cancer	3	0.031	212
WP4313	Ferroptosis	3	0.031	334.5
WP4541	Hippo-Merlin signaling dysregulation	3	0.031	193
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	3	0.031	298.5
WP4752	Base excision repair	3	0.031	466
WP4873	Peroxiredoxin 2 induced ovarian failure	3	0.031	475.75
WP2889	Oxytocin signaling	4	0.031	513
WP2911	miRNA targets in ECM and membrane receptors	4	0.031	466.5
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	4	0.031	283.5
WP366	TGF-beta signaling pathway	4	0.031	205
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	4	0.031	346
WP383	Striated muscle contraction pathway	4	0.031	462.5
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	4	0.031	296
WP4688	Serine metabolism	4	0.031	505.75
WP5031	Biotin metabolism, including IEMs	4	0.031	513
WP561	Heme biosynthesis	4	0.031	511.5
WP623	Oxidative phosphorylation	4	0.031	507.75
WP699	Aflatoxin B1 metabolism	4	0.031	504
WP734	Serotonin receptor 4/6/7 and NR3C signaling	4	0.031	471.5
WP183	Proteasome degradation	5	0.031	427.5
WP2112	IL-17 signaling pathway	5	0.031	369
WP3845	Canonical and non-canonical Notch signaling	5	0.031	396
WP4147	PTF1A related regulatory pathway	5	0.031	490.5
WP4211	Transcriptional cascade regulating adipogenesis	5	0.031	310.5
WP4758	Nephrotic syndrome	5	0.031	288
WP4962	Airway smooth muscle cell contraction	5	0.031	500.25
WP501	GPCRs, class C metabotropic glutamate, pheromone	5	0.031	515.5
WP5090	Complement system in neuronal development and plasticity	5	0.031	222
WP554	ACE inhibitor pathway	5	0.031	483
WP2491	Diclofenac metabolic pathway	10	0.031	587.5
WP3875	ATR signaling	10	0.031	586.5
WP3958	GPR40 pathway	10	0.031	565.75
WP4582	Cancer immunotherapy by CTLA4 blockade	10	0.031	331.5
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	10	0.031	272
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	10	0.031	295
WP78	TCA cycle (aka Krebs or citric acid cycle)	10	0.031	586.5
WP3845	Canonical and non-canonical Notch signaling	20	0.031	331
WP3941	Oxidative damage response	20	0.031	299
WP4873	Peroxiredoxin 2 induced ovarian failure	20	0.031	367.5
WP12	Osteoclast signaling	30	0.031	312
WP1424	Globo sphingolipid metabolism	30	0.031	345.5
WP2637	Interleukin-1 (IL-1) structural pathway	30	0.031	330
WP3644	NAD+ metabolism	30	0.031	381
WP3875	ATR signaling	30	0.031	640.25
WP400	p38 MAPK signaling pathway	30	0.031	299
WP4922	Mitochondrial complex IV assembly	30	0.031	633
WP5036	Angiotensin II receptor type 1 pathway	30	0.031	316.5
WP690	Polyol pathway	30	0.031	645.5
WP1584	Type II diabetes mellitus	2	0.03	426.75
WP1603	Nicotine effect on chromaffin cells	2	0.03	451.5
WP2371	Parkinson's disease pathway	2	0.03	441.5
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	2	0.03	399.5
WP3995	Prion disease pathway	2	0.03	307
WP4255	Non-small cell lung cancer	2	0.03	193
WP4495	IL-10 anti-inflammatory signaling pathway	2	0.03	421.5
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	2	0.03	437.75
WP143	Fatty acid beta-oxidation	3	0.03	475.5
WP1992	Genes targeted by miRNAs in adipocytes	3	0.03	454
WP3658	Wnt/beta-catenin signaling pathway in leukemia	3	0.03	242
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	3	0.03	434.25
WP3965	Lipid metabolism pathway	3	0.03	460
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	3	0.03	481
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	3	0.03	205
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3	0.03	268
WP4317	Mitochondrial fatty acid synthesis pathway	3	0.03	488.75
WP4584	Biomarkers for pyrimidine metabolism disorders	3	0.03	478.5
WP4656	Joubert syndrome	3	0.03	466.5
WP4659	Gastrin signaling pathway	3	0.03	201
WP481	Insulin signaling	3	0.03	175
WP4932	7q11.23 copy number variation syndrome	3	0.03	253
WP5061	Fatty acid transporters	3	0.03	483.5
WP138	Androgen receptor signaling pathway	4	0.03	223
WP1528	Physiological and pathological hypertrophy of the heart	4	0.03	288
WP2456	HIF1A and PPARG regulation of glycolysis	4	0.03	483.5
WP3634	Insulin signaling in adipocytes (normal condition)	4	0.03	495.75
WP3635	Insulin signaling in adipocytes (diabetic condition)	4	0.03	495.75
WP3651	Pathways affected in adenoid cystic carcinoma	4	0.03	209.5
WP4220	Neurotransmitter disorders	4	0.03	507.5
WP4313	Ferroptosis	4	0.03	280.5
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	4	0.03	513.75
WP12	Osteoclast signaling	5	0.03	454
WP1545	miRNAs involved in DNA damage response	5	0.03	243
WP3934	Leptin and adiponectin	5	0.03	524.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	5	0.03	364.5
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	5	0.03	263
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	5	0.03	517
WP4357	NRF2-ARE regulation	5	0.03	248.5
WP4389	Bile acids synthesis and enterohepatic circulation	5	0.03	496.5
WP4722	Glycerolipids and glycerophospholipids	5	0.03	509
WP581	EPO receptor signaling	5	0.03	287
WP623	Oxidative phosphorylation	5	0.03	524.5
WP3941	Oxidative damage response	10	0.03	288
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	10	0.03	426
WP4758	Nephrotic syndrome	10	0.03	295
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	10	0.03	304
WP4923	Autophagy	10	0.03	352.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	10	0.03	570.5
WP167	Eicosanoid synthesis	20	0.03	344
WP183	Proteasome degradation	20	0.03	373
WP2371	Parkinson's disease pathway	20	0.03	382
WP2637	Interleukin-1 (IL-1) structural pathway	20	0.03	301
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	20	0.03	322
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	20	0.03	335
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	20	0.03	287
WP524	G13 signaling pathway	20	0.03	333.5
WP585	Interferon type I signaling pathways	20	0.03	312.5
WP1603	Nicotine effect on chromaffin cells	30	0.03	430.25
WP2197	Endothelin pathways	30	0.03	313
WP2333	Trans-sulfuration pathway	30	0.03	415
WP3934	Leptin and adiponectin	30	0.03	425
WP3965	Lipid metabolism pathway	30	0.03	348
WP4312	Rett syndrome causing genes	30	0.03	306
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	30	0.03	287
WP5117	Cohesin complex - Cornelia de Lange syndrome	30	0.03	342
WP2007	Iron metabolism in placenta	2	0.029	448.25
WP2875	Constitutive androstane receptor pathway	2	0.029	412.5
WP3298	Melatonin metabolism and effects	2	0.029	413.75
WP3599	Transcription factor regulation in adipogenesis	2	0.029	404.5
WP3931	Embryonic stem cell pluripotency pathways	2	0.029	225
WP4141	PI3K/AKT/mTOR - VitD3 signaling	2	0.029	397.5
WP4537	Hippo-Yap signaling pathway	2	0.029	440
WP4549	Fragile X syndrome	2	0.029	244.5
WP47	Hedgehog signaling pathway Netpath	2	0.029	444.5
WP4917	Proximal tubule transport	2	0.029	428
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	2	0.029	452.5
WP5117	Cohesin complex - Cornelia de Lange syndrome	2	0.029	433.5
WP716	Vitamin A and carotenoid metabolism	2	0.029	424.75
WP2542	Sulindac metabolic pathway	3	0.029	486
WP3981	miRNA regulation of prostate cancer signaling pathways	3	0.029	224
WP4022	Pyrimidine metabolism	3	0.029	471.5
WP404	Nucleotide metabolism	3	0.029	480.5
WP5036	Angiotensin II receptor type 1 pathway	3	0.029	367.5
WP550	Biogenic amine synthesis	3	0.029	481
WP2355	Corticotropin-releasing hormone signaling pathway	4	0.029	212
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4	0.029	236
WP3585	Cytosine methylation	4	0.029	509.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	4	0.029	491.25
WP3941	Oxidative damage response	4	0.029	247
WP3958	GPR40 pathway	4	0.029	503.5
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	4	0.029	513.25
WP4331	Neovascularisation processes	4	0.029	222.5
WP4482	Vitamin D in inflammatory diseases	4	0.029	233
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	4	0.029	478.5
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	4	0.029	458.5
WP4950	16p11.2 distal deletion syndrome	4	0.029	373
WP4962	Airway smooth muscle cell contraction	4	0.029	489.5
WP501	GPCRs, class C metabotropic glutamate, pheromone	4	0.029	504
WP5117	Cohesin complex - Cornelia de Lange syndrome	4	0.029	466.5
WP2406	Cardiac progenitor differentiation	5	0.029	228
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5	0.029	255
WP2846	PCSK9-mediated LDL receptor degradation	5	0.029	519
WP3408	Evolocumab mechanism to reduce LDL cholesterol	5	0.029	519
WP3634	Insulin signaling in adipocytes (normal condition)	5	0.029	511
WP3635	Insulin signaling in adipocytes (diabetic condition)	5	0.029	511
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5	0.029	249.5
WP4533	Transcription co-factors SKI and SKIL protein partners	5	0.029	499.5
WP61	Notch signaling pathway (Netpath)	5	0.029	244
WP733	Serotonin receptor 2 and STAT3 signaling	5	0.029	521.5
WP98	Prostaglandin synthesis and regulation	5	0.029	253
WP100	Glutathione metabolism	10	0.029	554.5
WP2038	Microtubule cytoskeleton regulation	10	0.029	267
WP383	Striated muscle contraction pathway	10	0.029	311
WP3853	ERK pathway in Huntington's disease	10	0.029	373.5
WP3965	Lipid metabolism pathway	10	0.029	308.5
WP408	Oxidative stress response	10	0.029	266
WP4147	PTF1A related regulatory pathway	10	0.029	332
WP4549	Fragile X syndrome	10	0.029	310
WP4688	Serine metabolism	10	0.029	569.5
WP4922	Mitochondrial complex IV assembly	10	0.029	581.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	10	0.029	542.5
WP1495	Glycine metabolism	20	0.029	627.25
WP2029	Cell differentiation - index	20	0.029	342.5
WP2363	Gastric cancer network 2	20	0.029	333.5
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	20	0.029	295
WP2855	Dopaminergic neurogenesis	20	0.029	313
WP368	Mitochondrial long chain fatty acid beta-oxidation	20	0.029	502.25
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	20	0.029	430.5
WP167	Eicosanoid synthesis	30	0.029	369.5
WP2491	Diclofenac metabolic pathway	30	0.029	646
WP3286	Copper homeostasis	30	0.029	313
WP4321	Thermogenesis	30	0.029	341
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	30	0.029	334.5
WP438	Non-homologous end joining	30	0.029	434.5
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	30	0.029	294
WP4536	Genes related to primary cilium development (based on CRISPR)	30	0.029	463
WP4917	Proximal tubule transport	30	0.029	372
WP501	GPCRs, class C metabotropic glutamate, pheromone	30	0.029	406
WP1424	Globo sphingolipid metabolism	2	0.028	447.75
WP229	Irinotecan pathway	2	0.028	442.5
WP2369	Histone modifications	2	0.028	446.5
WP286	IL-3 signaling pathway	2	0.028	230
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	2	0.028	436.75
WP395	IL-4 signaling pathway	2	0.028	233.5
WP404	Nucleotide metabolism	2	0.028	447.5
WP4541	Hippo-Merlin signaling dysregulation	2	0.028	180
WP4629	Aerobic glycolysis	2	0.028	445
WP4698	Vitamin D-sensitive calcium signaling in depression	2	0.028	331
WP4904	LDLRAD4 and what we know about it	2	0.028	451
WP4912	SARS coronavirus and innate immunity	2	0.028	442
WP4940	15q11.2 copy number variation syndrome	2	0.028	452.5
WP561	Heme biosynthesis	2	0.028	453
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	3	0.028	453
WP3407	FTO obesity variant mechanism	3	0.028	462
WP3595	mir-124 predicted interactions with cell cycle and differentiation	3	0.028	486
WP3651	Pathways affected in adenoid cystic carcinoma	3	0.028	208.5
WP391	Mitochondrial gene expression	3	0.028	470.5
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	3	0.028	466.5
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	3	0.028	488
WP4220	Neurotransmitter disorders	3	0.028	486
WP4222	Phosphodiesterases in neuronal function	3	0.028	446.25
WP4225	Pyrimidine metabolism and related diseases	3	0.028	477
WP4269	Ethanol metabolism production of ROS by CYP2E1	3	0.028	471
WP4331	Neovascularisation processes	3	0.028	218.5
WP4479	Supression of HMGB1 mediated inflammation by THBD	3	0.028	466.5
WP4970	Galanin receptor pathway	3	0.028	232.5
WP500	Glycogen synthesis and degradation	3	0.028	465.5
WP699	Aflatoxin B1 metabolism	3	0.028	480.5
WP117	GPCRs, other	4	0.028	459.25
WP195	IL-1 signaling pathway	4	0.028	239.5
WP2112	IL-17 signaling pathway	4	0.028	448.75
WP2332	Interleukin-11 signaling pathway	4	0.028	234
WP2371	Parkinson's disease pathway	4	0.028	485
WP3286	Copper homeostasis	4	0.028	247
WP3930	EDA signaling in hair follicle development	4	0.028	499.5
WP3934	Leptin and adiponectin	4	0.028	506.25
WP3965	Lipid metabolism pathway	4	0.028	472.25
WP4222	Phosphodiesterases in neuronal function	4	0.028	389
WP4255	Non-small cell lung cancer	4	0.028	221.5
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	4	0.028	398.5
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4	0.028	315
WP61	Notch signaling pathway (Netpath)	4	0.028	229
WP2525	Trans-sulfuration and one-carbon metabolism	5	0.028	403
WP2640	Aripiprazole metabolic pathway	5	0.028	532
WP2870	Extracellular vesicle-mediated signaling in recipient cells	5	0.028	253.5
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	5	0.028	279.5
WP3892	Development of pulmonary dendritic cells and macrophage subsets	5	0.028	224
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	5	0.028	493.5
WP4249	Hedgehog signaling pathway	5	0.028	286
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	5	0.028	267
WP4331	Neovascularisation processes	5	0.028	239
WP4751	HIPK2 in kidney fibrosis	5	0.028	529.5
WP4950	16p11.2 distal deletion syndrome	5	0.028	289.5
WP117	GPCRs, other	10	0.028	315
WP1589	Folate-alcohol and cancer pathway hypotheses	10	0.028	554.75
WP2583	T cell receptor and co-stimulatory signaling	10	0.028	293
WP26	S1P receptor signal transduction	10	0.028	318
WP3286	Copper homeostasis	10	0.028	293
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	10	0.028	322
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	10	0.028	301.5
WP4150	Wnt signaling in kidney disease	10	0.028	364.5
WP4225	Pyrimidine metabolism and related diseases	10	0.028	555.75
WP4249	Hedgehog signaling pathway	10	0.028	297
WP4536	Genes related to primary cilium development (based on CRISPR)	10	0.028	554.75
WP4917	Proximal tubule transport	10	0.028	347
WP5038	Mitochondrial immune response to SARS-CoV-2	10	0.028	289
WP106	Alanine and aspartate metabolism	20	0.028	614.5
WP1424	Globo sphingolipid metabolism	20	0.028	347.5
WP1589	Folate-alcohol and cancer pathway hypotheses	20	0.028	367
WP1600	Nicotine metabolism in liver cells	20	0.028	617.5
WP2035	Follicle stimulating hormone (FSH) signaling pathway	20	0.028	327.5
WP205	IL-7 signaling pathway	20	0.028	242
WP2839	Hair follicle development: organogenesis - part 2 of 3	20	0.028	282.5
WP2895	Differentiation of white and brown adipocyte	20	0.028	337.5
WP3877	MYD88 distinct input-output pathway	20	0.028	351
WP4222	Phosphodiesterases in neuronal function	20	0.028	377.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	20	0.028	269
WP1591	Heart development	30	0.028	303.5
WP2583	T cell receptor and co-stimulatory signaling	30	0.028	319
WP3630	NAD metabolism, sirtuins and aging	30	0.028	329
WP4562	Canonical NF-kB pathway	30	0.028	359.5
WP4814	Somatic sex determination	30	0.028	437
WP2507	Nanomaterial induced apoptosis	2	0.027	416
WP2542	Sulindac metabolic pathway	2	0.027	452
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2	0.027	424
WP314	Fas ligand pathway and stress induction of heat shock proteins	2	0.027	276
WP3413	NOTCH1 regulation of endothelial cell calcification	2	0.027	422
WP3595	mir-124 predicted interactions with cell cycle and differentiation	2	0.027	453
WP3658	Wnt/beta-catenin signaling pathway in leukemia	2	0.027	277
WP4008	NO/cGMP/PKG mediated neuroprotection	2	0.027	376.75
WP4249	Hedgehog signaling pathway	2	0.027	389.75
WP4313	Ferroptosis	2	0.027	404.25
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	2	0.027	421.5
WP4584	Biomarkers for pyrimidine metabolism disorders	2	0.027	447.5
WP4674	Head and neck squamous cell carcinoma	2	0.027	180
WP698	Glucuronidation	2	0.027	446.5
WP117	GPCRs, other	3	0.027	457.25
WP2826	Cocaine metabolism	3	0.027	484.5
WP3630	NAD metabolism, sirtuins and aging	3	0.027	453
WP3680	Physico-chemical features and toxicity-associated pathways	3	0.027	208.5
WP3963	Mevalonate pathway	3	0.027	485
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	3	0.027	392.5
WP4255	Non-small cell lung cancer	3	0.027	204.5
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	3	0.027	413.75
WP4760	PKC-gamma calcium signaling pathway in ataxia	3	0.027	460
WP524	G13 signaling pathway	3	0.027	452.5
WP107	Translation factors	4	0.027	495.5
WP325	Triacylglyceride synthesis	4	0.027	498
WP3580	Methionine de novo and salvage pathway	4	0.027	495
WP3633	Caffeine and theobromine metabolism	4	0.027	511.5
WP3680	Physico-chemical features and toxicity-associated pathways	4	0.027	234.5
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	4	0.027	491
WP3892	Development of pulmonary dendritic cells and macrophage subsets	4	0.027	220.5
WP4147	PTF1A related regulatory pathway	4	0.027	488
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	4	0.027	481.75
WP4194	Hormonal control of pubertal growth spurt	4	0.027	514.5
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	4	0.027	500.5
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	4	0.027	285
WP2456	HIF1A and PPARG regulation of glycolysis	5	0.027	497.75
WP3941	Oxidative damage response	5	0.027	264
WP4204	Tumor suppressor activity of SMARCB1	5	0.027	254.5
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	5	0.027	514
WP4657	22q11.2 copy number variation syndrome	5	0.027	257.5
WP5120	Inclusion body myositis	5	0.027	487
WP244	Alpha 6 beta 4 signaling pathway	10	0.027	307
WP3529	Zinc homeostasis	10	0.027	578
WP3591	Sleep regulation	10	0.027	281.5
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	10	0.027	306.5
WP4211	Transcriptional cascade regulating adipogenesis	10	0.027	284
WP4919	Neuroinflammation	10	0.027	315
WP699	Aflatoxin B1 metabolism	10	0.027	561.5
WP2249	Metastatic brain tumor	20	0.027	276
WP2583	T cell receptor and co-stimulatory signaling	20	0.027	307
WP363	Wnt signaling pathway	20	0.027	283
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	20	0.027	387.5
WP3853	ERK pathway in Huntington's disease	20	0.027	372.5
WP3930	EDA signaling in hair follicle development	20	0.027	393
WP3996	Ethanol effects on histone modifications	20	0.027	322
WP4211	Transcriptional cascade regulating adipogenesis	20	0.027	296
WP4389	Bile acids synthesis and enterohepatic circulation	20	0.027	417.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	20	0.027	303.5
WP183	Proteasome degradation	30	0.027	406
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	30	0.027	339
WP2038	Microtubule cytoskeleton regulation	30	0.027	303.5
WP2855	Dopaminergic neurogenesis	30	0.027	346
WP304	Kit receptor signaling pathway	30	0.027	261
WP3585	Cytosine methylation	30	0.027	475
WP4259	Disorders of folate metabolism and transport	30	0.027	401.5
WP428	Wnt signaling	30	0.027	308
WP585	Interferon type I signaling pathways	30	0.027	330
WP2112	IL-17 signaling pathway	2	0.026	429.5
WP24	Peptide GPCRs	2	0.026	429.5
WP3935	Leptin-insulin signaling overlap	2	0.026	425.5
WP4225	Pyrimidine metabolism and related diseases	2	0.026	446.5
WP4357	NRF2-ARE regulation	2	0.026	409.5
WP4482	Vitamin D in inflammatory diseases	2	0.026	399.5
WP4532	Intraflagellar transport proteins binding to dynein	2	0.026	453.5
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	2	0.026	448
WP4751	HIPK2 in kidney fibrosis	2	0.026	453.5
WP1601	Fluoropyrimidine activity	3	0.026	456.25
WP2371	Parkinson's disease pathway	3	0.026	473.25
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	3	0.026	196
WP244	Alpha 6 beta 4 signaling pathway	3	0.026	424.5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	3	0.026	260
WP2943	Hypoxia-mediated EMT and stemness	3	0.026	487
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	3	0.026	368.5
WP3585	Cytosine methylation	3	0.026	486
WP3845	Canonical and non-canonical Notch signaling	3	0.026	459.5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	3	0.026	306.5
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	3	0.026	479.5
WP4482	Vitamin D in inflammatory diseases	3	0.026	263.5
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	3	0.026	472
WP4758	Nephrotic syndrome	3	0.026	406.25
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	3	0.026	407
WP98	Prostaglandin synthesis and regulation	3	0.026	265
WP3845	Canonical and non-canonical Notch signaling	4	0.026	456
WP4211	Transcriptional cascade regulating adipogenesis	4	0.026	430.5
WP4236	Krebs cycle disorders	4	0.026	514.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	4	0.026	254
WP4760	PKC-gamma calcium signaling pathway in ataxia	4	0.026	474
WP4804	Cholesterol biosynthesis with skeletal dysplasias	4	0.026	510.75
WP2197	Endothelin pathways	5	0.026	249
WP2855	Dopaminergic neurogenesis	5	0.026	384
WP2889	Oxytocin signaling	5	0.026	530.5
WP3595	mir-124 predicted interactions with cell cycle and differentiation	5	0.026	529
WP3853	ERK pathway in Huntington's disease	5	0.026	486.5
WP3930	EDA signaling in hair follicle development	5	0.026	513.5
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	5	0.026	473.5
WP5031	Biotin metabolism, including IEMs	5	0.026	529.5
WP673	ErbB signaling pathway	5	0.026	245
WP1423	Ganglio sphingolipid metabolism	10	0.026	574
WP1531	Vitamin D metabolism	10	0.026	361.5
WP183	Proteasome degradation	10	0.026	338
WP2029	Cell differentiation - index	10	0.026	350.5
WP2035	Follicle stimulating hormone (FSH) signaling pathway	10	0.026	313
WP2253	Pilocytic astrocytoma	10	0.026	578
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	10	0.026	575.5
WP241	One-carbon metabolism	10	0.026	301.5
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	10	0.026	254.5
WP3	Transcriptional activation by NRF2 in response to phytochemicals	10	0.026	322
WP3407	FTO obesity variant mechanism	10	0.026	336.5
WP363	Wnt signaling pathway	10	0.026	261.5
WP368	Mitochondrial long chain fatty acid beta-oxidation	10	0.026	573
WP4174	Metabolism of tetrahydrocannabinol (THC)	10	0.026	575.75
WP3527	Pre-implantation embryo	20	0.026	289.5
WP383	Striated muscle contraction pathway	20	0.026	355
WP4147	PTF1A related regulatory pathway	20	0.026	320.5
WP4224	Purine metabolism and related disorders	20	0.026	348.5
WP4656	Joubert syndrome	20	0.026	387.5
WP4722	Glycerolipids and glycerophospholipids	20	0.026	347
WP704	Methylation pathways	20	0.026	398
WP2029	Cell differentiation - index	30	0.026	341
WP2895	Differentiation of white and brown adipocyte	30	0.026	332
WP4008	NO/cGMP/PKG mediated neuroprotection	30	0.026	353
WP1531	Vitamin D metabolism	2	0.025	440.75
WP1946	Cori cycle	2	0.025	437
WP2018	RANKL/RANK signaling pathway	2	0.025	225
WP2029	Cell differentiation - index	2	0.025	438
WP2536	Colchicine metabolic pathway	2	0.025	452
WP2816	Felbamate metabolism	2	0.025	452
WP2839	Hair follicle development: organogenesis - part 2 of 3	2	0.025	264.5
WP3644	NAD+ metabolism	2	0.025	448.5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	2	0.025	410.25
WP3967	miR-509-3p alteration of YAP1/ECM axis	2	0.025	427.25
WP410	Exercise-induced circadian regulation	2	0.025	431
WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	2	0.025	438.5
WP4220	Neurotransmitter disorders	2	0.025	452
WP4241	Type 2 papillary renal cell carcinoma	2	0.025	385
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2	0.025	386.25
WP2007	Iron metabolism in placenta	3	0.025	482.75
WP2253	Pilocytic astrocytoma	3	0.025	484.5
WP2526	PDGF pathway	3	0.025	244.5
WP2536	Colchicine metabolic pathway	3	0.025	484.5
WP2816	Felbamate metabolism	3	0.025	484.5
WP3633	Caffeine and theobromine metabolism	3	0.025	487.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	3	0.025	222.5
WP3869	Cannabinoid receptor signaling	3	0.025	468.75
WP3934	Leptin and adiponectin	3	0.025	483.5
WP3971	OSX and miRNAs in tooth development	3	0.025	473.5
WP4174	Metabolism of tetrahydrocannabinol (THC)	3	0.025	484.5
WP4216	Chromosomal and microsatellite instability in colorectal cancer	3	0.025	220.5
WP4249	Hedgehog signaling pathway	3	0.025	287
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	3	0.025	482
WP4751	HIPK2 in kidney fibrosis	3	0.025	488
WP4804	Cholesterol biosynthesis with skeletal dysplasias	3	0.025	487.5
WP704	Methylation pathways	3	0.025	481
WP111	Electron transport chain: OXPHOS system in mitochondria	4	0.025	499.5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	4	0.025	226
WP2436	Dopamine metabolism	4	0.025	490
WP2795	Cardiac hypertrophic response	4	0.025	219
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	4	0.025	246
WP34	Ovarian infertility	4	0.025	253
WP3630	NAD metabolism, sirtuins and aging	4	0.025	449
WP4249	Hedgehog signaling pathway	4	0.025	277.5
WP4751	HIPK2 in kidney fibrosis	4	0.025	513
WP4905	1q21.1 copy number variation syndrome	4	0.025	491
WP673	ErbB signaling pathway	4	0.025	236
WP107	Translation factors	5	0.025	508
WP1425	Bone morphogenic protein (BMP) signaling and regulation	5	0.025	520
WP1603	Nicotine effect on chromaffin cells	5	0.025	527
WP2646	Lidocaine metabolism	5	0.025	521.25
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	5	0.025	241
WP2826	Cocaine metabolism	5	0.025	524.5
WP3413	NOTCH1 regulation of endothelial cell calcification	5	0.025	341
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	5	0.025	248.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	5	0.025	272
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	5	0.025	313
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	5	0.025	506.25
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	5	0.025	443.75
WP4853	Linoleic acid metabolism affected by coronavirus infection	5	0.025	529
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	5	0.025	302.5
WP734	Serotonin receptor 4/6/7 and NR3C signaling	5	0.025	477.25
WP12	Osteoclast signaling	10	0.025	265
WP134	Pentose phosphate metabolism	10	0.025	594
WP3644	NAD+ metabolism	10	0.025	556.5
WP3858	Toll-like receptor signaling related to MyD88	10	0.025	300.5
WP3930	EDA signaling in hair follicle development	10	0.025	555
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	10	0.025	547.25
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	10	0.025	292.5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	10	0.025	307
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	10	0.025	332.5
WP1422	Sphingolipid pathway	20	0.025	407
WP1591	Heart development	20	0.025	303
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	20	0.025	625.5
WP3591	Sleep regulation	20	0.025	300
WP3644	NAD+ metabolism	20	0.025	380
WP428	Wnt signaling	20	0.025	299.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	20	0.025	304.5
WP4562	Canonical NF-kB pathway	20	0.025	335.5
WP100	Glutathione metabolism	30	0.025	421.5
WP2406	Cardiac progenitor differentiation	30	0.025	323
WP241	One-carbon metabolism	30	0.025	340.5
WP2643	Nanoparticle-mediated activation of receptor signaling	30	0.025	316
WP4288	MTHFR deficiency	30	0.025	327.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	30	0.025	357.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	30	0.025	357
WP197	Cholesterol biosynthesis pathway	2	0.024	449.75
WP2197	Endothelin pathways	2	0.024	415
WP313	Hepatocyte growth factor receptor signaling	2	0.024	358
WP3585	Cytosine methylation	2	0.024	453
WP3630	NAD metabolism, sirtuins and aging	2	0.024	427.75
WP4155	Endometrial cancer	2	0.024	198
WP4174	Metabolism of tetrahydrocannabinol (THC)	2	0.024	452
WP4259	Disorders of folate metabolism and transport	2	0.024	448.25
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2	0.024	425.25
WP4874	CAMKK2 pathway	2	0.024	391.5
WP5120	Inclusion body myositis	2	0.024	438.75
WP727	Monoamine transport	2	0.024	415.75
WP98	Prostaglandin synthesis and regulation	2	0.024	385.5
WP2112	IL-17 signaling pathway	3	0.024	455.75
WP3286	Copper homeostasis	3	0.024	254.5
WP34	Ovarian infertility	3	0.024	254
WP3634	Insulin signaling in adipocytes (normal condition)	3	0.024	474
WP3635	Insulin signaling in adipocytes (diabetic condition)	3	0.024	474
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	3	0.024	269.5
WP3972	PDGFR-beta pathway	3	0.024	298.5
WP4194	Hormonal control of pubertal growth spurt	3	0.024	488
WP4566	Translation inhibitors in chronically activated PDGFRA cells	3	0.024	415
WP623	Oxidative phosphorylation	3	0.024	486
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	4	0.024	461
WP2509	Nanoparticle triggered autophagic cell death	4	0.024	389.5
WP2513	Nanoparticle triggered regulated necrosis	4	0.024	478.75
WP2533	Glycerophospholipid biosynthetic pathway	4	0.024	503.5
WP2640	Aripiprazole metabolic pathway	4	0.024	514.5
WP4317	Mitochondrial fatty acid synthesis pathway	4	0.024	514.5
WP4389	Bile acids synthesis and enterohepatic circulation	4	0.024	489
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	4	0.024	514
WP4533	Transcription co-factors SKI and SKIL protein partners	4	0.024	493.5
WP5044	Kynurenine pathway and links to cell senescence	4	0.024	282.5
WP111	Electron transport chain: OXPHOS system in mitochondria	5	0.024	514.5
WP2332	Interleukin-11 signaling pathway	5	0.024	247
WP244	Alpha 6 beta 4 signaling pathway	5	0.024	315.5
WP2447	Amyotrophic lateral sclerosis (ALS)	5	0.024	292
WP2513	Nanoparticle triggered regulated necrosis	5	0.024	490.75
WP4313	Ferroptosis	5	0.024	281.5
WP4324	Mitochondrial complex I assembly model OXPHOS system	5	0.024	530.5
WP4400	FABP4 in ovarian cancer	5	0.024	532.25
WP205	IL-7 signaling pathway	10	0.024	242
WP3871	Valproic acid pathway	10	0.024	580.5
WP4204	Tumor suppressor activity of SMARCB1	10	0.024	302.5
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	10	0.024	323
WP4760	PKC-gamma calcium signaling pathway in ataxia	10	0.024	323
WP4861	Endoplasmic reticulum stress response in coronavirus infection	10	0.024	318
WP1603	Nicotine effect on chromaffin cells	20	0.024	615.5
WP3858	Toll-like receptor signaling related to MyD88	20	0.024	349
WP4191	Caloric restriction and aging	20	0.024	339.5
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	20	0.024	295
WP4758	Nephrotic syndrome	20	0.024	351
WP4760	PKC-gamma calcium signaling pathway in ataxia	20	0.024	379
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	20	0.024	617
WP4818	Conversion of angiotensinogen to angiotensin II	20	0.024	621.5
WP4917	Proximal tubule transport	20	0.024	360
WP1425	Bone morphogenic protein (BMP) signaling and regulation	30	0.024	418
WP244	Alpha 6 beta 4 signaling pathway	30	0.024	348.5
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	30	0.024	348
WP3851	TLR4 signaling and tolerance	30	0.024	330.5
WP3871	Valproic acid pathway	30	0.024	636.25
WP3971	OSX and miRNAs in tooth development	30	0.024	370.5
WP4224	Purine metabolism and related disorders	30	0.024	378.5
WP4313	Ferroptosis	30	0.024	331.5
WP4357	NRF2-ARE regulation	30	0.024	307
WP4582	Cancer immunotherapy by CTLA4 blockade	30	0.024	356.5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	30	0.024	366
WP304	Kit receptor signaling pathway	2	0.023	197
WP3633	Caffeine and theobromine metabolism	2	0.023	453
WP366	TGF-beta signaling pathway	2	0.023	159.5
WP3934	Leptin and adiponectin	2	0.023	450.5
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2	0.023	258.5
WP4585	Cancer immunotherapy by PD-1 blockade	2	0.023	415.25
WP4760	PKC-gamma calcium signaling pathway in ataxia	2	0.023	441
WP4873	Peroxiredoxin 2 induced ovarian failure	2	0.023	444.5
WP5049	Glycolysis in senescence	2	0.023	427.5
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	2	0.023	452.5
WP694	Arylamine metabolism	2	0.023	452.5
WP699	Aflatoxin B1 metabolism	2	0.023	448.5
WP704	Methylation pathways	2	0.023	448
WP733	Serotonin receptor 2 and STAT3 signaling	2	0.023	449.5
WP1528	Physiological and pathological hypertrophy of the heart	3	0.023	318
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	3	0.023	457.75
WP2406	Cardiac progenitor differentiation	3	0.023	217
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	3	0.023	462
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	3	0.023	469
WP3940	One-carbon metabolism and related pathways	3	0.023	426
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	3	0.023	443.5
WP4324	Mitochondrial complex I assembly model OXPHOS system	3	0.023	488.25
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	3	0.023	462.75
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3	0.023	442.75
WP501	GPCRs, class C metabotropic glutamate, pheromone	3	0.023	481.75
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3	0.023	442.75
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	3	0.023	487.5
WP673	ErbB signaling pathway	3	0.023	212
WP694	Arylamine metabolism	3	0.023	486
WP2007	Iron metabolism in placenta	4	0.023	504.25
WP2197	Endothelin pathways	4	0.023	260.5
WP241	One-carbon metabolism	4	0.023	484.25
WP3407	FTO obesity variant mechanism	4	0.023	473.5
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	4	0.023	476
WP3644	NAD+ metabolism	4	0.023	502.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	4	0.023	272.5
WP4150	Wnt signaling in kidney disease	4	0.023	483
WP4479	Supression of HMGB1 mediated inflammation by THBD	4	0.023	482.25
WP4582	Cancer immunotherapy by CTLA4 blockade	4	0.023	478
WP477	Cytoplasmic ribosomal proteins	4	0.023	504.25
WP4861	Endoplasmic reticulum stress response in coronavirus infection	4	0.023	301
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	4	0.023	510
WP106	Alanine and aspartate metabolism	5	0.023	524.5
WP1602	Nicotine effect on dopaminergic neurons	5	0.023	520
WP2038	Microtubule cytoskeleton regulation	5	0.023	212.5
WP2533	Glycerophospholipid biosynthetic pathway	5	0.023	517.5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	5	0.023	253
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	5	0.023	234.5
WP3286	Copper homeostasis	5	0.023	266
WP3407	FTO obesity variant mechanism	5	0.023	466
WP3958	GPR40 pathway	5	0.023	518.5
WP4656	Joubert syndrome	5	0.023	473.5
WP4688	Serine metabolism	5	0.023	521.5
WP4963	p53 transcriptional gene network	5	0.023	294.5
WP500	Glycogen synthesis and degradation	5	0.023	489.5
WP704	Methylation pathways	5	0.023	516.5
WP1602	Nicotine effect on dopaminergic neurons	10	0.023	572.75
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	10	0.023	474.5
WP4222	Phosphodiesterases in neuronal function	10	0.023	335.5
WP428	Wnt signaling	10	0.023	280.5
WP4342	Vitamins A and D - action mechanisms	10	0.023	365
WP4656	Joubert syndrome	10	0.023	363.5
WP4722	Glycerolipids and glycerophospholipids	10	0.023	379
WP4874	CAMKK2 pathway	10	0.023	269.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	10	0.023	536.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	20	0.023	501.5
WP1528	Physiological and pathological hypertrophy of the heart	20	0.023	305
WP3890	Nanomaterial-induced inflammasome activation	20	0.023	363
WP3965	Lipid metabolism pathway	20	0.023	335.5
WP4008	NO/cGMP/PKG mediated neuroprotection	20	0.023	365
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	20	0.023	357.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	20	0.023	433
WP623	Oxidative phosphorylation	20	0.023	616.25
WP4191	Caloric restriction and aging	30	0.023	335
WP4220	Neurotransmitter disorders	30	0.023	469.75
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	30	0.023	333
WP4495	IL-10 anti-inflammatory signaling pathway	30	0.023	289
WP5103	Progeria-associated lipodystrophy	30	0.023	338
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	30	0.023	399
WP1495	Glycine metabolism	2	0.022	454.25
WP183	Proteasome degradation	2	0.022	428.75
WP2035	Follicle stimulating hormone (FSH) signaling pathway	2	0.022	424.75
WP3634	Insulin signaling in adipocytes (normal condition)	2	0.022	446.25
WP3635	Insulin signaling in adipocytes (diabetic condition)	2	0.022	446.25
WP4030	SCFA and skeletal muscle substrate metabolism	2	0.022	450
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2	0.022	450.5
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	2	0.022	446.75
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	2	0.022	425.75
WP5031	Biotin metabolism, including IEMs	2	0.022	453.5
WP100	Glutathione metabolism	3	0.022	480.5
WP2197	Endothelin pathways	3	0.022	400.75
WP2436	Dopamine metabolism	3	0.022	472
WP2456	HIF1A and PPARG regulation of glycolysis	3	0.022	467
WP314	Fas ligand pathway and stress induction of heat shock proteins	3	0.022	248
WP3656	Interleukin-1 induced activation of NF-kB	3	0.022	463.5
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	3	0.022	488.5
WP4688	Serine metabolism	3	0.022	484
WP5049	Glycolysis in senescence	3	0.022	455
WP545	Complement activation	3	0.022	484
WP1531	Vitamin D metabolism	4	0.022	489.25
WP183	Proteasome degradation	4	0.022	464.75
WP2447	Amyotrophic lateral sclerosis (ALS)	4	0.022	271
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	4	0.022	254
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	4	0.022	241
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	4	0.022	489
WP4269	Ethanol metabolism production of ROS by CYP2E1	4	0.022	486
WP4853	Linoleic acid metabolism affected by coronavirus infection	4	0.022	513
WP4923	Autophagy	4	0.022	491.25
WP4970	Galanin receptor pathway	4	0.022	250
WP5101	Congenital generalized lipodystrophy (CGL)	4	0.022	460.75
WP1422	Sphingolipid pathway	5	0.022	515.25
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	5	0.022	470.5
WP2371	Parkinson's disease pathway	5	0.022	497
WP2509	Nanoparticle triggered autophagic cell death	5	0.022	369.5
WP34	Ovarian infertility	5	0.022	254.5
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5	0.022	261.5
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	5	0.022	506.5
WP3869	Cannabinoid receptor signaling	5	0.022	500
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	5	0.022	318
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	5	0.022	531.25
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	5	0.022	251.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	5	0.022	298
WP4922	Mitochondrial complex IV assembly	5	0.022	528.5
WP5044	Kynurenine pathway and links to cell senescence	5	0.022	273
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	5	0.022	529
WP5101	Congenital generalized lipodystrophy (CGL)	5	0.022	386
WP1528	Physiological and pathological hypertrophy of the heart	10	0.022	290.5
WP167	Eicosanoid synthesis	10	0.022	326
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	10	0.022	325
WP2007	Iron metabolism in placenta	10	0.022	563
WP3640	Imatinib and chronic myeloid leukemia	10	0.022	251.5
WP3891	Benzene metabolism	10	0.022	561
WP3933	Kennedy pathway from sphingolipids	10	0.022	571.75
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	10	0.022	279.5
WP3996	Ethanol effects on histone modifications	10	0.022	288
WP400	p38 MAPK signaling pathway	10	0.022	257.5
WP4224	Purine metabolism and related disorders	10	0.022	382.5
WP4583	Biomarkers for urea cycle disorders	10	0.022	579
WP4784	Proteoglycan biosynthesis	10	0.022	578.25
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	20	0.022	345.5
WP26	S1P receptor signal transduction	20	0.022	348
WP3413	NOTCH1 regulation of endothelial cell calcification	20	0.022	343
WP3630	NAD metabolism, sirtuins and aging	20	0.022	334
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	20	0.022	330.5
WP3871	Valproic acid pathway	20	0.022	619.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	20	0.022	619.25
WP4906	3q29 copy number variation syndrome	20	0.022	301
WP4949	16p11.2 proximal deletion syndrome	20	0.022	324.5
WP694	Arylamine metabolism	20	0.022	617.5
WP1589	Folate-alcohol and cancer pathway hypotheses	30	0.022	372
WP2035	Follicle stimulating hormone (FSH) signaling pathway	30	0.022	343.5
WP4204	Tumor suppressor activity of SMARCB1	30	0.022	325.5
WP4222	Phosphodiesterases in neuronal function	30	0.022	415.5
WP4656	Joubert syndrome	30	0.022	412.5
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	30	0.022	346
WP4923	Autophagy	30	0.022	353
WP12	Osteoclast signaling	2	0.021	431
WP2366	Butyrate-induced histone acetylation	2	0.021	450.25
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	2	0.021	412.5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	2	0.021	399.25
WP391	Mitochondrial gene expression	2	0.021	444
WP3927	BMP signaling in eyelid development	2	0.021	421
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	2	0.021	394
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	2	0.021	440.25
WP4656	Joubert syndrome	2	0.021	440
WP4657	22q11.2 copy number variation syndrome	2	0.021	209.5
WP4659	Gastrin signaling pathway	2	0.021	173.5
WP4688	Serine metabolism	2	0.021	449.5
WP4756	Renin-angiotensin-aldosterone system (RAAS)	2	0.021	407.25
WP4792	Purine metabolism	2	0.021	450.5
WP4806	EGFR tyrosine kinase inhibitor resistance	2	0.021	182
WP49	IL-2 signaling pathway	2	0.021	219
WP5037	Riboflavin and CoQ disorders	2	0.021	453.5
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	2	0.021	421.5
WP24	Peptide GPCRs	3	0.021	456.25
WP2636	Common pathways underlying drug addiction	3	0.021	451.25
WP2640	Aripiprazole metabolic pathway	3	0.021	489
WP2646	Lidocaine metabolism	3	0.021	483
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	3	0.021	244
WP2911	miRNA targets in ECM and membrane receptors	3	0.021	459.5
WP3591	Sleep regulation	3	0.021	374
WP3890	Nanomaterial-induced inflammasome activation	3	0.021	466
WP4789	MED and pseudoachondroplasia genes	3	0.021	488
WP4942	15q13.3 copy number variation syndrome	3	0.021	457.75
WP561	Heme biosynthesis	3	0.021	487.5
WP1602	Nicotine effect on dopaminergic neurons	4	0.021	505
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	4	0.021	512.75
WP2035	Follicle stimulating hormone (FSH) signaling pathway	4	0.021	414
WP26	S1P receptor signal transduction	4	0.021	482.25
WP2839	Hair follicle development: organogenesis - part 2 of 3	4	0.021	246.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	4	0.021	441.25
WP4288	MTHFR deficiency	4	0.021	482.75
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4	0.021	362
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	4	0.021	418.5
WP4789	MED and pseudoachondroplasia genes	4	0.021	513.5
WP4872	MAP3K1 role in promoting and blocking gonadal determination	4	0.021	487.5
WP49	IL-2 signaling pathway	4	0.021	227.5
WP4947	Nitric oxide metabolism in cystic fibrosis	4	0.021	490.5
WP5052	Nephrogenesis	4	0.021	495
WP2276	Glial cell differentiation	5	0.021	528.5
WP2637	Interleukin-1 (IL-1) structural pathway	5	0.021	250.5
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	5	0.021	508.25
WP3965	Lipid metabolism pathway	5	0.021	444.75
WP4236	Krebs cycle disorders	5	0.021	532
WP428	Wnt signaling	5	0.021	243
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	5	0.021	530
WP4760	PKC-gamma calcium signaling pathway in ataxia	5	0.021	480.75
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	5	0.021	514.25
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	5	0.021	516.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	5	0.021	521.75
WP2795	Cardiac hypertrophic response	10	0.021	262
WP288	Nod-like receptor (NLR) signaling pathway	10	0.021	475
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	10	0.021	278.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	10	0.021	301
WP4400	FABP4 in ovarian cancer	10	0.021	593
WP4949	16p11.2 proximal deletion syndrome	10	0.021	304
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	10	0.021	555.25
WP2038	Microtubule cytoskeleton regulation	20	0.021	294
WP2643	Nanoparticle-mediated activation of receptor signaling	20	0.021	309.5
WP288	Nod-like receptor (NLR) signaling pathway	20	0.021	364.5
WP3656	Interleukin-1 induced activation of NF-kB	20	0.021	333.5
WP3927	BMP signaling in eyelid development	20	0.021	339.5
WP3958	GPR40 pathway	20	0.021	398
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	20	0.021	324
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	20	0.021	367.5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	20	0.021	338.5
WP4927	COVID-19, thrombosis and anticoagulation	20	0.021	621.75
WP5038	Mitochondrial immune response to SARS-CoV-2	20	0.021	324.5
WP5044	Kynurenine pathway and links to cell senescence	20	0.021	299.5
WP1422	Sphingolipid pathway	30	0.021	439
WP2249	Metastatic brain tumor	30	0.021	258.5
WP78	TCA cycle (aka Krebs or citric acid cycle)	30	0.021	645
WP107	Translation factors	2	0.02	444
WP1422	Sphingolipid pathway	2	0.02	449
WP1541	Energy metabolism	2	0.02	397.5
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	2	0.02	429
WP1604	Codeine and morphine metabolism	2	0.02	437
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	2	0.02	261
WP2332	Interleukin-11 signaling pathway	2	0.02	251.5
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	2	0.02	398.5
WP3680	Physico-chemical features and toxicity-associated pathways	2	0.02	202
WP3941	Oxidative damage response	2	0.02	336.5
WP4222	Phosphodiesterases in neuronal function	2	0.02	431
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2	0.02	432.25
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2	0.02	415
WP4932	7q11.23 copy number variation syndrome	2	0.02	285
WP4949	16p11.2 proximal deletion syndrome	2	0.02	303
WP500	Glycogen synthesis and degradation	2	0.02	437
WP550	Biogenic amine synthesis	2	0.02	448
WP61	Notch signaling pathway (Netpath)	2	0.02	224
WP111	Electron transport chain: OXPHOS system in mitochondria	3	0.02	479
WP1545	miRNAs involved in DNA damage response	3	0.02	226
WP2038	Microtubule cytoskeleton regulation	3	0.02	221.5
WP2447	Amyotrophic lateral sclerosis (ALS)	3	0.02	346.5
WP2846	PCSK9-mediated LDL receptor degradation	3	0.02	481.25
WP3408	Evolocumab mechanism to reduce LDL cholesterol	3	0.02	481.25
WP3413	NOTCH1 regulation of endothelial cell calcification	3	0.02	439
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	3	0.02	330
WP3670	Interactions between LOXL4 and oxidative stress pathway	3	0.02	451.5
WP3853	ERK pathway in Huntington's disease	3	0.02	465.5
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	3	0.02	284
WP4236	Krebs cycle disorders	3	0.02	489.25
WP4905	1q21.1 copy number variation syndrome	3	0.02	475
WP4963	p53 transcriptional gene network	3	0.02	278
WP5037	Riboflavin and CoQ disorders	3	0.02	488
WP61	Notch signaling pathway (Netpath)	3	0.02	220
WP2333	Trans-sulfuration pathway	4	0.02	505
WP2646	Lidocaine metabolism	4	0.02	507
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	4	0.02	247
WP288	Nod-like receptor (NLR) signaling pathway	4	0.02	494.5
WP3413	NOTCH1 regulation of endothelial cell calcification	4	0.02	399
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	4	0.02	275.5
WP3927	BMP signaling in eyelid development	4	0.02	418
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	4	0.02	280
WP4174	Metabolism of tetrahydrocannabinol (THC)	4	0.02	508.5
WP4297	Thiamine metabolic pathways	4	0.02	507.5
WP4536	Genes related to primary cilium development (based on CRISPR)	4	0.02	503.5
WP4656	Joubert syndrome	4	0.02	478
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	4	0.02	286
WP1600	Nicotine metabolism in liver cells	5	0.02	528.5
WP205	IL-7 signaling pathway	5	0.02	236
WP241	One-carbon metabolism	5	0.02	484
WP288	Nod-like receptor (NLR) signaling pathway	5	0.02	507
WP4150	Wnt signaling in kidney disease	5	0.02	490.75
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	5	0.02	497.25
WP4923	Autophagy	5	0.02	500
WP2533	Glycerophospholipid biosynthetic pathway	10	0.02	557.5
WP2637	Interleukin-1 (IL-1) structural pathway	10	0.02	273
WP313	Hepatocyte growth factor receptor signaling	10	0.02	279.5
WP3655	Hypothetical craniofacial development pathway	10	0.02	576.5
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	10	0.02	384
WP3924	Hfe effect on hepcidin production	10	0.02	543
WP4228	Vitamin B6-dependent and responsive disorders	10	0.02	593
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	10	0.02	285
WP4566	Translation inhibitors in chronically activated PDGFRA cells	10	0.02	308.5
WP4962	Airway smooth muscle cell contraction	10	0.02	376
WP5044	Kynurenine pathway and links to cell senescence	10	0.02	302.5
WP623	Oxidative phosphorylation	10	0.02	579
WP733	Serotonin receptor 2 and STAT3 signaling	10	0.02	570.75
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	20	0.02	342
WP2854	Gene regulatory network modelling somitogenesis	20	0.02	431
WP4205	MET in type 1 papillary renal cell carcinoma	20	0.02	293.5
WP4495	IL-10 anti-inflammatory signaling pathway	20	0.02	308
WP4532	Intraflagellar transport proteins binding to dynein	20	0.02	623.25
WP4582	Cancer immunotherapy by CTLA4 blockade	20	0.02	331.5
WP4583	Biomarkers for urea cycle disorders	20	0.02	616.75
WP4725	Sphingolipid metabolism overview	20	0.02	388
WP4726	Sphingolipid metabolism: integrated pathway	20	0.02	388
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	20	0.02	332.5
WP4928	MAPK pathway in congenital thyroid cancer	20	0.02	282
WP4962	Airway smooth muscle cell contraction	20	0.02	361
WP1423	Ganglio sphingolipid metabolism	30	0.02	404.5
WP3655	Hypothetical craniofacial development pathway	30	0.02	416.5
WP3858	Toll-like receptor signaling related to MyD88	30	0.02	367
WP3890	Nanomaterial-induced inflammasome activation	30	0.02	365
WP4533	Transcription co-factors SKI and SKIL protein partners	30	0.02	359
WP4583	Biomarkers for urea cycle disorders	30	0.02	624.5
WP4584	Biomarkers for pyrimidine metabolism disorders	30	0.02	440.5
WP4906	3q29 copy number variation syndrome	30	0.02	311
WP704	Methylation pathways	30	0.02	396
WP2795	Cardiac hypertrophic response	2	0.019	246
WP3676	BDNF-TrkB signaling	2	0.019	438
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2	0.019	415
WP4723	Omega-3 / omega-6 fatty acid synthesis	2	0.019	449.25
WP4724	Omega-9 fatty acid synthesis	2	0.019	446.5
WP4963	p53 transcriptional gene network	2	0.019	364.5
WP5052	Nephrogenesis	2	0.019	444.25
WP5064	7-oxo-C and 7-beta-HC pathways	2	0.019	439
WP58	Monoamine GPCRs	2	0.019	453
WP2795	Cardiac hypertrophic response	3	0.019	208.5
WP325	Triacylglyceride synthesis	3	0.019	474.75
WP3640	Imatinib and chronic myeloid leukemia	3	0.019	220.5
WP3676	BDNF-TrkB signaling	3	0.019	465.5
WP3927	BMP signaling in eyelid development	3	0.019	442.5
WP4147	PTF1A related regulatory pathway	3	0.019	471.5
WP4150	Wnt signaling in kidney disease	3	0.019	467.25
WP4191	Caloric restriction and aging	3	0.019	452.75
WP4224	Purine metabolism and related disorders	3	0.019	479
WP4259	Disorders of folate metabolism and transport	3	0.019	482
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	3	0.019	230.5
WP4962	Airway smooth muscle cell contraction	3	0.019	471
WP5052	Nephrogenesis	3	0.019	476
WP733	Serotonin receptor 2 and STAT3 signaling	3	0.019	484.75
WP22	IL-9 signaling pathway	4	0.019	484.5
WP244	Alpha 6 beta 4 signaling pathway	4	0.019	387
WP2542	Sulindac metabolic pathway	4	0.019	509.5
WP2596	Gastric acid production	4	0.019	507
WP2880	Glucocorticoid receptor pathway	4	0.019	237
WP2943	Hypoxia-mediated EMT and stemness	4	0.019	510
WP3656	Interleukin-1 induced activation of NF-kB	4	0.019	469.75
WP3940	One-carbon metabolism and related pathways	4	0.019	292
WP4400	FABP4 in ovarian cancer	4	0.019	514.5
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	4	0.019	508
WP4949	16p11.2 proximal deletion syndrome	4	0.019	258
WP5038	Mitochondrial immune response to SARS-CoV-2	4	0.019	470.75
WP78	TCA cycle (aka Krebs or citric acid cycle)	4	0.019	512
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	5	0.019	530
WP2333	Trans-sulfuration pathway	5	0.019	519.75
WP2436	Dopamine metabolism	5	0.019	502.5
WP2491	Diclofenac metabolic pathway	5	0.019	530
WP2839	Hair follicle development: organogenesis - part 2 of 3	5	0.019	252.5
WP2911	miRNA targets in ECM and membrane receptors	5	0.019	475.25
WP313	Hepatocyte growth factor receptor signaling	5	0.019	242
WP3644	NAD+ metabolism	5	0.019	514.75
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	5	0.019	498
WP4174	Metabolism of tetrahydrocannabinol (THC)	5	0.019	524.5
WP4194	Hormonal control of pubertal growth spurt	5	0.019	531.5
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	5	0.019	243
WP4919	Neuroinflammation	5	0.019	328
WP4921	Mitochondrial complex III assembly	5	0.019	533
WP4949	16p11.2 proximal deletion syndrome	5	0.019	264
WP690	Polyol pathway	5	0.019	530
WP1995	Effects of nitric oxide	10	0.019	376
WP3940	One-carbon metabolism and related pathways	10	0.019	294.5
WP4288	MTHFR deficiency	10	0.019	300
WP4562	Canonical NF-kB pathway	10	0.019	431
WP4725	Sphingolipid metabolism overview	10	0.019	520.75
WP4726	Sphingolipid metabolism: integrated pathway	10	0.019	520.75
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	10	0.019	324
WP4921	Mitochondrial complex III assembly	10	0.019	594.75
WP5074	Kallmann syndrome	10	0.019	473
WP516	Hypertrophy model	10	0.019	307
WP111	Electron transport chain: OXPHOS system in mitochondria	20	0.019	480.5
WP2007	Iron metabolism in placenta	20	0.019	411.5
WP2290	RalA downstream regulated genes	20	0.019	612.25
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	20	0.019	535
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	20	0.019	345
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	20	0.019	479.5
WP438	Non-homologous end joining	20	0.019	615
WP4966	Fluoroacetic acid toxicity	20	0.019	622.25
WP528	Acetylcholine synthesis	20	0.019	398
WP699	Aflatoxin B1 metabolism	20	0.019	436
WP2636	Common pathways underlying drug addiction	30	0.019	384
WP3595	mir-124 predicted interactions with cell cycle and differentiation	30	0.019	472
WP3634	Insulin signaling in adipocytes (normal condition)	30	0.019	373
WP3635	Insulin signaling in adipocytes (diabetic condition)	30	0.019	373
WP3996	Ethanol effects on histone modifications	30	0.019	329.5
WP4157	GABA metabolism (aka GHB)	30	0.019	647.5
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	30	0.019	641.5
WP4205	MET in type 1 papillary renal cell carcinoma	30	0.019	290.5
WP4269	Ethanol metabolism production of ROS by CYP2E1	30	0.019	350
WP4297	Thiamine metabolic pathways	30	0.019	448.5
WP4483	Relationship between inflammation, COX-2 and EGFR	30	0.019	275
WP4707	Aspirin and miRNAs	30	0.019	271
WP4873	Peroxiredoxin 2 induced ovarian failure	30	0.019	384.5
WP2586	Aryl hydrocarbon receptor Netpath	2	0.018	197
WP3286	Copper homeostasis	2	0.018	289
WP3580	Methionine de novo and salvage pathway	2	0.018	445
WP3971	OSX and miRNAs in tooth development	2	0.018	442.25
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	2	0.018	454.5
WP4236	Krebs cycle disorders	2	0.018	455
WP4479	Supression of HMGB1 mediated inflammation by THBD	2	0.018	436.75
WP4480	Altered glycosylation of MUC1 in tumor microenvironment	2	0.018	426
WP4521	Glycosylation and related congenital defects	2	0.018	453
WP4589	Major receptors targeted by epinephrine and norepinephrine	2	0.018	453.5
WP4947	Nitric oxide metabolism in cystic fibrosis	2	0.018	440
WP516	Hypertrophy model	2	0.018	415
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3	0.018	188
WP26	S1P receptor signal transduction	3	0.018	467
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3	0.018	226
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	3	0.018	231
WP3858	Toll-like receptor signaling related to MyD88	3	0.018	460.25
WP3996	Ethanol effects on histone modifications	3	0.018	426
WP4586	Metabolism of alpha-linolenic acid	3	0.018	462.75
WP4874	CAMKK2 pathway	3	0.018	225
WP516	Hypertrophy model	3	0.018	416
WP521	Amino acid conjugation of benzoic acid	3	0.018	490
WP1422	Sphingolipid pathway	4	0.018	500.5
WP3676	BDNF-TrkB signaling	4	0.018	478
WP3869	Cannabinoid receptor signaling	4	0.018	490.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	4	0.018	238
WP4583	Biomarkers for urea cycle disorders	4	0.018	509
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	4	0.018	498.5
WP2542	Sulindac metabolic pathway	5	0.018	526.5
WP3656	Interleukin-1 induced activation of NF-kB	5	0.018	472.75
WP368	Mitochondrial long chain fatty acid beta-oxidation	5	0.018	523.25
WP3858	Toll-like receptor signaling related to MyD88	5	0.018	450
WP3963	Mevalonate pathway	5	0.018	525.5
WP4224	Purine metabolism and related disorders	5	0.018	510.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	5	0.018	251
WP4582	Cancer immunotherapy by CTLA4 blockade	5	0.018	496.5
WP4725	Sphingolipid metabolism overview	5	0.018	513.25
WP4726	Sphingolipid metabolism: integrated pathway	5	0.018	513.25
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	5	0.018	528
WP4872	MAP3K1 role in promoting and blocking gonadal determination	5	0.018	501.5
WP497	Urea cycle and metabolism of amino groups	5	0.018	517.5
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	10	0.018	309.5
WP2513	Nanoparticle triggered regulated necrosis	10	0.018	357
WP3413	NOTCH1 regulation of endothelial cell calcification	10	0.018	336
WP3869	Cannabinoid receptor signaling	10	0.018	381.5
WP4191	Caloric restriction and aging	10	0.018	314
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	10	0.018	292.5
WP4905	1q21.1 copy number variation syndrome	10	0.018	362.5
WP521	Amino acid conjugation of benzoic acid	10	0.018	592.5
WP2253	Pilocytic astrocytoma	20	0.018	464.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	20	0.018	363
WP2943	Hypoxia-mediated EMT and stemness	20	0.018	622.5
WP3670	Interactions between LOXL4 and oxidative stress pathway	20	0.018	336
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	20	0.018	248
WP3676	BDNF-TrkB signaling	20	0.018	384
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	20	0.018	321
WP3875	ATR signaling	20	0.018	626.25
WP3933	Kennedy pathway from sphingolipids	20	0.018	414.5
WP4288	MTHFR deficiency	20	0.018	336.5
WP4357	NRF2-ARE regulation	20	0.018	306
WP4536	Genes related to primary cilium development (based on CRISPR)	20	0.018	444.5
WP4707	Aspirin and miRNAs	20	0.018	275
WP4815	Glycosaminoglycan degradation	20	0.018	624.5
WP4874	CAMKK2 pathway	20	0.018	283
WP111	Electron transport chain: OXPHOS system in mitochondria	30	0.018	481.5
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	30	0.018	642
WP2007	Iron metabolism in placenta	30	0.018	402.5
WP334	GPCRs, class B secretin-like	30	0.018	429.5
WP3869	Cannabinoid receptor signaling	30	0.018	416.5
WP4586	Metabolism of alpha-linolenic acid	30	0.018	398
WP5038	Mitochondrial immune response to SARS-CoV-2	30	0.018	344
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	30	0.018	459
WP1545	miRNAs involved in DNA damage response	2	0.017	248
WP167	Eicosanoid synthesis	2	0.017	424
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	2	0.017	181
WP2276	Glial cell differentiation	2	0.017	453.5
WP244	Alpha 6 beta 4 signaling pathway	2	0.017	422.5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	2	0.017	193
WP2943	Hypoxia-mediated EMT and stemness	2	0.017	453.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2	0.017	432.75
WP357	Fatty acid biosynthesis	2	0.017	445
WP3853	ERK pathway in Huntington's disease	2	0.017	434.5
WP3875	ATR signaling	2	0.017	453
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	2	0.017	449
WP4269	Ethanol metabolism production of ROS by CYP2E1	2	0.017	441.5
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	2	0.017	454
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	2	0.017	426
WP4905	1q21.1 copy number variation syndrome	2	0.017	442.5
WP4923	Autophagy	2	0.017	442.5
WP1603	Nicotine effect on chromaffin cells	3	0.017	486
WP2332	Interleukin-11 signaling pathway	3	0.017	222
WP2889	Oxytocin signaling	3	0.017	489
WP2895	Differentiation of white and brown adipocyte	3	0.017	457
WP3580	Methionine de novo and salvage pathway	3	0.017	478.5
WP4030	SCFA and skeletal muscle substrate metabolism	3	0.017	479
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3	0.017	446
WP4400	FABP4 in ovarian cancer	3	0.017	489
WP4861	Endoplasmic reticulum stress response in coronavirus infection	3	0.017	418
WP49	IL-2 signaling pathway	3	0.017	219
WP4947	Nitric oxide metabolism in cystic fibrosis	3	0.017	472
WP58	Monoamine GPCRs	3	0.017	487.5
WP1600	Nicotine metabolism in liver cells	4	0.017	509
WP2643	Nanoparticle-mediated activation of receptor signaling	4	0.017	291.5
WP334	GPCRs, class B secretin-like	4	0.017	504.5
WP3591	Sleep regulation	4	0.017	294
WP3595	mir-124 predicted interactions with cell cycle and differentiation	4	0.017	509.5
WP363	Wnt signaling pathway	4	0.017	224
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	4	0.017	258
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	4	0.017	380
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	4	0.017	484.25
WP4942	15q13.3 copy number variation syndrome	4	0.017	460.25
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	4	0.017	501
WP1589	Folate-alcohol and cancer pathway hypotheses	5	0.017	518.25
WP1992	Genes targeted by miRNAs in adipocytes	5	0.017	375.5
WP2485	NAD biosynthesis II (from tryptophan)	5	0.017	533.5
WP26	S1P receptor signal transduction	5	0.017	490.5
WP2636	Common pathways underlying drug addiction	5	0.017	325.5
WP2795	Cardiac hypertrophic response	5	0.017	233
WP3630	NAD metabolism, sirtuins and aging	5	0.017	430
WP3871	Valproic acid pathway	5	0.017	528.25
WP4288	MTHFR deficiency	5	0.017	479
WP4707	Aspirin and miRNAs	5	0.017	283.5
WP4874	CAMKK2 pathway	5	0.017	239
WP1992	Genes targeted by miRNAs in adipocytes	10	0.017	309
WP22	IL-9 signaling pathway	10	0.017	351.5
WP3890	Nanomaterial-induced inflammasome activation	10	0.017	349
WP3947	Serotonin and anxiety	10	0.017	309
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	10	0.017	569.5
WP4269	Ethanol metabolism production of ROS by CYP2E1	10	0.017	349.5
WP4533	Transcription co-factors SKI and SKIL protein partners	10	0.017	393.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	10	0.017	267
WP5121	Sphingolipid metabolism in senescence	10	0.017	266
WP692	Sulfation biotransformation reaction	10	0.017	580.5
WP127	IL-5 signaling pathway	20	0.017	287
WP2533	Glycerophospholipid biosynthetic pathway	20	0.017	408
WP2646	Lidocaine metabolism	20	0.017	444
WP334	GPCRs, class B secretin-like	20	0.017	409.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	20	0.017	331
WP4174	Metabolism of tetrahydrocannabinol (THC)	20	0.017	604.5
WP4297	Thiamine metabolic pathways	20	0.017	613
WP4313	Ferroptosis	20	0.017	331.5
WP4483	Relationship between inflammation, COX-2 and EGFR	20	0.017	296
WP4564	Neural crest cell migration during development	20	0.017	282
WP4688	Serine metabolism	20	0.017	600.75
WP4784	Proteoglycan biosynthesis	20	0.017	495.5
WP127	IL-5 signaling pathway	30	0.017	275.5
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	30	0.017	335.5
WP3633	Caffeine and theobromine metabolism	30	0.017	642.5
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	30	0.017	321
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	30	0.017	402.5
WP3891	Benzene metabolism	30	0.017	416
WP3933	Kennedy pathway from sphingolipids	30	0.017	391.5
WP4846	SARS-CoV-2 and COVID-19 pathway	30	0.017	353.5
WP4872	MAP3K1 role in promoting and blocking gonadal determination	30	0.017	399.5
WP4962	Airway smooth muscle cell contraction	30	0.017	351
WP5121	Sphingolipid metabolism in senescence	30	0.017	284
WP712	Estrogen signaling pathway	30	0.017	287.5
WP2038	Microtubule cytoskeleton regulation	2	0.016	391.5
WP241	One-carbon metabolism	2	0.016	438.5
WP2447	Amyotrophic lateral sclerosis (ALS)	2	0.016	406.5
WP2456	HIF1A and PPARG regulation of glycolysis	2	0.016	439.75
WP334	GPCRs, class B secretin-like	2	0.016	449.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	2	0.016	406.75
WP3869	Cannabinoid receptor signaling	2	0.016	442
WP3890	Nanomaterial-induced inflammasome activation	2	0.016	438
WP4271	Vitamin B12 disorders	2	0.016	451.5
WP4564	Neural crest cell migration during development	2	0.016	324
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	2	0.016	452
WP4853	Linoleic acid metabolism affected by coronavirus infection	2	0.016	454.5
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	2	0.016	444.5
WP4970	Galanin receptor pathway	2	0.016	297.5
WP5089	Kinin-Kallikrein pathway	2	0.016	452.5
WP5103	Progeria-associated lipodystrophy	2	0.016	416.5
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	2	0.016	446.5
WP167	Eicosanoid synthesis	3	0.016	446
WP1995	Effects of nitric oxide	3	0.016	467
WP2113	Type III interferon signaling	3	0.016	484.75
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	3	0.016	207
WP3941	Oxidative damage response	3	0.016	249.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	3	0.016	458.25
WP4564	Neural crest cell migration during development	3	0.016	231
WP4785	Somitogenesis in the context of spondylocostal dysostosis	3	0.016	486
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	3	0.016	441.5
WP5044	Kynurenine pathway and links to cell senescence	3	0.016	296
WP134	Pentose phosphate metabolism	4	0.016	515.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	4	0.016	506.5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	4	0.016	217
WP313	Hepatocyte growth factor receptor signaling	4	0.016	232.5
WP3670	Interactions between LOXL4 and oxidative stress pathway	4	0.016	449.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	4	0.016	238.5
WP3858	Toll-like receptor signaling related to MyD88	4	0.016	469.25
WP3963	Mevalonate pathway	4	0.016	507.5
WP4286	Genotoxicity pathway	4	0.016	269
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	4	0.016	228
WP4722	Glycerolipids and glycerophospholipids	4	0.016	499.25
WP4919	Neuroinflammation	4	0.016	365.5
WP4922	Mitochondrial complex IV assembly	4	0.016	509.5
WP497	Urea cycle and metabolism of amino groups	4	0.016	504
WP678	Arachidonate epoxygenase / epoxide hydrolase	4	0.016	505.5
WP134	Pentose phosphate metabolism	5	0.016	534
WP1455	Serotonin transporter activity	5	0.016	494
WP334	GPCRs, class B secretin-like	5	0.016	517.5
WP3640	Imatinib and chronic myeloid leukemia	5	0.016	234
WP3874	Canonical and non-canonical TGF-B signaling	5	0.016	473
WP4157	GABA metabolism (aka GHB)	5	0.016	531.5
WP4789	MED and pseudoachondroplasia genes	5	0.016	530.5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5	0.016	288.5
WP49	IL-2 signaling pathway	5	0.016	249.5
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	5	0.016	512
WP5122	Prostaglandin and leukotriene metabolism in senescence	5	0.016	265.5
WP78	TCA cycle (aka Krebs or citric acid cycle)	5	0.016	530.5
WP111	Electron transport chain: OXPHOS system in mitochondria	10	0.016	556.25
WP2363	Gastric cancer network 2	10	0.016	298.5
WP334	GPCRs, class B secretin-like	10	0.016	559
WP3676	BDNF-TrkB signaling	10	0.016	381
WP5101	Congenital generalized lipodystrophy (CGL)	10	0.016	284
WP528	Acetylcholine synthesis	10	0.016	560.25
WP1602	Nicotine effect on dopaminergic neurons	20	0.016	499.5
WP2513	Nanoparticle triggered regulated necrosis	20	0.016	349
WP3869	Cannabinoid receptor signaling	20	0.016	378.5
WP400	p38 MAPK signaling pathway	20	0.016	291.5
WP4159	GABA receptor signaling	20	0.016	473
WP4225	Pyrimidine metabolism and related diseases	20	0.016	406
WP5121	Sphingolipid metabolism in senescence	20	0.016	292
WP1995	Effects of nitric oxide	30	0.016	370.5
WP2253	Pilocytic astrocytoma	30	0.016	400
WP3927	BMP signaling in eyelid development	30	0.016	328
WP3930	EDA signaling in hair follicle development	30	0.016	413.5
WP5044	Kynurenine pathway and links to cell senescence	30	0.016	315.5
WP545	Complement activation	30	0.016	461.75
WP623	Oxidative phosphorylation	30	0.016	553
WP1602	Nicotine effect on dopaminergic neurons	2	0.015	452
WP2333	Trans-sulfuration pathway	2	0.015	450.5
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2	0.015	294.5
WP2846	PCSK9-mediated LDL receptor degradation	2	0.015	449.25
WP2889	Oxytocin signaling	2	0.015	454
WP3408	Evolocumab mechanism to reduce LDL cholesterol	2	0.015	449.25
WP3655	Hypothetical craniofacial development pathway	2	0.015	450.5
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	2	0.015	441.5
WP3930	EDA signaling in hair follicle development	2	0.015	446.5
WP3981	miRNA regulation of prostate cancer signaling pathways	2	0.015	225
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	2	0.015	236.5
WP4565	Neural crest cell migration in cancer	2	0.015	317
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2	0.015	416
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	2	0.015	444
WP4725	Sphingolipid metabolism overview	2	0.015	447.75
WP4726	Sphingolipid metabolism: integrated pathway	2	0.015	447.75
WP1600	Nicotine metabolism in liver cells	3	0.015	487.5
WP2276	Glial cell differentiation	3	0.015	488
WP241	One-carbon metabolism	3	0.015	469.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	3	0.015	458.5
WP3644	NAD+ metabolism	3	0.015	479.75
WP3655	Hypothetical craniofacial development pathway	3	0.015	484
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	3	0.015	310.5
WP4533	Transcription co-factors SKI and SKIL protein partners	3	0.015	474.5
WP4565	Neural crest cell migration in cancer	3	0.015	231
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	3	0.015	475
WP4923	Autophagy	3	0.015	474.25
WP106	Alanine and aspartate metabolism	4	0.015	509
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	4	0.015	453.75
WP1591	Heart development	4	0.015	253.5
WP1995	Effects of nitric oxide	4	0.015	486
WP2038	Microtubule cytoskeleton regulation	4	0.015	220.5
WP205	IL-7 signaling pathway	4	0.015	227
WP2636	Common pathways underlying drug addiction	4	0.015	414.25
WP2637	Interleukin-1 (IL-1) structural pathway	4	0.015	246
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	4	0.015	465.5
WP3640	Imatinib and chronic myeloid leukemia	4	0.015	229.5
WP3871	Valproic acid pathway	4	0.015	509.75
WP4224	Purine metabolism and related disorders	4	0.015	495.5
WP438	Non-homologous end joining	4	0.015	508.5
WP5121	Sphingolipid metabolism in senescence	4	0.015	252.5
WP5122	Prostaglandin and leukotriene metabolism in senescence	4	0.015	260
WP694	Arylamine metabolism	4	0.015	509.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	5	0.015	516
WP3670	Interactions between LOXL4 and oxidative stress pathway	5	0.015	366.5
WP3875	ATR signaling	5	0.015	529.5
WP3890	Nanomaterial-induced inflammasome activation	5	0.015	491.75
WP3938	miR-222 in exercise-induced cardiac growth	5	0.015	515.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	5	0.015	472.25
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	5	0.015	531
WP4286	Genotoxicity pathway	5	0.015	300.5
WP4571	Urea cycle and related diseases	5	0.015	528
WP4861	Endoplasmic reticulum stress response in coronavirus infection	5	0.015	292.5
WP4905	1q21.1 copy number variation syndrome	5	0.015	498
WP4947	Nitric oxide metabolism in cystic fibrosis	5	0.015	503.75
WP5038	Mitochondrial immune response to SARS-CoV-2	5	0.015	462.5
WP2643	Nanoparticle-mediated activation of receptor signaling	10	0.015	304
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	10	0.015	545.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	10	0.015	329
WP3670	Interactions between LOXL4 and oxidative stress pathway	10	0.015	297
WP3938	miR-222 in exercise-induced cardiac growth	10	0.015	551.5
WP4317	Mitochondrial fatty acid synthesis pathway	10	0.015	590
WP4532	Intraflagellar transport proteins binding to dynein	10	0.015	585
WP4585	Cancer immunotherapy by PD-1 blockade	10	0.015	336.5
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	10	0.015	318
WP4872	MAP3K1 role in promoting and blocking gonadal determination	10	0.015	371
WP4928	MAPK pathway in congenital thyroid cancer	10	0.015	289
WP3299	let-7 inhibition of ES cell reprogramming	20	0.015	332
WP3891	Benzene metabolism	20	0.015	384
WP3943	Robo4 and VEGF signaling pathways crosstalk	20	0.015	345
WP4030	SCFA and skeletal muscle substrate metabolism	20	0.015	416
WP4150	Wnt signaling in kidney disease	20	0.015	375.5
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	20	0.015	606.5
WP4533	Transcription co-factors SKI and SKIL protein partners	20	0.015	360.5
WP4537	Hippo-Yap signaling pathway	20	0.015	341.5
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	20	0.015	323
WP4804	Cholesterol biosynthesis with skeletal dysplasias	20	0.015	617
WP712	Estrogen signaling pathway	20	0.015	304
WP26	S1P receptor signal transduction	30	0.015	364
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	30	0.015	366
WP3529	Zinc homeostasis	30	0.015	495.75
WP3938	miR-222 in exercise-induced cardiac growth	30	0.015	397
WP3958	GPR40 pathway	30	0.015	424.5
WP3967	miR-509-3p alteration of YAP1/ECM axis	30	0.015	345
WP4159	GABA receptor signaling	30	0.015	467.5
WP4537	Hippo-Yap signaling pathway	30	0.015	349.5
WP4589	Major receptors targeted by epinephrine and norepinephrine	30	0.015	472
WP4949	16p11.2 proximal deletion syndrome	30	0.015	334
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	30	0.015	351
WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	30	0.015	637
WP5101	Congenital generalized lipodystrophy (CGL)	30	0.015	356
WP1423	Ganglio sphingolipid metabolism	2	0.014	452
WP143	Fatty acid beta-oxidation	2	0.014	445
WP1455	Serotonin transporter activity	2	0.014	440.25
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	2	0.014	454
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	2	0.014	433.5
WP2636	Common pathways underlying drug addiction	2	0.014	432.25
WP3591	Sleep regulation	2	0.014	416
WP3940	One-carbon metabolism and related pathways	2	0.014	421.5
WP4150	Wnt signaling in kidney disease	2	0.014	441.5
WP4157	GABA metabolism (aka GHB)	2	0.014	454.75
WP4389	Bile acids synthesis and enterohepatic circulation	2	0.014	442.5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2	0.014	407
WP4961	STING pathway in Kawasaki-like disease and COVID-19	2	0.014	423.75
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	2	0.014	449
WP545	Complement activation	2	0.014	452.25
WP2509	Nanoparticle triggered autophagic cell death	3	0.014	442.25
WP2513	Nanoparticle triggered regulated necrosis	3	0.014	468
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3	0.014	249
WP313	Hepatocyte growth factor receptor signaling	3	0.014	212
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	3	0.014	489.25
WP3874	Canonical and non-canonical TGF-B signaling	3	0.014	462
WP3926	ApoE and miR-146 in inflammation and atherosclerosis	3	0.014	476.25
WP4883	SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms	3	0.014	479
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	3	0.014	487
WP2485	NAD biosynthesis II (from tryptophan)	4	0.014	515.75
WP2491	Diclofenac metabolic pathway	4	0.014	512
WP3996	Ethanol effects on histone modifications	4	0.014	292
WP4228	Vitamin B6-dependent and responsive disorders	4	0.014	515.5
WP4571	Urea cycle and related diseases	4	0.014	511.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	4	0.014	489.5
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	4	0.014	491.75
WP4815	Glycosaminoglycan degradation	4	0.014	511
WP5103	Progeria-associated lipodystrophy	4	0.014	294
WP3676	BDNF-TrkB signaling	5	0.014	490.75
WP3940	One-carbon metabolism and related pathways	5	0.014	265
WP5121	Sphingolipid metabolism in senescence	5	0.014	262
WP1422	Sphingolipid pathway	10	0.014	547.5
WP2485	NAD biosynthesis II (from tryptophan)	10	0.014	594
WP2636	Common pathways underlying drug addiction	10	0.014	305
WP2895	Differentiation of white and brown adipocyte	10	0.014	295
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	10	0.014	593
WP3877	MYD88 distinct input-output pathway	10	0.014	326
WP3927	BMP signaling in eyelid development	10	0.014	322
WP3943	Robo4 and VEGF signaling pathways crosstalk	10	0.014	338.5
WP4504	Cysteine and methionine catabolism	10	0.014	556
WP4586	Metabolism of alpha-linolenic acid	10	0.014	370
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	10	0.014	319
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	10	0.014	579
WP4906	3q29 copy number variation syndrome	10	0.014	274
WP5037	Riboflavin and CoQ disorders	10	0.014	582.5
WP5103	Progeria-associated lipodystrophy	10	0.014	313
WP1455	Serotonin transporter activity	20	0.014	350
WP1992	Genes targeted by miRNAs in adipocytes	20	0.014	339
WP2338	miRNA biogenesis	20	0.014	627.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	20	0.014	380
WP2636	Common pathways underlying drug addiction	20	0.014	370
WP2805	exRNA mechanism of action and biogenesis	20	0.014	627.5
WP3	Transcriptional activation by NRF2 in response to phytochemicals	20	0.014	329
WP4504	Cysteine and methionine catabolism	20	0.014	409.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	20	0.014	385
WP4589	Major receptors targeted by epinephrine and norepinephrine	20	0.014	614
WP5074	Kallmann syndrome	20	0.014	406.5
WP5101	Congenital generalized lipodystrophy (CGL)	20	0.014	343
WP5103	Progeria-associated lipodystrophy	20	0.014	329
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	20	0.014	607
WP2943	Hypoxia-mediated EMT and stemness	30	0.014	638
WP311	Ketone bodies synthesis and degradation	30	0.014	648
WP3299	let-7 inhibition of ES cell reprogramming	30	0.014	311
WP3676	BDNF-TrkB signaling	30	0.014	397
WP4194	Hormonal control of pubertal growth spurt	30	0.014	648.5
WP4271	Vitamin B12 disorders	30	0.014	469
WP4389	Bile acids synthesis and enterohepatic circulation	30	0.014	441
WP4595	Urea cycle and associated pathways	30	0.014	414.5
WP4900	Purinergic signaling	30	0.014	445
WP111	Electron transport chain: OXPHOS system in mitochondria	2	0.013	448
WP1992	Genes targeted by miRNAs in adipocytes	2	0.013	431.5
WP2363	Gastric cancer network 2	2	0.013	384.25
WP2436	Dopamine metabolism	2	0.013	441.5
WP2640	Aripiprazole metabolic pathway	2	0.013	455
WP288	Nod-like receptor (NLR) signaling pathway	2	0.013	446.5
WP3529	Zinc homeostasis	2	0.013	453
WP363	Wnt signaling pathway	2	0.013	194
WP3891	Benzene metabolism	2	0.013	449.25
WP3892	Development of pulmonary dendritic cells and macrophage subsets	2	0.013	407.5
WP3963	Mevalonate pathway	2	0.013	452.25
WP4317	Mitochondrial fatty acid synthesis pathway	2	0.013	455
WP4504	Cysteine and methionine catabolism	2	0.013	448.75
WP4536	Genes related to primary cilium development (based on CRISPR)	2	0.013	450.5
WP4562	Canonical NF-kB pathway	2	0.013	442.5
WP477	Cytoplasmic ribosomal proteins	2	0.013	449.5
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	2	0.013	453.5
WP4962	Airway smooth muscle cell contraction	2	0.013	442
WP501	GPCRs, class C metabotropic glutamate, pheromone	2	0.013	449.75
WP5044	Kynurenine pathway and links to cell senescence	2	0.013	403
WP5061	Fatty acid transporters	2	0.013	450.5
WP623	Oxidative phosphorylation	2	0.013	452.5
WP673	ErbB signaling pathway	2	0.013	198
WP106	Alanine and aspartate metabolism	3	0.013	486
WP107	Translation factors	3	0.013	478
WP1425	Bone morphogenic protein (BMP) signaling and regulation	3	0.013	483
WP1455	Serotonin transporter activity	3	0.013	467.75
WP2491	Diclofenac metabolic pathway	3	0.013	487.5
WP334	GPCRs, class B secretin-like	3	0.013	483
WP3679	Cell-type dependent selectivity of CCK2R signaling	3	0.013	466.5
WP3871	Valproic acid pathway	3	0.013	486.5
WP3930	EDA signaling in hair follicle development	3	0.013	480
WP3938	miR-222 in exercise-induced cardiac growth	3	0.013	479
WP4288	MTHFR deficiency	3	0.013	466.5
WP438	Non-homologous end joining	3	0.013	486.5
WP4521	Glycosylation and related congenital defects	3	0.013	487.5
WP4562	Canonical NF-kB pathway	3	0.013	474
WP4582	Cancer immunotherapy by CTLA4 blockade	3	0.013	467
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	3	0.013	489.25
WP4722	Glycerolipids and glycerophospholipids	3	0.013	476
WP477	Cytoplasmic ribosomal proteins	3	0.013	482
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	3	0.013	488
WP4940	15q11.2 copy number variation syndrome	3	0.013	486
WP4949	16p11.2 proximal deletion syndrome	3	0.013	250
WP5089	Kinin-Kallikrein pathway	3	0.013	486
WP5101	Congenital generalized lipodystrophy (CGL)	3	0.013	453.75
WP678	Arachidonate epoxygenase / epoxide hydrolase	3	0.013	484
WP2276	Glial cell differentiation	4	0.013	511.75
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	4	0.013	515.5
WP3655	Hypothetical craniofacial development pathway	4	0.013	506.5
WP3890	Nanomaterial-induced inflammasome activation	4	0.013	478.25
WP3943	Robo4 and VEGF signaling pathways crosstalk	4	0.013	467.5
WP3947	Serotonin and anxiety	4	0.013	446.25
WP400	p38 MAPK signaling pathway	4	0.013	256
WP4157	GABA metabolism (aka GHB)	4	0.013	514.5
WP428	Wnt signaling	4	0.013	227.5
WP4874	CAMKK2 pathway	4	0.013	231
WP1528	Physiological and pathological hypertrophy of the heart	5	0.013	283
WP1995	Effects of nitric oxide	5	0.013	498
WP2596	Gastric acid production	5	0.013	522.75
WP2895	Differentiation of white and brown adipocyte	5	0.013	396.5
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	5	0.013	533.5
WP363	Wnt signaling pathway	5	0.013	233
WP3877	MYD88 distinct input-output pathway	5	0.013	404
WP3927	BMP signaling in eyelid development	5	0.013	340
WP4317	Mitochondrial fatty acid synthesis pathway	5	0.013	532.5
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5	0.013	346
WP5103	Progeria-associated lipodystrophy	5	0.013	277.5
WP2249	Metastatic brain tumor	10	0.013	269.5
WP2366	Butyrate-induced histone acetylation	10	0.013	570.25
WP3656	Interleukin-1 induced activation of NF-kB	10	0.013	304.5
WP3672	lncRNA-mediated mechanisms of therapeutic resistance	10	0.013	283
WP3874	Canonical and non-canonical TGF-B signaling	10	0.013	320
WP4030	SCFA and skeletal muscle substrate metabolism	10	0.013	568.5
WP4297	Thiamine metabolic pathways	10	0.013	577.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	10	0.013	385.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	10	0.013	579.75
WP4904	LDLRAD4 and what we know about it	10	0.013	569
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	10	0.013	575
WP545	Complement activation	10	0.013	580.5
WP117	GPCRs, other	20	0.013	382
WP3529	Zinc homeostasis	20	0.013	614.5
WP3633	Caffeine and theobromine metabolism	20	0.013	626.5
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	20	0.013	380
WP3947	Serotonin and anxiety	20	0.013	344
WP4204	Tumor suppressor activity of SMARCB1	20	0.013	324
WP4521	Glycosylation and related congenital defects	20	0.013	617
WP4846	SARS-CoV-2 and COVID-19 pathway	20	0.013	340
WP4872	MAP3K1 role in promoting and blocking gonadal determination	20	0.013	362.5
WP497	Urea cycle and metabolism of amino groups	20	0.013	475.5
WP516	Hypertrophy model	20	0.013	308.5
WP78	TCA cycle (aka Krebs or citric acid cycle)	20	0.013	628.5
WP1600	Nicotine metabolism in liver cells	30	0.013	635
WP3	Transcriptional activation by NRF2 in response to phytochemicals	30	0.013	338.5
WP3947	Serotonin and anxiety	30	0.013	358.5
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	30	0.013	434.5
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	30	0.013	485
WP4521	Glycosylation and related congenital defects	30	0.013	556.25
WP4804	Cholesterol biosynthesis with skeletal dysplasias	30	0.013	452.5
WP4818	Conversion of angiotensinogen to angiotensin II	30	0.013	637
WP4904	LDLRAD4 and what we know about it	30	0.013	436.5
WP5074	Kallmann syndrome	30	0.013	408.5
WP80	Nucleotide GPCRs	30	0.013	641
WP100	Glutathione metabolism	2	0.012	445.25
WP1591	Heart development	2	0.012	391.5
WP2113	Type III interferon signaling	2	0.012	449.5
WP2513	Nanoparticle triggered regulated necrosis	2	0.012	437
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2	0.012	257
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2	0.012	356
WP325	Triacylglyceride synthesis	2	0.012	444.5
WP3407	FTO obesity variant mechanism	2	0.012	436
WP3874	Canonical and non-canonical TGF-B signaling	2	0.012	433.25
WP3877	MYD88 distinct input-output pathway	2	0.012	426.5
WP3965	Lipid metabolism pathway	2	0.012	434
WP4224	Purine metabolism and related disorders	2	0.012	444.25
WP428	Wnt signaling	2	0.012	197
WP4324	Mitochondrial complex I assembly model OXPHOS system	2	0.012	454.25
WP4561	Cell migration and invasion through p75NTR	2	0.012	402.5
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	2	0.012	455
WP4789	MED and pseudoachondroplasia genes	2	0.012	454
WP4927	COVID-19, thrombosis and anticoagulation	2	0.012	452.5
WP4942	15q13.3 copy number variation syndrome	2	0.012	431.25
WP134	Pentose phosphate metabolism	3	0.012	491
WP1422	Sphingolipid pathway	3	0.012	480.5
WP183	Proteasome degradation	3	0.012	459.25
WP2333	Trans-sulfuration pathway	3	0.012	484
WP2637	Interleukin-1 (IL-1) structural pathway	3	0.012	232
WP2643	Nanoparticle-mediated activation of receptor signaling	3	0.012	294
WP3596	miR-517 relationship with ARCN1 and USP1	3	0.012	438.5
WP363	Wnt signaling pathway	3	0.012	210.5
WP368	Mitochondrial long chain fatty acid beta-oxidation	3	0.012	484.5
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	3	0.012	472.5
WP3877	MYD88 distinct input-output pathway	3	0.012	451.5
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3	0.012	290.5
WP3924	Hfe effect on hepcidin production	3	0.012	476
WP3958	GPR40 pathway	3	0.012	485.25
WP428	Wnt signaling	3	0.012	204
WP4707	Aspirin and miRNAs	3	0.012	367
WP4922	Mitochondrial complex IV assembly	3	0.012	486.75
WP78	TCA cycle (aka Krebs or citric acid cycle)	3	0.012	488.5
WP80	Nucleotide GPCRs	3	0.012	486.75
WP1603	Nicotine effect on chromaffin cells	4	0.012	509
WP2895	Differentiation of white and brown adipocyte	4	0.012	464.25
WP368	Mitochondrial long chain fatty acid beta-oxidation	4	0.012	507.25
WP3875	ATR signaling	4	0.012	513
WP3924	Hfe effect on hepcidin production	4	0.012	497.5
WP4205	MET in type 1 papillary renal cell carcinoma	4	0.012	235
WP4725	Sphingolipid metabolism overview	4	0.012	499.25
WP4726	Sphingolipid metabolism: integrated pathway	4	0.012	499.25
WP4818	Conversion of angiotensinogen to angiotensin II	4	0.012	509.5
WP4846	SARS-CoV-2 and COVID-19 pathway	4	0.012	490.5
WP5037	Riboflavin and CoQ disorders	4	0.012	511.75
WP516	Hypertrophy model	4	0.012	328
WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	5	0.012	421.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	5	0.012	524.5
WP2363	Gastric cancer network 2	5	0.012	275.5
WP2643	Nanoparticle-mediated activation of receptor signaling	5	0.012	273
WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	5	0.012	486.25
WP3674	Tgif disruption of Shh signaling	5	0.012	509.5
WP3996	Ethanol effects on histone modifications	5	0.012	278
WP4205	MET in type 1 papillary renal cell carcinoma	5	0.012	244
WP4228	Vitamin B6-dependent and responsive disorders	5	0.012	533.5
WP4297	Thiamine metabolic pathways	5	0.012	524.75
WP4583	Biomarkers for urea cycle disorders	5	0.012	525.5
WP4846	SARS-CoV-2 and COVID-19 pathway	5	0.012	505
WP4942	15q13.3 copy number variation syndrome	5	0.012	391.5
WP5030	Ethylmalonic encephalopathy	5	0.012	532.5
WP516	Hypertrophy model	5	0.012	292.5
WP80	Nucleotide GPCRs	5	0.012	529.5
WP1455	Serotonin transporter activity	10	0.012	382.5
WP2640	Aripiprazole metabolic pathway	10	0.012	592
WP3679	Cell-type dependent selectivity of CCK2R signaling	10	0.012	362
WP4271	Vitamin B12 disorders	10	0.012	579
WP4564	Neural crest cell migration during development	10	0.012	280
WP734	Serotonin receptor 4/6/7 and NR3C signaling	10	0.012	365
WP80	Nucleotide GPCRs	10	0.012	583.5
WP244	Alpha 6 beta 4 signaling pathway	20	0.012	324.5
WP3874	Canonical and non-canonical TGF-B signaling	20	0.012	360
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	20	0.012	627.25
WP4269	Ethanol metabolism production of ROS by CYP2E1	20	0.012	356
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	20	0.012	473.5
WP4565	Neural crest cell migration in cancer	20	0.012	285.5
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	20	0.012	629
WP4904	LDLRAD4 and what we know about it	20	0.012	420.5
WP692	Sulfation biotransformation reaction	20	0.012	610.75
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	30	0.012	442.5
WP247	Small ligand GPCRs	30	0.012	423
WP2854	Gene regulatory network modelling somitogenesis	30	0.012	413
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	30	0.012	437.25
WP3674	Tgif disruption of Shh signaling	30	0.012	408.5
WP368	Mitochondrial long chain fatty acid beta-oxidation	30	0.012	465.25
WP3924	Hfe effect on hepcidin production	30	0.012	402
WP4236	Krebs cycle disorders	30	0.012	648
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	30	0.012	329
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	30	0.012	646.5
WP4760	PKC-gamma calcium signaling pathway in ataxia	30	0.012	375
WP4784	Proteoglycan biosynthesis	30	0.012	459.25
WP4785	Somitogenesis in the context of spondylocostal dysostosis	30	0.012	442.5
WP699	Aflatoxin B1 metabolism	30	0.012	424.5
WP134	Pentose phosphate metabolism	2	0.011	455.5
WP1425	Bone morphogenic protein (BMP) signaling and regulation	2	0.011	450
WP1528	Physiological and pathological hypertrophy of the heart	2	0.011	410
WP1589	Folate-alcohol and cancer pathway hypotheses	2	0.011	449.5
WP2290	RalA downstream regulated genes	2	0.011	450.5
WP2485	NAD biosynthesis II (from tryptophan)	2	0.011	455.25
WP2643	Nanoparticle-mediated activation of receptor signaling	2	0.011	410.5
WP2895	Differentiation of white and brown adipocyte	2	0.011	433.5
WP2911	miRNA targets in ECM and membrane receptors	2	0.011	433.25
WP3656	Interleukin-1 induced activation of NF-kB	2	0.011	435.75
WP3674	Tgif disruption of Shh signaling	2	0.011	444.5
WP3947	Serotonin and anxiety	2	0.011	427.5
WP3996	Ethanol effects on histone modifications	2	0.011	415.5
WP4191	Caloric restriction and aging	2	0.011	430
WP4210	Tryptophan catabolism leading to NAD+ production	2	0.011	454
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	2	0.011	445
WP4919	Neuroinflammation	2	0.011	425.5
WP4921	Mitochondrial complex III assembly	2	0.011	455.5
WP497	Urea cycle and metabolism of amino groups	2	0.011	447.25
WP521	Amino acid conjugation of benzoic acid	2	0.011	455
WP205	IL-7 signaling pathway	3	0.011	214
WP2366	Butyrate-induced histone acetylation	3	0.011	481
WP2839	Hair follicle development: organogenesis - part 2 of 3	3	0.011	235
WP288	Nod-like receptor (NLR) signaling pathway	3	0.011	478
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	3	0.011	446
WP3947	Serotonin and anxiety	3	0.011	441.5
WP422	MAPK cascade	3	0.011	466
WP4228	Vitamin B6-dependent and responsive disorders	3	0.011	489.5
WP4271	Vitamin B12 disorders	3	0.011	486
WP4286	Genotoxicity pathway	3	0.011	267
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	3	0.011	469
WP4815	Glycosaminoglycan degradation	3	0.011	488
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	3	0.011	470.5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	3	0.011	331
WP5038	Mitochondrial immune response to SARS-CoV-2	3	0.011	463.5
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	3	0.011	477
WP5122	Prostaglandin and leukotriene metabolism in senescence	3	0.011	281.5
WP692	Sulfation biotransformation reaction	3	0.011	487
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	4	0.011	494.75
WP311	Ketone bodies synthesis and degradation	4	0.011	513.75
WP3877	MYD88 distinct input-output pathway	4	0.011	448.5
WP22	IL-9 signaling pathway	5	0.011	497
WP2943	Hypoxia-mediated EMT and stemness	5	0.011	528.5
WP3633	Caffeine and theobromine metabolism	5	0.011	529.5
WP3679	Cell-type dependent selectivity of CCK2R signaling	5	0.011	498.75
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	5	0.011	238
WP400	p38 MAPK signaling pathway	5	0.011	257.5
WP4904	LDLRAD4 and what we know about it	5	0.011	520.25
WP4906	3q29 copy number variation syndrome	5	0.011	254
WP5074	Kallmann syndrome	5	0.011	508
WP528	Acetylcholine synthesis	5	0.011	517.5
WP247	Small ligand GPCRs	10	0.011	558
WP3596	miR-517 relationship with ARCN1 and USP1	10	0.011	314.5
WP438	Non-homologous end joining	10	0.011	578
WP4900	Purinergic signaling	10	0.011	565.5
WP497	Urea cycle and metabolism of amino groups	10	0.011	567
WP712	Estrogen signaling pathway	10	0.011	299
WP1423	Ganglio sphingolipid metabolism	20	0.011	419.5
WP3679	Cell-type dependent selectivity of CCK2R signaling	20	0.011	383
WP3938	miR-222 in exercise-induced cardiac growth	20	0.011	399
WP3940	One-carbon metabolism and related pathways	20	0.011	324
WP4586	Metabolism of alpha-linolenic acid	20	0.011	376
WP4900	Purinergic signaling	20	0.011	477
WP545	Complement activation	20	0.011	614.25
WP734	Serotonin receptor 4/6/7 and NR3C signaling	20	0.011	376.5
WP1455	Serotonin transporter activity	30	0.011	371.5
WP1602	Nicotine effect on dopaminergic neurons	30	0.011	455
WP3645	NAD+ biosynthetic pathways	30	0.011	427
WP3656	Interleukin-1 induced activation of NF-kB	30	0.011	340
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	30	0.011	330
WP4532	Intraflagellar transport proteins binding to dynein	30	0.011	636.25
WP4725	Sphingolipid metabolism overview	30	0.011	426
WP4726	Sphingolipid metabolism: integrated pathway	30	0.011	426
WP497	Urea cycle and metabolism of amino groups	30	0.011	456.5
WP205	IL-7 signaling pathway	2	0.01	246
WP2509	Nanoparticle triggered autophagic cell death	2	0.01	421.5
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	2	0.01	422
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	2	0.01	442
WP3858	Toll-like receptor signaling related to MyD88	2	0.01	432.25
WP3944	Serotonin and anxiety-related events	2	0.01	430
WP4194	Hormonal control of pubertal growth spurt	2	0.01	454.5
WP4286	Genotoxicity pathway	2	0.01	366.5
WP4288	MTHFR deficiency	2	0.01	437.25
WP438	Non-homologous end joining	2	0.01	453.5
WP4400	FABP4 in ovarian cancer	2	0.01	455
WP4595	Urea cycle and associated pathways	2	0.01	435.5
WP4722	Glycerolipids and glycerophospholipids	2	0.01	447.25
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2	0.01	441.75
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	2	0.01	440
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	2	0.01	452
WP5122	Prostaglandin and leukotriene metabolism in senescence	2	0.01	401.5
WP1602	Nicotine effect on dopaminergic neurons	3	0.01	484
WP2645	Heroin metabolism	3	0.01	489
WP2854	Gene regulatory network modelling somitogenesis	3	0.01	480
WP311	Ketone bodies synthesis and degradation	3	0.01	488.5
WP4157	GABA metabolism (aka GHB)	3	0.01	489.5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	3	0.01	213
WP4483	Relationship between inflammation, COX-2 and EGFR	3	0.01	305
WP4571	Urea cycle and related diseases	3	0.01	487.5
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3	0.01	411
WP4906	3q29 copy number variation syndrome	3	0.01	246
WP4919	Neuroinflammation	3	0.01	441.25
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	3	0.01	482
WP1455	Serotonin transporter activity	4	0.01	483
WP1992	Genes targeted by miRNAs in adipocytes	4	0.01	464.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	4	0.01	504
WP3679	Cell-type dependent selectivity of CCK2R signaling	4	0.01	483
WP3933	Kennedy pathway from sphingolipids	4	0.01	506
WP3938	miR-222 in exercise-induced cardiac growth	4	0.01	502.5
WP4707	Aspirin and miRNAs	4	0.01	299
WP4921	Mitochondrial complex III assembly	4	0.01	515.5
WP5074	Kallmann syndrome	4	0.01	497.25
WP5089	Kinin-Kallikrein pathway	4	0.01	509.5
WP1423	Ganglio sphingolipid metabolism	5	0.01	521.5
WP2007	Iron metabolism in placenta	5	0.01	518.25
WP3944	Serotonin and anxiety-related events	5	0.01	419
WP4562	Canonical NF-kB pathway	5	0.01	506.5
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	10	0.01	294
WP3944	Serotonin and anxiety-related events	10	0.01	323
WP4205	MET in type 1 papillary renal cell carcinoma	10	0.01	269.5
WP4313	Ferroptosis	10	0.01	302
WP4483	Relationship between inflammation, COX-2 and EGFR	10	0.01	298
WP4565	Neural crest cell migration in cancer	10	0.01	284
WP4742	Ketogenesis and ketolysis	10	0.01	578.5
WP4942	15q13.3 copy number variation syndrome	10	0.01	306.5
WP2597	Secretion of hydrochloric acid in parietal cells	20	0.01	627
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	20	0.01	605.25
WP3924	Hfe effect on hepcidin production	20	0.01	393.5
WP3944	Serotonin and anxiety-related events	20	0.01	373
WP4210	Tryptophan catabolism leading to NAD+ production	20	0.01	629
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	20	0.01	344
WP4905	1q21.1 copy number variation syndrome	20	0.01	356.5
WP4940	15q11.2 copy number variation syndrome	20	0.01	605.5
WP4947	Nitric oxide metabolism in cystic fibrosis	20	0.01	372
WP5037	Riboflavin and CoQ disorders	20	0.01	622.75
WP117	GPCRs, other	30	0.01	385.5
WP1992	Genes targeted by miRNAs in adipocytes	30	0.01	354
WP22	IL-9 signaling pathway	30	0.01	377
WP3670	Interactions between LOXL4 and oxidative stress pathway	30	0.01	378
WP3874	Canonical and non-canonical TGF-B signaling	30	0.01	375
WP4561	Cell migration and invasion through p75NTR	30	0.01	312
WP4788	Autosomal recessive osteopetrosis pathways	30	0.01	429.5
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	30	0.01	446
WP516	Hypertrophy model	30	0.01	325.5
WP692	Sulfation biotransformation reaction	30	0.01	438.5
WP106	Alanine and aspartate metabolism	2	0.009	452.5
WP136	Phase I biotransformations, non P450	2	0.009	453.5
WP1600	Nicotine metabolism in liver cells	2	0.009	453.5
WP1995	Effects of nitric oxide	2	0.009	438.5
WP2596	Gastric acid production	2	0.009	451.75
WP3300	Dual hijack model of Vif in HIV infection	2	0.009	442
WP3670	Interactions between LOXL4 and oxidative stress pathway	2	0.009	426.5
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2	0.009	376.75
WP3924	Hfe effect on hepcidin production	2	0.009	445.5
WP3943	Robo4 and VEGF signaling pathways crosstalk	2	0.009	433.5
WP3958	GPR40 pathway	2	0.009	450.5
WP4147	PTF1A related regulatory pathway	2	0.009	441
WP4205	MET in type 1 papillary renal cell carcinoma	2	0.009	249.5
WP4299	Lamin A-processing pathway	2	0.009	449.5
WP4707	Aspirin and miRNAs	2	0.009	415.5
WP4788	Autosomal recessive osteopetrosis pathways	2	0.009	445
WP5038	Mitochondrial immune response to SARS-CoV-2	2	0.009	432.5
WP78	TCA cycle (aka Krebs or citric acid cycle)	2	0.009	454
WP1591	Heart development	3	0.009	256.5
WP2533	Glycerophospholipid biosynthetic pathway	3	0.009	482
WP4297	Thiamine metabolic pathways	3	0.009	486
WP4589	Major receptors targeted by epinephrine and norepinephrine	3	0.009	487.5
WP4818	Conversion of angiotensinogen to angiotensin II	3	0.009	487.25
WP4872	MAP3K1 role in promoting and blocking gonadal determination	3	0.009	471.5
WP5074	Kallmann syndrome	3	0.009	475
WP167	Eicosanoid synthesis	4	0.009	414.25
WP2645	Heroin metabolism	4	0.009	513.5
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	4	0.009	472.5
WP4483	Relationship between inflammation, COX-2 and EGFR	4	0.009	281
WP4586	Metabolism of alpha-linolenic acid	4	0.009	473
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	4	0.009	508
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	4	0.009	499.5
WP127	IL-5 signaling pathway	5	0.009	251.5
WP1591	Heart development	5	0.009	256
WP311	Ketone bodies synthesis and degradation	5	0.009	531.5
WP3947	Serotonin and anxiety	5	0.009	387
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	5	0.009	521.5
WP4191	Caloric restriction and aging	5	0.009	412
WP438	Non-homologous end joining	5	0.009	527
WP4483	Relationship between inflammation, COX-2 and EGFR	5	0.009	275
WP4804	Cholesterol biosynthesis with skeletal dysplasias	5	0.009	528
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	5	0.009	526.75
WP1591	Heart development	10	0.009	297
WP3645	NAD+ biosynthetic pathways	10	0.009	565.5
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	10	0.009	573.5
WP4561	Cell migration and invasion through p75NTR	10	0.009	310
WP4846	SARS-CoV-2 and COVID-19 pathway	10	0.009	391.5
WP2366	Butyrate-induced histone acetylation	20	0.009	439.5
WP247	Small ligand GPCRs	20	0.009	386.5
WP405	Eukaryotic transcription initiation	20	0.009	468
WP4595	Urea cycle and associated pathways	20	0.009	378
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	20	0.009	357.5
WP5089	Kinin-Kallikrein pathway	20	0.009	617
WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	20	0.009	418.5
WP2290	RalA downstream regulated genes	30	0.009	419
WP4150	Wnt signaling in kidney disease	30	0.009	400
WP4210	Tryptophan catabolism leading to NAD+ production	30	0.009	644.5
WP4225	Pyrimidine metabolism and related diseases	30	0.009	406
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	30	0.009	390
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	30	0.009	365
WP4815	Glycosaminoglycan degradation	30	0.009	642.5
WP5037	Riboflavin and CoQ disorders	30	0.009	632.5
WP694	Arylamine metabolism	30	0.009	624.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	2	0.008	451.75
WP2338	miRNA biogenesis	2	0.008	454
WP247	Small ligand GPCRs	2	0.008	448
WP26	S1P receptor signal transduction	2	0.008	440
WP2645	Heroin metabolism	2	0.008	454
WP2805	exRNA mechanism of action and biogenesis	2	0.008	454
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	2	0.008	448.5
WP3679	Cell-type dependent selectivity of CCK2R signaling	2	0.008	443.5
WP4228	Vitamin B6-dependent and responsive disorders	2	0.008	455
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	2	0.008	452
WP4297	Thiamine metabolic pathways	2	0.008	451.5
WP4571	Urea cycle and related diseases	2	0.008	453
WP4586	Metabolism of alpha-linolenic acid	2	0.008	434.25
WP4815	Glycosaminoglycan degradation	2	0.008	454
WP4922	Mitochondrial complex IV assembly	2	0.008	452.75
WP5101	Congenital generalized lipodystrophy (CGL)	2	0.008	431.5
WP5121	Sphingolipid metabolism in senescence	2	0.008	394.25
WP1589	Folate-alcohol and cancer pathway hypotheses	3	0.008	483
WP2363	Gastric cancer network 2	3	0.008	288.5
WP2485	NAD biosynthesis II (from tryptophan)	3	0.008	490.75
WP2596	Gastric acid production	3	0.008	484.5
WP3875	ATR signaling	3	0.008	489
WP4205	MET in type 1 papillary renal cell carcinoma	3	0.008	214.5
WP4210	Tryptophan catabolism leading to NAD+ production	3	0.008	488.5
WP4532	Intraflagellar transport proteins binding to dynein	3	0.008	488
WP4561	Cell migration and invasion through p75NTR	3	0.008	278.5
WP4583	Biomarkers for urea cycle disorders	3	0.008	485.75
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	3	0.008	486
WP4921	Mitochondrial complex III assembly	3	0.008	490.75
WP497	Urea cycle and metabolism of amino groups	3	0.008	481.5
WP5121	Sphingolipid metabolism in senescence	3	0.008	246
WP127	IL-5 signaling pathway	4	0.008	241
WP2363	Gastric cancer network 2	4	0.008	277
WP2536	Colchicine metabolic pathway	4	0.008	508.5
WP2597	Secretion of hydrochloric acid in parietal cells	4	0.008	512
WP2816	Felbamate metabolism	4	0.008	508.5
WP3299	let-7 inhibition of ES cell reprogramming	4	0.008	312
WP3596	miR-517 relationship with ARCN1 and USP1	4	0.008	418.5
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	4	0.008	374
WP3674	Tgif disruption of Shh signaling	4	0.008	492
WP3874	Canonical and non-canonical TGF-B signaling	4	0.008	465.5
WP4159	GABA receptor signaling	4	0.008	508.5
WP4561	Cell migration and invasion through p75NTR	4	0.008	258
WP4562	Canonical NF-kB pathway	4	0.008	492
WP4595	Urea cycle and associated pathways	4	0.008	484.5
WP4904	LDLRAD4 and what we know about it	4	0.008	506.5
WP4906	3q29 copy number variation syndrome	4	0.008	250
WP5119	NIPBL role in DNA damage - Cornelia de Lange syndrome	4	0.008	509.5
WP528	Acetylcholine synthesis	4	0.008	501.25
WP2253	Pilocytic astrocytoma	5	0.008	523.25
WP2597	Secretion of hydrochloric acid in parietal cells	5	0.008	530
WP3645	NAD+ biosynthetic pathways	5	0.008	517.5
WP3655	Hypothetical craniofacial development pathway	5	0.008	521.25
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	5	0.008	296.5
WP422	MAPK cascade	5	0.008	483.5
WP4504	Cysteine and methionine catabolism	5	0.008	517
WP4586	Metabolism of alpha-linolenic acid	5	0.008	477.5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5	0.008	258.5
WP4900	Purinergic signaling	5	0.008	515.5
WP5037	Riboflavin and CoQ disorders	5	0.008	529
WP694	Arylamine metabolism	5	0.008	527.5
WP2290	RalA downstream regulated genes	10	0.008	574
WP3299	let-7 inhibition of ES cell reprogramming	10	0.008	293
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	10	0.008	286
WP4966	Fluoroacetic acid toxicity	10	0.008	585
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	10	0.008	544.5
WP22	IL-9 signaling pathway	20	0.008	354
WP4194	Hormonal control of pubertal growth spurt	20	0.008	632.25
WP4507	Molybdenum cofactor (Moco) biosynthesis	20	0.008	626
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	20	0.008	385
WP2338	miRNA biogenesis	30	0.008	640.5
WP2513	Nanoparticle triggered regulated necrosis	30	0.008	367
WP2805	exRNA mechanism of action and biogenesis	30	0.008	640.5
WP3944	Serotonin and anxiety-related events	30	0.008	383.5
WP422	MAPK cascade	30	0.008	416.5
WP4504	Cysteine and methionine catabolism	30	0.008	416.5
WP4966	Fluoroacetic acid toxicity	30	0.008	636.5
WP528	Acetylcholine synthesis	30	0.008	379
WP22	IL-9 signaling pathway	2	0.007	439.75
WP3596	miR-517 relationship with ARCN1 and USP1	2	0.007	422
WP3640	Imatinib and chronic myeloid leukemia	2	0.007	244
WP3871	Valproic acid pathway	2	0.007	453.5
WP400	p38 MAPK signaling pathway	2	0.007	391.5
WP4159	GABA receptor signaling	2	0.007	452
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	2	0.007	451.5
WP4583	Biomarkers for urea cycle disorders	2	0.007	452
WP4784	Proteoglycan biosynthesis	2	0.007	453
WP4861	Endoplasmic reticulum stress response in coronavirus infection	2	0.007	415
WP5030	Ethylmalonic encephalopathy	2	0.007	455
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	2	0.007	445
WP690	Polyol pathway	2	0.007	454
WP712	Estrogen signaling pathway	2	0.007	393.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	3	0.007	485.5
WP2338	miRNA biogenesis	3	0.007	488.5
WP2805	exRNA mechanism of action and biogenesis	3	0.007	488.5
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	3	0.007	485
WP3891	Benzene metabolism	3	0.007	482
WP3944	Serotonin and anxiety-related events	3	0.007	448.5
WP4595	Urea cycle and associated pathways	3	0.007	466.75
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	3	0.007	253
WP4928	MAPK pathway in congenital thyroid cancer	3	0.007	267.5
WP712	Estrogen signaling pathway	3	0.007	279.5
WP1423	Ganglio sphingolipid metabolism	4	0.007	504.5
WP247	Small ligand GPCRs	4	0.007	500
WP3944	Serotonin and anxiety-related events	4	0.007	449.5
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	4	0.007	504
WP4191	Caloric restriction and aging	4	0.007	450.25
WP4271	Vitamin B12 disorders	4	0.007	508.25
WP4532	Intraflagellar transport proteins binding to dynein	4	0.007	513
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	4	0.007	258
WP80	Nucleotide GPCRs	4	0.007	511.25
WP167	Eicosanoid synthesis	5	0.007	345.5
WP2854	Gene regulatory network modelling somitogenesis	5	0.007	514.5
WP3299	let-7 inhibition of ES cell reprogramming	5	0.007	277
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	5	0.007	455.5
WP3596	miR-517 relationship with ARCN1 and USP1	5	0.007	374
WP3933	Kennedy pathway from sphingolipids	5	0.007	523.5
WP4159	GABA receptor signaling	5	0.007	520
WP4564	Neural crest cell migration during development	5	0.007	261
WP4565	Neural crest cell migration in cancer	5	0.007	263
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	5	0.007	493.75
WP4784	Proteoglycan biosynthesis	5	0.007	525.25
WP4788	Autosomal recessive osteopetrosis pathways	5	0.007	511.5
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	5	0.007	526.5
WP127	IL-5 signaling pathway	10	0.007	272
WP2338	miRNA biogenesis	10	0.007	586.5
WP2805	exRNA mechanism of action and biogenesis	10	0.007	586.5
WP3674	Tgif disruption of Shh signaling	10	0.007	388
WP4159	GABA receptor signaling	10	0.007	572.5
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	10	0.007	574.25
WP4589	Major receptors targeted by epinephrine and norepinephrine	10	0.007	579.5
WP4595	Urea cycle and associated pathways	10	0.007	368
WP4707	Aspirin and miRNAs	10	0.007	284
WP694	Arylamine metabolism	10	0.007	582.5
WP3645	NAD+ biosynthetic pathways	20	0.007	403.5
WP4742	Ketogenesis and ketolysis	20	0.007	617
WP80	Nucleotide GPCRs	20	0.007	625.5
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	30	0.007	403.5
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	30	0.007	420
WP4792	Purine metabolism	30	0.007	444.5
WP4799	Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV spike protein	30	0.007	625.5
WP4942	15q13.3 copy number variation syndrome	30	0.007	367
WP4947	Nitric oxide metabolism in cystic fibrosis	30	0.007	383
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	30	0.007	421
WP734	Serotonin receptor 4/6/7 and NR3C signaling	30	0.007	390
WP2597	Secretion of hydrochloric acid in parietal cells	2	0.006	453.5
WP2637	Interleukin-1 (IL-1) structural pathway	2	0.006	273
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	2	0.006	452
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	2	0.006	455
WP368	Mitochondrial long chain fatty acid beta-oxidation	2	0.006	451.5
WP3933	Kennedy pathway from sphingolipids	2	0.006	452.5
WP422	MAPK cascade	2	0.006	437
WP4533	Transcription co-factors SKI and SKIL protein partners	2	0.006	445.5
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	2	0.006	441
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	2	0.006	403
WP4900	Purinergic signaling	2	0.006	448.5
WP4966	Fluoroacetic acid toxicity	2	0.006	453.5
WP80	Nucleotide GPCRs	2	0.006	453.25
WP1423	Ganglio sphingolipid metabolism	3	0.006	481.75
WP2290	RalA downstream regulated genes	3	0.006	486
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	3	0.006	474.5
WP2597	Secretion of hydrochloric acid in parietal cells	3	0.006	488.5
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	3	0.006	482
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	3	0.006	486
WP4504	Cysteine and methionine catabolism	3	0.006	484.5
WP4792	Purine metabolism	3	0.006	486.5
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	3	0.006	486.5
WP5103	Progeria-associated lipodystrophy	3	0.006	423.75
WP2253	Pilocytic astrocytoma	4	0.006	507.5
WP2854	Gene regulatory network modelling somitogenesis	4	0.006	504.5
WP3645	NAD+ biosynthetic pathways	4	0.006	501.5
WP4210	Tryptophan catabolism leading to NAD+ production	4	0.006	511.5
WP4927	COVID-19, thrombosis and anticoagulation	4	0.006	509.5
WP4928	MAPK pathway in congenital thyroid cancer	4	0.006	252
WP545	Complement activation	4	0.006	509.5
WP692	Sulfation biotransformation reaction	4	0.006	510
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	5	0.006	509.5
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	5	0.006	478
WP3891	Benzene metabolism	5	0.006	516.25
WP4210	Tryptophan catabolism leading to NAD+ production	5	0.006	530.5
WP692	Sulfation biotransformation reaction	5	0.006	528
WP712	Estrogen signaling pathway	5	0.006	272
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	10	0.006	587
WP2854	Gene regulatory network modelling somitogenesis	10	0.006	560
WP2943	Hypoxia-mediated EMT and stemness	10	0.006	583
WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	10	0.006	586.5
WP422	MAPK cascade	10	0.006	366.5
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	10	0.006	589.25
WP4792	Purine metabolism	10	0.006	574.5
WP4804	Cholesterol biosynthesis with skeletal dysplasias	10	0.006	582.5
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	10	0.006	575.25
WP136	Phase I biotransformations, non P450	20	0.006	620.5
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	20	0.006	362.5
WP422	MAPK cascade	20	0.006	392
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	20	0.006	607.25
WP4561	Cell migration and invasion through p75NTR	20	0.006	326.5
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	20	0.006	610.5
WP136	Phase I biotransformations, non P450	30	0.006	636.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	30	0.006	378.5
WP405	Eukaryotic transcription initiation	30	0.006	442.5
WP4742	Ketogenesis and ketolysis	30	0.006	515
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	30	0.006	375.5
WP4905	1q21.1 copy number variation syndrome	30	0.006	395
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	30	0.006	476.25
WP5050	TCA cycle in senescence	30	0.006	392
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	30	0.006	427
WP2491	Diclofenac metabolic pathway	2	0.005	454
WP2854	Gene regulatory network modelling somitogenesis	2	0.005	449
WP4483	Relationship between inflammation, COX-2 and EGFR	2	0.005	405
WP4742	Ketogenesis and ketolysis	2	0.005	452.5
WP4818	Conversion of angiotensinogen to angiotensin II	2	0.005	453.5
WP4846	SARS-CoV-2 and COVID-19 pathway	2	0.005	442.5
WP678	Arachidonate epoxygenase / epoxide hydrolase	2	0.005	450.25
WP22	IL-9 signaling pathway	3	0.005	472.5
WP3933	Kennedy pathway from sphingolipids	3	0.005	483
WP400	p38 MAPK signaling pathway	3	0.005	298
WP4725	Sphingolipid metabolism overview	3	0.005	479.5
WP4726	Sphingolipid metabolism: integrated pathway	3	0.005	479.5
WP4927	COVID-19, thrombosis and anticoagulation	3	0.005	486
WP528	Acetylcholine synthesis	3	0.005	483.25
WP136	Phase I biotransformations, non P450	4	0.005	511
WP2249	Metastatic brain tumor	4	0.005	279.5
WP2366	Butyrate-induced histone acetylation	4	0.005	507
WP4521	Glycosylation and related congenital defects	4	0.005	510.5
WP4565	Neural crest cell migration in cancer	4	0.005	246
WP4589	Major receptors targeted by epinephrine and norepinephrine	4	0.005	510.75
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	4	0.005	358.5
WP690	Polyol pathway	4	0.005	513
WP712	Estrogen signaling pathway	4	0.005	263
WP2290	RalA downstream regulated genes	5	0.005	525.5
WP2338	miRNA biogenesis	5	0.005	529.5
WP2805	exRNA mechanism of action and biogenesis	5	0.005	529.5
WP3529	Zinc homeostasis	5	0.005	528.5
WP4030	SCFA and skeletal muscle substrate metabolism	5	0.005	516.5
WP4271	Vitamin B12 disorders	5	0.005	525
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	5	0.005	350
WP4561	Cell migration and invasion through p75NTR	5	0.005	271.5
WP4595	Urea cycle and associated pathways	5	0.005	493
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	5	0.005	304
WP4792	Purine metabolism	5	0.005	525.25
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	5	0.005	525.5
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	5	0.005	485
WP5089	Kinin-Kallikrein pathway	5	0.005	527
WP136	Phase I biotransformations, non P450	10	0.005	582.25
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	10	0.005	344.5
WP405	Eukaryotic transcription initiation	10	0.005	570.25
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	10	0.005	579
WP4521	Glycosylation and related congenital defects	10	0.005	579.5
WP4788	Autosomal recessive osteopetrosis pathways	10	0.005	544.25
WP4940	15q11.2 copy number variation syndrome	10	0.005	578.5
WP1995	Effects of nitric oxide	20	0.005	355
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	20	0.005	364
WP311	Ketone bodies synthesis and degradation	20	0.005	630.5
WP3674	Tgif disruption of Shh signaling	20	0.005	394
WP4271	Vitamin B12 disorders	20	0.005	615
WP4342	Vitamins A and D - action mechanisms	20	0.005	338.5
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	20	0.005	399.5
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	30	0.005	368
WP4688	Serine metabolism	30	0.005	451
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	2	0.004	444.5
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	2	0.004	440.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	2	0.004	424
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	2	0.004	414.5
WP5074	Kallmann syndrome	2	0.004	445
WP528	Acetylcholine synthesis	2	0.004	449.5
WP136	Phase I biotransformations, non P450	3	0.004	488
WP2249	Metastatic brain tumor	3	0.004	319.5
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	3	0.004	480.75
WP3299	let-7 inhibition of ES cell reprogramming	3	0.004	380.5
WP3529	Zinc homeostasis	3	0.004	487.5
WP4159	GABA receptor signaling	3	0.004	486.25
WP4788	Autosomal recessive osteopetrosis pathways	3	0.004	475.5
WP4846	SARS-CoV-2 and COVID-19 pathway	3	0.004	473.5
WP4900	Purinergic signaling	3	0.004	482
WP4904	LDLRAD4 and what we know about it	3	0.004	484.5
WP5030	Ethylmalonic encephalopathy	3	0.004	490.75
WP690	Polyol pathway	3	0.004	488
WP1589	Folate-alcohol and cancer pathway hypotheses	4	0.004	502.5
WP2290	RalA downstream regulated genes	4	0.004	507.5
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	4	0.004	507.5
WP422	MAPK cascade	4	0.004	475.5
WP4504	Cysteine and methionine catabolism	4	0.004	502
WP4564	Neural crest cell migration during development	4	0.004	246
WP4784	Proteoglycan biosynthesis	4	0.004	508
WP4785	Somitogenesis in the context of spondylocostal dysostosis	4	0.004	510.25
WP4940	15q11.2 copy number variation syndrome	4	0.004	508
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	4	0.004	476
WP2536	Colchicine metabolic pathway	5	0.004	524.5
WP2645	Heroin metabolism	5	0.004	531.75
WP2816	Felbamate metabolism	5	0.004	524.5
WP3300	Dual hijack model of Vif in HIV infection	5	0.004	497.5
WP3924	Hfe effect on hepcidin production	5	0.004	511
WP4532	Intraflagellar transport proteins binding to dynein	5	0.004	529
WP4589	Major receptors targeted by epinephrine and norepinephrine	5	0.004	524.5
WP545	Complement activation	5	0.004	525
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	10	0.004	409.5
WP2597	Secretion of hydrochloric acid in parietal cells	10	0.004	585.5
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	10	0.004	574.25
WP4507	Molybdenum cofactor (Moco) biosynthesis	10	0.004	585
WP4815	Glycosaminoglycan degradation	10	0.004	583.5
WP4818	Conversion of angiotensinogen to angiotensin II	10	0.004	581.5
WP4947	Nitric oxide metabolism in cystic fibrosis	10	0.004	397
WP5089	Kinin-Kallikrein pathway	10	0.004	579.5
WP3596	miR-517 relationship with ARCN1 and USP1	20	0.004	339.5
WP4942	15q13.3 copy number variation syndrome	20	0.004	369.5
WP4927	COVID-19, thrombosis and anticoagulation	30	0.004	635
WP5089	Kinin-Kallikrein pathway	30	0.004	570.25
WP311	Ketone bodies synthesis and degradation	2	0.003	455
WP4582	Cancer immunotherapy by CTLA4 blockade	2	0.003	441.75
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	2	0.003	379
WP4906	3q29 copy number variation syndrome	2	0.003	383.25
WP4928	MAPK pathway in congenital thyroid cancer	2	0.003	397
WP127	IL-5 signaling pathway	3	0.003	231.5
WP247	Small ligand GPCRs	3	0.003	480.75
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	3	0.003	464
WP3300	Dual hijack model of Vif in HIV infection	3	0.003	474
WP3645	NAD+ biosynthetic pathways	3	0.003	481.25
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	3	0.003	485.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	3	0.003	448.5
WP4966	Fluoroacetic acid toxicity	3	0.003	488
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	3	0.003	463.5
WP2338	miRNA biogenesis	4	0.003	513
WP2805	exRNA mechanism of action and biogenesis	4	0.003	513
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	4	0.003	507.5
WP3300	Dual hijack model of Vif in HIV infection	4	0.003	491.5
WP4030	SCFA and skeletal muscle substrate metabolism	4	0.003	503
WP405	Eukaryotic transcription initiation	4	0.003	504.5
WP4788	Autosomal recessive osteopetrosis pathways	4	0.003	494
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	4	0.003	509.5
WP5030	Ethylmalonic encephalopathy	4	0.003	516.25
WP136	Phase I biotransformations, non P450	5	0.003	529
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	5	0.003	522.75
WP405	Eukaryotic transcription initiation	5	0.003	519
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	5	0.003	527
WP4521	Glycosylation and related congenital defects	5	0.003	529.5
WP4815	Glycosaminoglycan degradation	5	0.003	528.75
WP4818	Conversion of angiotensinogen to angiotensin II	5	0.003	526.75
WP4940	15q11.2 copy number variation syndrome	5	0.003	524
WP5050	TCA cycle in senescence	5	0.003	496.5
WP4927	COVID-19, thrombosis and anticoagulation	10	0.003	583
WP2826	Cocaine metabolism	20	0.003	604.5
WP4788	Autosomal recessive osteopetrosis pathways	20	0.003	405
WP2249	Metastatic brain tumor	2	0.002	397.5
WP2533	Glycerophospholipid biosynthetic pathway	2	0.002	450.5
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	2	0.002	432.75
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	2	0.002	435.5
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	2	0.002	443
WP3674	Tgif disruption of Shh signaling	3	0.002	476
WP4742	Ketogenesis and ketolysis	3	0.002	486.5
WP4784	Proteoglycan biosynthesis	3	0.002	486
WP3891	Benzene metabolism	4	0.002	502.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	4	0.002	388.5
WP4507	Molybdenum cofactor (Moco) biosynthesis	4	0.002	513
WP4792	Purine metabolism	4	0.002	509
WP4900	Purinergic signaling	4	0.002	503.5
WP4966	Fluoroacetic acid toxicity	4	0.002	511.5
WP5050	TCA cycle in senescence	4	0.002	482
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	4	0.002	485.5
WP2366	Butyrate-induced histone acetylation	5	0.002	521.5
WP247	Small ligand GPCRs	5	0.002	517
WP4742	Ketogenesis and ketolysis	5	0.002	526.5
WP4785	Somitogenesis in the context of spondylocostal dysostosis	5	0.002	525.75
WP4927	COVID-19, thrombosis and anticoagulation	5	0.002	526.25
WP4928	MAPK pathway in congenital thyroid cancer	5	0.002	260.5
WP2889	Oxytocin signaling	10	0.002	586.5
WP3300	Dual hijack model of Vif in HIV infection	10	0.002	369
WP4210	Tryptophan catabolism leading to NAD+ production	10	0.002	586.75
WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	10	0.002	590
WP5030	Ethylmalonic encephalopathy	10	0.002	592
WP4792	Purine metabolism	20	0.002	605.25
WP2597	Secretion of hydrochloric acid in parietal cells	30	0.002	645
WP3679	Cell-type dependent selectivity of CCK2R signaling	30	0.002	401.5
WP4507	Molybdenum cofactor (Moco) biosynthesis	30	0.002	644.5
WP3299	let-7 inhibition of ES cell reprogramming	2	0.001	410
WP3645	NAD+ biosynthetic pathways	2	0.001	448.25
WP405	Eukaryotic transcription initiation	2	0.001	450
WP4931	Direct reversal repair	2	0.001	455
WP405	Eukaryotic transcription initiation	3	0.001	482.25
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	3	0.001	469.5
WP4299	Lamin A-processing pathway	3	0.001	482.25
WP5050	TCA cycle in senescence	3	0.001	469
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	3	0.001	468.75
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	4	0.001	483
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	4	0.001	508
WP2249	Metastatic brain tumor	5	0.001	278
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	5	0.001	497
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	5	0.001	524
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	5	0.001	526
WP4966	Fluoroacetic acid toxicity	5	0.001	529
WP311	Ketone bodies synthesis and degradation	10	0.001	589
WP3633	Caffeine and theobromine metabolism	10	0.001	587
WP5050	TCA cycle in senescence	10	0.001	366
WP5065	SARS-CoV-2 altering angiogenesis via NRP1	10	0.001	348.5
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	10	0.001	364
WP3300	Dual hijack model of Vif in HIV infection	30	0.001	449.5
WP3940	One-carbon metabolism and related pathways	30	0.001	354
WP127	IL-5 signaling pathway	2	0	231.5
WP1438	Influenza A virus infection	2	0	433.5
WP4153	Degradation pathway of sphingolipids, including diseases	2	0	455
WP4506	Tyrosine metabolism	2	0	455
WP4507	Molybdenum cofactor (Moco) biosynthesis	2	0	454
WP4918	Cellular proteostasis	2	0	455
WP5050	TCA cycle in senescence	2	0	440
WP1438	Influenza A virus infection	3	0	461.75
WP4153	Degradation pathway of sphingolipids, including diseases	3	0	490
WP4506	Tyrosine metabolism	3	0	490
WP4507	Molybdenum cofactor (Moco) biosynthesis	3	0	488.5
WP4918	Cellular proteostasis	3	0	490
WP4931	Direct reversal repair	3	0	490
WP1438	Influenza A virus infection	4	0	465.75
WP3529	Zinc homeostasis	4	0	511.5
WP4153	Degradation pathway of sphingolipids, including diseases	4	0	515
WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	4	0	508
WP4299	Lamin A-processing pathway	4	0	505.5
WP4506	Tyrosine metabolism	4	0	515
WP4742	Ketogenesis and ketolysis	4	0	509.5
WP4918	Cellular proteostasis	4	0	515
WP4931	Direct reversal repair	4	0	515.5
WP1438	Influenza A virus infection	5	0	484
WP4153	Degradation pathway of sphingolipids, including diseases	5	0	532.5
WP4299	Lamin A-processing pathway	5	0	520
WP4506	Tyrosine metabolism	5	0	532.5
WP4507	Molybdenum cofactor (Moco) biosynthesis	5	0	529.75
WP4918	Cellular proteostasis	5	0	532.5
WP4931	Direct reversal repair	5	0	533.25
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	5	0	499.25
WP1438	Influenza A virus infection	10	0	357.5
WP2536	Colchicine metabolic pathway	10	0	575.75
WP2645	Heroin metabolism	10	0	588.25
WP2816	Felbamate metabolism	10	0	575.75
WP4153	Degradation pathway of sphingolipids, including diseases	10	0	592
WP4194	Hormonal control of pubertal growth spurt	10	0	592
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	10	0	381.5
WP4299	Lamin A-processing pathway	10	0	570.5
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	10	0	287
WP4506	Tyrosine metabolism	10	0	592
WP4918	Cellular proteostasis	10	0	592
WP4931	Direct reversal repair	10	0	592.5
WP661	Glucose homeostasis	10	0	585.5
WP134	Pentose phosphate metabolism	20	0	635
WP1438	Influenza A virus infection	20	0	385
WP2485	NAD biosynthesis II (from tryptophan)	20	0	635
WP2536	Colchicine metabolic pathway	20	0	604.5
WP2640	Aripiprazole metabolic pathway	20	0	631.5
WP2645	Heroin metabolism	20	0	629.5
WP2816	Felbamate metabolism	20	0	604.5
WP2846	PCSK9-mediated LDL receptor degradation	20	0	422
WP2889	Oxytocin signaling	20	0	628
WP3300	Dual hijack model of Vif in HIV infection	20	0	411
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	20	0	635
WP3408	Evolocumab mechanism to reduce LDL cholesterol	20	0	422
WP4153	Degradation pathway of sphingolipids, including diseases	20	0	633.5
WP4228	Vitamin B6-dependent and responsive disorders	20	0	634.5
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	20	0	403
WP4299	Lamin A-processing pathway	20	0	416
WP4317	Mitochondrial fatty acid synthesis pathway	20	0	631
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	20	0	631
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	20	0	243
WP4400	FABP4 in ovarian cancer	20	0	634.5
WP4506	Tyrosine metabolism	20	0	633.5
WP4918	Cellular proteostasis	20	0	633.5
WP4921	Mitochondrial complex III assembly	20	0	634.5
WP4931	Direct reversal repair	20	0	634
WP5030	Ethylmalonic encephalopathy	20	0	633.5
WP5050	TCA cycle in senescence	20	0	379
WP521	Amino acid conjugation of benzoic acid	20	0	632
WP661	Glucose homeostasis	20	0	624
WP733	Serotonin receptor 2 and STAT3 signaling	20	0	456
WP134	Pentose phosphate metabolism	30	0	651.75
WP1438	Influenza A virus infection	30	0	418
WP1495	Glycine metabolism	30	0	640.5
WP2366	Butyrate-induced histone acetylation	30	0	415
WP2485	NAD biosynthesis II (from tryptophan)	30	0	651
WP2536	Colchicine metabolic pathway	30	0	411
WP2640	Aripiprazole metabolic pathway	30	0	648
WP2645	Heroin metabolism	30	0	647.5
WP2646	Lidocaine metabolism	30	0	424.5
WP2816	Felbamate metabolism	30	0	411
WP2826	Cocaine metabolism	30	0	420
WP2846	PCSK9-mediated LDL receptor degradation	30	0	442.5
WP2889	Oxytocin signaling	30	0	644
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	30	0	651
WP3408	Evolocumab mechanism to reduce LDL cholesterol	30	0	442.5
WP3596	miR-517 relationship with ARCN1 and USP1	30	0	331
WP4030	SCFA and skeletal muscle substrate metabolism	30	0	385
WP4153	Degradation pathway of sphingolipids, including diseases	30	0	650
WP4174	Metabolism of tetrahydrocannabinol (THC)	30	0	446
WP4228	Vitamin B6-dependent and responsive disorders	30	0	651.75
WP4284	Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer	30	0	432
WP4299	Lamin A-processing pathway	30	0	411
WP4317	Mitochondrial fatty acid synthesis pathway	30	0	648
WP4342	Vitamins A and D - action mechanisms	30	0	347
WP4397	Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors	30	0	648
WP4399	MicroRNA network associated with chronic lymphocytic leukemia	30	0	233
WP4400	FABP4 in ovarian cancer	30	0	651
WP4506	Tyrosine metabolism	30	0	650
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	30	0	415.5
WP4918	Cellular proteostasis	30	0	650
WP4921	Mitochondrial complex III assembly	30	0	651.5
WP4931	Direct reversal repair	30	0	650
WP4940	15q11.2 copy number variation syndrome	30	0	420
WP5030	Ethylmalonic encephalopathy	30	0	650.5
WP521	Amino acid conjugation of benzoic acid	30	0	649.5
WP661	Glucose homeostasis	30	0	641
WP733	Serotonin receptor 2 and STAT3 signaling	30	0	405.5
